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Abstract
Alzheimer's disease (AD) is hallmarked by the presence o fn eurofibrillary tangles and
amylo id-]!plaques. Amyloid-I I plaques consist of the amyloid-f) peptide (AI)) that has
been shown to inducetoxieclkctsonneurons through theactivationofstress-re lated
signalling and neuronal loss. The small heat shock protein. IIspBl (a lso referred to as
Hsp27 and Hsp25 in mouse). is accumu lated in 15% o fn eocort ical amyloid-]! plaques in
AD brains (Wi lhclmus. 2( 06). Whether this represents a potentially protective response
to stress. or is part of the disease process is unknown . We have previousl y reported that
expression of IlspB I not only protects co rt ica l neurons against amyloid tox icity. but also
enhances total neurite growth in these neurons ( King £'1 al.. 2( 09 ).
The amylo id-f) peptide is derived from the proteolyt ic processing of the Amyloid
Precursor Protein (API') by f)-and y-sccrctascs. Mutations in API' alter secretase
cleavage sites. resulting in higher production of the toxic Af)( 1-42) peptide that
undergoes aggregation more readily. Since Hspl3l has been shown to protect neurons
against amylo id toxicit y. it is conceivable that HspB 1 may interact directly with AI) or
API'. Recent studies have demonstrated exogenous IlspB I binding to synthetic Afl. We
have replicated these results in an attempt to determine the roleof HspBI in the inclusion
of AI)aggregates. We hypothesize that Hspl3l interacts with Aft or its precursor API'. to
either alter the distribution of AfVAl'1' within the cell. or its release from the cell.

In order to test our hypot hesis, we incubated His-tugged HspBI with synthetic Afl( 1-42).
at physio logica l temperature 37°C overnight . lmmunoprccipitation. using agarosc
protein A /G beads incubated with the monoclonal ant i-His primary antibody. was used
fill ' our primary analysis ofinteraction. Western blotting ofthe nitrocellulose membrane.
using the 6E lOp -amylo id ( 1-16) mouse monoclona l antibody. demonstrates that All is
immunoprccipit atcd with His-HspB I, These results point to a direct interactio n between
IlspB1 and A[l(1-42). Wc investigatcd the interaction of HspB I with API' in II EK293
cell line express ing wild-type API' (AI'I' -wl) or AI'I'-swcdish mutation (AI'I' -swcl that
predom inately yields AII(1-42) through immunoprccipitation, His-tugged HspB I was
incubated with the conditioned media fro m the AI' I'-wt and AI'I'-swc cells overnig ht at
37°C. lmmunoprccipitai ion was performed using magnetic protein A /G beads incubated
with either 6E 10 p-amyloid ( 1-16) mouse monoclona l antibod y. or anti-HspB I human
(SI'A-XOJ)rabbit polyclonal antibody. Subsequent western blotting oft he nitrocellulose
memb rane using the 6E I0 and the XOJantibodics demonstrate that API' is
immunoprccipitatcd with His-HspB I.
These data suggest lispS I. perhaps via its chaperone activit y. may he altering productio n
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1.1 Familia l Alzheimer's Disease
In 25 years. the now 500.000 Canadians a ffected by AD will double as the first "ba by
boomer" turns 65 this year. Hcalthcarc costs will increase tenfold from S15 million per
annum to S153 million . While the well-known sporadic limn is more common. 4-5'X, or
the repo rted AD cases arc under age 65 presenting with the familial form of AD.
Diagnosis in these genetically predisposed individuals can occur as young as 30 years of
age (www.alzheimer.ca). Early - onset Familial AD (FAD) symptomatically present s
indistinguishab ly from sporadic or late-onset Alzheimer' s disease (SAD) . Clinically.
both arc characterized by progressive neuronal deterioration resulting in loss o fme mory,
spatial or ientat ion. language defic its. mood as well as personality changes (Morris ct al..
19X9). Physiologically however . there exist differences in disease origin between AD
types. FAD is an autosomal domin ant genetic form of AD. OCCUlTing through mutations
that usually result in increased deposition of the cytotoxic Amyloid beta I-·Q (A]] 1-42)
liagmcnt (A. Eckert ct al.. 2003 : A. Eckert. Marques, Kcil, Schusscl, & Muller. 2003:
Citron ct al., 19l)2 : Weidemann ct al., 1( 97). Three well studied mutations identified in
FAD arc: I) prcscnilin- I on chromosome 14 (Alzheimer's Disease Collaborative Group .
1( 95) . 2) presenilin- Z on chromosome I (Lcvy-Lahad ct al., 1(95) and 3) Amyloid
Precursor Protein (API') on chromo some 2 1 (R. E. Tanzi ct al.. ] 9X7) accounting tor 2%
ofal l FAD cases (Q ucrfurth ct al.. 1(9 5). Triso my-Z l cases arc shown to exhibit FAD
pathology, asso ciating an extra co py ofthe APr gcne with deve lopment o r FAD
(Q ucrfurth, Wijsman, St Geo rge- Hyslop, & Se lkoe, 1( 95).
A major facto r in FAD comm on to all mutations is an altera tion in All genera tion or
cleara nce (Goa tc et al.. 1( 91) . Oft he 2 \ API' allelic mutations ide nti fied, all occur
within or immed iately borderin g on the A[l coding region (Goatc ct al.. \(91) suggesting
that A[l plays a central role in AD pathogenesis (A. Eckert ct al.. 20(3 ). Mutations with in
the All sequence influence aggregation ofA ]] by disturbing the structure ofthe
accum ulated peptide (Mori.C. 2( 02) . Mutat ions bordering on the A[l cod ing region
increase All product ion by affecting API' processing, favouring the amy loidogcnic II
pathway (See Figure 1.3) (Cai, Golde, & Younkin , 1993: Citron ct al.. 1996: Mori ct al..
2(02). Certa in populations appear to be exc lusive Ill!' individual mutation s. For
example, in my research I have specifically focused on the so-called Swedi sh mutation .
The Swedish double mutation consists of substitutions of the Lysh711 and Mcth71residue s
with Asn and Leu preceding the H ~ term inus o r A[I. yield ing a 5-X fold increase in
aggregate prone All (1-42 ) production through enhanced API' vulnerability to ll-secretase
cleavage (C itron et al.. 1992: Schcuncr, Eckman, Jensen, Song, Citron, Suzuki, Bird,
Hardy, Hulton , Kukull, Larson ct a l.. 1996: M. Mullan ct ul., 1992a) . The propens ity or
A[l( 1-42) to agg regate and form plaques that degenera te neurons is the focal point ofthe
amyloid hypoth esis, one o f the proposed prerequi sites of AD.
1.2 C ur rent Hyp othe ses
Three hypotheses arc sugg es ted to account Ill! ' the patho genesis of AD wit h each
bein g exten sivel y studied as the prim ar y insu lt that initiate s the disea se . C urrently. it
appea rs AI3acc um ulation is pre sent init ially . 1()IIO\\ed by tau hypcrphospho rylation, in
co njunc t ion with inflam mato ry res po nses that create a co nt inuum of ins ults. resu lt ing in a
disease state.
1.2.1 Amyloid Cascade Hypo thesis
T he Amy lo id Cas ca de Hypothes is (Figu re 1.1) was int rodu ced in 1992 so o n allcr
the 1\ 13pepti de was found to be the pr imar y co mpo nent ofseni le plaqu es (SP s) believed
to be one of the path ogenic lesion s found in AD brain s (Ma ster s ct a l., 19X5). T his
prop osed that All accumulation wa s the crucial mea sure of AD pathology (J . A. lIardy 8:
Higgin s. 1( 92). T hc di scovery that AI3 was a prod uct of API' meta bo lism (Sclkoc.
2006a) and that mut ation s wit hin A PI' a lte red AI3depo sit ion (H aass ct al., 1992: Se ubert
ct a l., 1992 : Haass.C . 1( 92 ). furt her streng thened the case fix Af3 bein g at the cor e of A D.
Adva nces in thc sequence o fe ve nts in dementia pathology have o ffered suppor t to
T he Amy lo id Cascade Hypo thes is. First ly. an a lterna te limn o fdementia, Fro nto tempo ra l
dementia with Parkinson ism (FTD I') . is characterized by ta u neuro fibrillary tang les
s imila r to tho se found in A D. yet AI3 plaque s arc absent (Goedert , C ro wther. 8:
Spi llantini. 199X). T his sugg cs ts that severe tau misfoklin g is not su ffic ien t to tr igger the
fornmtion ofS l' s found in A D. Seco nd ly. t ransgenic mice o vcrcx prcssi ng bo th mutant
API' and mutant tau exhibit escalated neurofibrill ary tangles in comparison to mice
overcxprcss ing mutant tau alone (1. Lewis ct al.. 2( 0 1) suggesting API' mutations as an
enhancer of further neuro-toxic insults. Th irdly. recent evidence has shown All d imers
generate tau hyperposphorylation causing neurite degenerat ion (Jin, Shepardson. Yang.
Chen. Walsh. & Sclkoc, 20 1Ia). Lastly. a buildup of l\[l is observed in the brain before
symptoms arise (D. M. Walsh. Klyubin. Fadeeva. Rowan. & Sclkoc, 2(02 ) suggesting
that All accumulation precedes clinical signs of AD.
However. the Amylo id Hypothesis has fallen under crit icism as the initiator or
AD since clinical tria ls found no improvement in cognitive function in patients
immunized aga inst All. despite evidence of plaque clearance in the post-mortem brains
(Go lde. Petrucelli. & Lewis. 20 10: Holmes et al.. 200S). While amyloid load appears to
poorly correlate with severity ofcognitive decline in AD. SPs are present in symptomatic
AD. Furthermore. the discrepancy in amyloid load and degree o f cogni tive decline is
controv ersial because a de finite toxic All species has yet to be determ ined ill vivo
(discussed further under "Amylo id-]! Production and Toxicity").
1.2.2 Hypcrphosphorylatcd Tau Hypothesis
The other major hypothesis surrounding AD onset and progression is the
disruption of microtubule assembly and function due to hypcrphosphorylatcd, insoluble.
filamentous Tau protein. Alteration of tau phosphorylation is the principle cause of FTs
thought to play a key role in AD onset (Hernandez, Gomez de Barreda. Fuster-Mata nzo.
Lucas. 8: Avila. 2( 10). Tau is expressed in the central and peripheral nervous system and.
to a lesser exte nt in kidney. lung and test is (Gu. Oyama. 8: lhara, 1( 96). It is most
abundant in neuronal axons (Lee 8: Troja nowski. 200 Ia). but can also be found in
sornatodcndritic compartments (Tashiro. Hasegawa. lhara, 8: lwatsuho, 1(9 7) and
oligodcndrocytcs (c. Klein et al., 20(2 ).
Tau consists ofan N-terminal projection region. a proline-rich doma in. a C-
terminal region and a microtubule binding domain (MB D) through which tau protein
binds to and thus stabilizes microtubule assembly (Mandclkow ct al., 1(96) (Kar. Fan.
Smith. Goed ert. 8: Amos. 2003: Santarclla ct al., 2(0 4). The tandem repeat sequences
within the MBD are thought to direct ly bind microtubulcs through their positive net
charge. which interact s with negatively charged residues in tubulin (Jho, Zhul ina, Kim. 8:
Pincus. 2010: Kar cr ul., 20(3) . Phosphorylat ion oftuu directly influences its ability to
regu late microtubule asse mbly by neutralizing the positive charge and altering
con formation oft he MI3D. detaching tau from the microtubulcs (Fischer ct al., 2(09 ).
The detac hed tau can accumulate in neuronal cell bodies and ncuritcs. forming insoluble
fi laments and Nf Ts (Lee 8: Trojanow ski. 2001b: von Bergen. Barghorn , Biernat.
Mandclkow.z; Mandclkow, 2005: von Bergen. Li, 8: Mandclkow, 2( 05). In addit ion.
the iVIBD or tau contains critical sequences that can assume the l~-sheet structures
required for tau aggregation and formation o r pathological inclusions (von Bergen ct al..
200 I: von Bergen ct al., 20(5) .
Similar to All. tau mutations have been identified which heighte n product ion of
one iso form ofta u over another. Mutations leading to changes in the ratio of three-repeat
to lour-r epeat isoforms may result in an excess oft au in relation to microtubu le binding
sites. allowing ti l!' excess tau availability for filament assembly (Hulton et al.. 199X:
Spillantini et al.. 199X: Spillantini. Crowther. Karnphorst. I-1eutink. & van Swictcn.
199X). Missense mutations that affect all isoforms of tau result in reduced microtubule
assembly (Hasegawa. Smith. & Goedert, 199X). thus causing microtubul e destabilization
and detrim ental effect s on axonal transport .
In addition. since tau activity is regulated by the phosphorylat ion state.
hypcrphosphorylation of tau as seen in AD depresses the ability o f tau to bind to
microtubulcs (Lindwall & Cole. 19X4: Hampel et al.. 2(10). Enquiry into the mechanism
behind tau hypcrphosphorylat ion has lead to the disco very of many tau kinases including
cyclin-dcpcndcnt protein kinase 5 (cdk-S). cyclic adenosine monopho sphate (cAMI') -
depend ent protein kinase (I'KA) and the most therapeutic ally promising glycogen
synthase kinasc-J ]! ( G S K-3 r~ ) (Mendes et al.. 2009: Schaffer et al.. 200X), Dysregulation
of thcsc kinascs and phosphatascs is thought to result in tau hyperphosphorylat ion. Alli s
thought to promote GSK-3 r~ activation as it is up-regulated in AD brains and its activity
is shown to increase with aging (Schaffer et al.. 200X). Trials implement ing the GSK-3 1~
inhibitor. lithium. failed to show alterations in tau. phospho tau. All (1-4 2) levels or
cognitive performance in mild AD patients (Hampel et al.. 20 10: Mendes et al.. 20m ).
however. this may be owing to lithium's non-specific ity as an inhibitor. Interestingly.
Hspl3l has been shown to bind hypcrphosphorylatcd tau and promote its
dephospho rylation and de gradation. the reby promoting cellu lar surviva l (Sh imura, M iura -
Shim ura . 8.:.Kosik. 2( 04 ).
T he usc of trans genic mice has demonstrated that reduction or both so luble All
and tau is needed to ameliorate co gnitive de ficit s seen in trip le tra nsgen ics that have S l's
as well as NT Fs (O ddo , Caccamo . Smit h. Green. 8.:.La Feria. 2( 06) concl uding that AD
pat ho genesis ca nnot be reso lved witho ut co ns ideri ng bo th prote ins .
1.2.3 Intl amm ati on and Ox ida tive St ress in AD
Stud ies fro m the IlJlJO's fol lowed in fla mmat ion as a ca usa tive facto r in AD. yet
tod ay it remains unc lear w het her inll amm ation rep resents a cause or a co nseque nce or
AD. Clin ica l evidence in su pport or a ro le til!' infl ammation includes elevated cytokincs,
in flam ma to ry agent s found in ac ute infl amm ator y respon ses. and act ivated microgli a in
post-mortem AD brain compared to age -matched controls ( Filli t ct 'II.. 1991 : Frank -
Ca nnon. Alto . McAlpinc. 8.:.Tan sey. 200 lJ). Retrospect ive stud ies or individuals under
lon g-term treatment with SA IDs (Ion-steroidal ant i- in tla m mato ry drugs) have
demonstrated delayed on se t and reduce d severity or AD sy mptoms. a ltho ugh recen t tr ial s
have fa iled to co nfi rm thi s (Szekel y 8.:.Za ndi. 2( 10).
Ac tiva ted microgl ia ce lls surro und All plaqu es in bot h hum an AI) and tran sgeni c
mouse AD brai ns. however the ir exact co ntribu t ion to plaque format ion is unkn ow n
(Johnston. Bou tin. 8.:.A llan. 2( 11). Overa ll. it appea rs that moderate activat ion may be
bene ficia l thro ugh an increa se in All cleara nce (Boi sso nneault et 'II.. 2009: K. Chen ct 'II..
2(06). whereas strong activation mig ht slow down the ability to clear All. inc rease
productio n o f pro-inflammatory cytokincs and acce lerate neuronal da mage (Arna ud.
Rob aki s. & Figue iredo - Pereira, 2(06) . Micro glia l ce lls immu noreactive fo r intc rlcuki n- I
we re increased in tissue sect io ns of A D patient s (Griffin et a l.. 1( 89) and in AI' I'/ I'S 1
transgenic mice (Hi ckm an. Alliso n. & EI Khou ry. 2(08) . Interleu kin-6 immun oreact ivity
in Sl's and neurons in AD brain s initially was thought to be incr eased (B aue r et al.. 1992:
Heyser. Mas liah, Sa mim i. Campbell. & Go ld. 1( 97). yet recent papers show a protecti ve
ro le o fi ntcrleukin-o in plaque clearance (Chakrab arty et al.. 2(10). Intere stin gly.
intcrl eukin -6 increa ses API' synthes is in neur on al ce lls (Altstic l & Sperber. 1( 9 1) and
interleukin- I st imulates API' synthes is in endo theli al ce lls (Go ldg ahcr et al.. 1( 89) .
Increase in an alterna te cytok inc. T lF« . resu lted in increased tau hypc rphosph orylat ion .
intra-neurona l Ar~ de posi ts and also neuron al death in trip le tran sgen ic A D min :
(Ja ncls ins et al., 2(08 ). One theor y behi nd the role ofintlammat ion in AD is that a local
insult in the brai n perh aps amy loid agg regation wi ll sti mulate produ ction ofcytokinc s
and whi le initiatin g Al~ clearance. prolonged ac tivation (coupled with pro longed cytokinc
re leas e) increases product ion o f API'. T his co mbi ned with a ltere d API' proc essi ng.
whether fro m genet ic mutations or otherwise. brings abo ut a cyclic patt ern o f
immuno reactiv ity (Fig ure 1.2).
Astrog lios is is found in AD brain s as we ll (Ak iyama et al., 2( 00). Previou s
studies hav e revealed A l~ pre sent in as trocy te processes (Kurt. Davies. & Kidd , 1(99 ) and
lyses of Ar~ loaded as trocyt es resulted in the form ation ofS Ps ( age Ie. D'Andrea. Lee.
Venkataraman. & Wang . 2(03). Studies have show n evidence otccllular All
internalization from degenera ting synapscs and de ndrites openin g the possibi lity of
externa l uptake of Ar~ by astrocytcs via endocytosis (Nage le ct al., 200.1). Also.
extrace llular so luble oligomeric forms o fA r~ may stimulate A r~ produ ction within
astrocytcs (1. L. Perez ct al., 2( 10)(DaRoc ha-So uto ct al., 2( 11). l-xtruccllular AI~ is
thought to limn pores or ion channels in the cellular membrane thereb y allowing influx of
excess Ca2' subsequently activat ing detrimental signalling cascades such as caspasc and
calpain activat ion (Kawahara & Kuroda. 2000: .1. L. Perez ct al., 2( 10). Trea tment with
A I~ can act ivate both .INK and p.1liMAI'K signalling pathways thus activating apoptoiic
signalling (A. Eckert ct al., 2(0 1).
Taken toget her, it appe ars accum ulation of i\f~ into oligo mcrs. although yet
unkno wn if thro ugh interna l or external production . can trigger astroc yte act ivation .
possibly throu gh increased calcium influx. in turn synthesizing and secret ing toxic
substances contributing to AD neurotoxicity (Dalcoc ha-Souto ct ul., 2( 11).
1..1 Amyloid Precursor Protein
Amy lo id Precursor Protein (APP) is a type -I transmembra ne protein, with a large
extracellular glycosy lutcd N-tcrminus and a shorter cytoplasmic C-tcnninus. ubiquitou sly
expressed in many cell types and highly conserved acro ss spec ies (Figure 1..1) (Kang ct
al., 19li7). The A I~ porti on of API' is located at the ce ll surface with part o r thc peptide
embedded in the membr ane (Mattson. 2( 04). Alternative splicing creates three iso form s
o f API' in huma n: 770. 75 1 and 695 (R. E. Tanzi ct al., 19lili). with thc 695 isof orm
preferentially expre ssed in neurons (Sisodia . Koo. Ho ff man, Perry. & Price, 199.1). API'
has been show n to be concentra ted in the syna pses o f neu ro ns. and increases in the rat io
of the neuro nal A p p6 '15 isofo rm to othe rs. is associated wit h AD (Matsui et al.. 2( 07 ).
API' undergoes post -tra nslat ional modifications including g lycosy lat ion, tyrosi ne
sulfat io n an d phosphorylat ion. Mutations of API' (i ncl udin g the Swe dish muta t ion) are
no t thou ght to be loss-o f- funct ion mutat ions mean ing such mutation s do not interf ere
wit h App 's biolog ical funct ion (M. Mu llan ct al.. 1l}l}2a). l lcn cc , AI\ is thou ght to be a
by-product of API' met abo lism and ap pear s to have no d irect assoc iat ion w ith A p p 's
biolog ica l ro le (Cit ro n ct al.. !l}l}2; Citro n. Tcplow . 8.:Sc lkoc . ! l}l}5; C itro n ct al.. 1l}!)6:
Goa tc ct a l.. 1l}l}I; Sc lkoc ct a I., 1l}!)6).
A PI' is tho ug ht to have nume rou s bio log ica l funct ions. As a ce ll surface recept or
(Ho 8.:Sud hof 2004; Kan g cr al.. Il}S7). API' may have the ability to induc e ce ll
signa lling ( I' . R. Tu rner. O'Co nnor. Tate. 8.:Abraham. 20(3). functio ning as a rece pto r-
like modulatory protein in neuro na l processes (A shle y. Packard. Ata man . 8.:Budnik.
2( 05 ). influencing Wn t sig na llin g. AP I' is suggested to mediate I\-catenin
downrcgulation in primary neuro ns by spec ific pho sphory lation orl)..cat eni n resid ues (Y .
Chen 8.:Bodie s. 2(07) . In ad di tio n. A p p's lar ge ext race llu lar doma in is capable or
binding to severa l ex tracell u lar matrix proteins. a llud ing to a ro le in ce ll-ce ll an d ce ll-
ma trix adhes ion (M att so n. 1l}l(7). In neu ron s. API' is present in g ro wth co nes ofncurit cs
and bo th presyn apti c and postsynaptic s ites (Ferrei ra. Caceres . 8.:Kosik . 1l}l}J ; Sa ho.
lk in, Bux ba um. 8.:Grcc nga rd , 20(3). API' is show n to increas e sy naptic form ation and
repair after inj ury (Pri llcr ct al.. 2(06). neur ite outgro wth (R. G . Per ez. Sq uazzo . 8.:Koo,
1l}l(6) and plays a role in ce ll migrat ion ( Re inhard. He bert. 8.:De Stroo pcr, 20(5).
Knock-down of API' through i ll utero clcctroporation in rodent develo ping cortex.
revealed a dependency on API' fill' correct migration of neuronal precursor cells into the
cortica l plate (Young-Pearse ct al.. 2(0 7). Whereas knock-down o r API' inhibited
cortical plate entry. over-ex pression of API' caused accelerat ed migrat ion of cells past the
cort ical plate boundary, confirming the requirement of normal API' levels fill' COITect
neuronal migration (Yeung-Pearse ct al.. 2( 07 ).
1.3.1 Proteolytic processing of Amyloid Precursor Protein
API' undergoes two types of proteolytic processing by sccrctasc enzymes
differ ing in whether All peptide is produced (F igure 1.3). Non-arny loidogcnic processing
hegins with the release ofthe extracellular N-terminus o r API' hy u-sccrcrasc or
ADAM IO between residues Arlit> and Arll 7 within the Afl region thereby precluding All
production (Sisodia, 1( 92). The released N-terminus ofAl' P from the cell surface
produced by u-sccrcta sc is denoted as soluble API' alpha or sAl' l'u . This leaves an li3
amino acid cytoplasmic membrane-bound fragment (OU /CTFu) . which constitutes the
middle p3 fragment (cxtraccllularly released) and API' intrace llular domain (A l f D)
(intrace llular). The CTF is cleaved by v-sccrctasc, generating the non-aggregating p3
fragment which substitutes 1'01' the toxic Arl (Frigcrio ct al.. 20 I0; S. A. Small & Gandy.
20( 6). All API' fragments generated by API' processing have been identified in one or
more bio logical processes. yet details on the specific functions ofthe fragments are
unkno wn since inve stigati on has focu sed pr imaril y on the A~ peptide in its relation to
AD (S ummarized in Table I) .
Ac tivation o fm uscarinic acety lcho line recepto rs incre ases product ion o r sA l' l'u.
sugges ting that non-am yloido ge nie proces sing is favoured by neuronal act ivity (B uckne r.
Andrews-Ha nna. & Schactcr, 200 X). Act ivity dependence on API' process ing is no t a
novel findin g (Cirrito ct al., 2005 ; Kamc nctz ct al., 200 3: Nitsch. Farber. Growde n, &
Wurtrnan, 1993; Sc lkoc, 2006 b). howe ver. why cer ta in neuro ns arc robus tly affec ted by
A I~ accum ulat ion whil e others appea r unsusccpt iblc, is a fairl y new focus, Support is
growing (or a link between i\ r~ deposition , vulnera ble hc terom odal associ ation areas and
co rt ica l dysfunctio n in AD (Buck ner ct al., 2005: Buckner ct al ., 2009: Klunk ct al .,
2( 04 ). Co rt ical region s imp licated in AD have been ide ntified as connectiona l "hubs" or
area s that act as communication stations for inform ation proc essin g connecting otherwise
seg regated brain systems across task states (Sporns. Ton oni . 8: Edelma n. 2000: Sporns 8:
Kott er. 2004; Sporns. Ho ney. 8: Kotter. 2(0 7). Moreover, in restin g human s. incre ased
activi ty in the defaul t network (Maw yer ct al., 2(01). an area which corre spond s to
ident ified hub s (medial prefr o ntal cortex. medial temporal lobe . posterior cingulatc
co rt ex), positively cor relates with SI' load (B uckner ct al., 2( 05).
Co nversely. Ar~ produ ction from API' processing occurs thro ugh the
am yloidogen ie path way requiring the BAC E enzyme or I ~ - sccrct ase (Vassar ct al.. 1999) .
BAC E cleaves API' at the N-termina l end or the Ar~ sequence thus enab ling Ar~
production and secretio n o f so luble API' beta ( sAppr~) . C lcuvugc by y-sccrctasc clea ves
the membrane cy top las mic terminal fragme nt (C99 /CTFI I) at posi tion Afl41142 libcrat ing
the C-tc rm inus or Aft a llowing entry into the extr ace llu lar mili eu . T he remai ning A IC D
can trans loca tc to the nucle us whe re it regul ate s gc nc expre ssion incl udi ng induc tio n or
apo pto tic genes thro ug h bind ing with Fc65 and Ti p60 (13'10 ct '11.. 2007: Cao 8: S udho f
200 I: D. M. Wal sh et '11.. 2(02 ). Amylo idogcnic processing can be mod ulated by
a ltering APP' s susceptib ility to BAC E cleavage throu gh ce llu lar locali zation .
1.3. 2 Intr ace llu lar Trafficki ng o f the Amylo id Prec ursor Prot ein
Nascent APP , tran scribed in the nucleu s, is traffi cked throu gh the end opl asmi c
ret iculum (E R) to the go lgi apparatus. where post-tran slati on al modificat ion s. N-
g lycos lylat ion and O- g lyco s lya t ion occ urs. and co ntinues th rou gh the tra ns go lg i net work
(TG ) to yie ld mature APP protein (Figure 1.4) . API' travels th ro ug h the secretory
pa thw ay to the plasma membrane where A DA 1\'110 (u-sccrciasc) initia tes non-
arn yloidogcnic API' processing. A pool of APP doc s no t unde rgo immediate process ing.
and as a co nseq uence is intern a lized by the cell (Haass et '11.. 1992 : Haass. Koo, Mellon .
Hun g. 8: Sclkoc , 1( 92) . API' then e ither recycles back to the cell surfa ce or is tar geted to
the lat e endoso mes /lysos o mes (M arquez-Sterl ing. Lo. Siso d ia, 8: Koo. 1997: Pasternak ,
Ca llahan. 8: Ma huran . 2004: Yam azaki, Koo, 8: Sc lkoc, 1(96). Here AI' P encou nter s
transmcmbrancous BA C E in the cndo somcs o f the earl y cnd ocytic pathway, the first step
in AI) pro duc tio n (Haass et '11.. 1992: Lor enzen ct '11..2( 10 ). Identified so rt ing motif s in
API' ( - P-X- Y) and BA C E (D-X -X-L- L) cyto plasm ic ta ils tar get both prot eins for
transport to cndosomcs via cla thr in coated vesicles (BA C E from TG N-en do somes: AI'I'
fro m ce ll surf acc-cndosorncs) (W , 1. Che n, Go ldstei n, & Bro wn , 1990: He, l.i , C ha ng . &
Ta ng , 20(5). Fina liz ing the produ cti on o rA II. v-sccrc tasc (a mult imcric pro tein co mp lex
cons isting of I'S-I and PS -2 and the si te for FA D prese nilin mut atio ns). has bee n fou nd
enr ic hed in the late cndoso mcs/lysosornc s (Pa sternak et a l., 200-1). Evide nce for the
cndo somal /l ysosornal locali za tion of the amy lo idog cnic sccrctus cs is pro vided by reduced
A ll production whe n block ing the internalization of ce ll surface A I' I' (Cirrit o et a l., 2005 :
Koo & Squazzo , I(94). and the ac idi fication of the cnd osom al-I ysosom al path way
(Kuether, Haass, & Ste ine r. 20 06 : Sc hrader-Fisc her & Pagan ctt i. 1996 : V ingt de ux ct al.,
2(07) . Reporter sys te m studies coupling y-sccrc tas c to fluorescence ha ve indicated the
presen ce olv-sccrctasc in the cndocytic pathway. suggesting the e ndosomes as the major
s ites 1l1l'AIl production (Kact hcr ct a l., 2(06).
Theories ex ist that mut ati on s in A I' I' result in a greater pool ofcndocytoscd A I' I'.
res ultin g in increased ava ilab ility o rA PI' for BAC E cle a vage wi thin the cndocytic
pathway. thu s exp laini ng the increa sed A [l prod uctio n ob served (Ha rtmann ct ul., 19(n).
T he re is a lso evidence lor BAC E and so lub le All co- locali zation to the TG I . giving the
o ppor tun ity 1111' amy lo idog cn ic cleavage of AI'I' 10 occur bef ore it encounters u-secrctasc
at the pla sm a membrane (G ree nfie ld et a l., I(99 ). T he Swe di sh muta tion increases the
ra te or [l-c lcava gc by 5- 10 fo ld (S inha & Licbc rb urg, I(99) and is prop osed to a lter th e
trafficking of A I' I' (A l' Pswc) . T his mutation pa rtly disr upts so rt ing ofsecreted A I' I' (De
Stroo pcr et al ., I(95) and appears to undergo I{-cleavage during tran s it to the ce ll surface
(Haass. Hun g, Schlo ssmachcr, Tcplow. & Sclkoc, ]993 : Haa ss. Hung , Sclkoc, S: Tcplow.
1994: Thinakaran. Tcp low, Siman. Greenberg. & Sisodia. 1(96) . Amyloidogcnically
cleaved A I'I'/Al~ is then trafficked through the cndocytic pathway to the Iysosomc s where
the y-sccrclasc complex finalizes Al~ production . Since the site lor processing is thought
to differ in rclat ion to the type ofAl'P (wt versus mutated). the exact details ofthe
transportation process back to the cell surface for release of the soluble AI'I' forms and
All arc unclear at this time.
A novel pathway in AI'I' rc-uptakc by cells directly from cell surface into the
lysoso rncs, thereby bypass ing the cndoso rna l co mpart men ts, has been shown by Lorenzen
and col leagues. Fluorcscc ntly labelled Al' Pwt is show n enriched in the lysoso mcs, and
the direct pathway from ce ll surface to lysosom e ap pears to be blocke d by the Swedish
mutation (Lorenzen et al.. 2(10). A possible parallel to this trafficking pathway may be
the prion protein (Prf') which normally traffics thro ugh the cndocytic compart ments.
except when patho logically misfo ldcd, appcars to traffic directl y to the Iysosomcs
(Magalhacs ct al.. 2(02)- Give n that the Swedish mutation is not be lieved to alte r the
folding of ' the API' prot ein (ra ther the All prod uction). Al' Pswc may be normally
trafficked through the cndocyt ic co mpart me nts evad ing direc t entry into Iysomsomcs
from the ce ll surface , Ift hc pathwa y chos en has an influence on the type o r API'
processing (i .c. amylc idog cnic versus non-umyloido gcnic). end ocytosis throu gh the
cndocyt ic co mpart ment may lead to mor e efficient AI'I' c leavage by the sccrctusc
enzymes and thus high er All production. whereas rapid transport to the Iysosom cs may
lead to degrada tion by lysosomal protcases (Lorenzen ct al.. :W10). This highlights the
complexity yet to be resolved in API' tra ffic king and processing of both normal and
mutated API'.
1.4 Arnyloid-f Productio n and Tox icity
Antyloid is defined as a heterogenous class of tissue protein precipitates which
share a common [i-shcct secondary structure (Gandy. 2(02). Amylo id can be produced
throughout various areas of the body (systemic amyloid) or be confined to a parti cular
area such as renal amyloid or cerebral amyloid as seen in AD (Ga ndy & Pctunccska.
2(00) . Increases in either total Allor the relative concentration of both All (1-40) (more
concentrated incerebrovascu lar plaques) and All (1-42) (more conce ntrated in neuritic
plaques) have been implicated in FAD and SAD (Luc ct al.. l lJlJlJ). Multiple disease
assoc iations exist with amyloid deposition including inclusion body myosit is (muscle
disease) and cerebral amyloid angiopathy (Rcvcsz, Holton. & Lashley. 2(02). Although
All is acknowledged as a toxic species of AD. All docs not exist specifical ly to cause AD
(Lahiri & Maloney. 2( 10). All has been shown to 11<1 \'1: a multitude olnonnal biological
processes such as activation o I'kinase enzymes (Bogoycv itch, Boehm. Oakley .
Kellerman. & Barr. 2004; Tabaton, Zhu, Perry. Smith. & Gilibcrto, 2( 10). regulation of
cholestero l transport (Igbavboa, Sun. Weisman. He. & Wood. 200lJ; Yao &
Papado poulos. 2(02). functioning as a transcription factor (Bailey ct al.. 2011: B.
Maloney & Lahiri, 2(1 1). and anti-microbial activity which may be associated with A[rs
pro -inflamm at o ry ac tiv ity (Sosc ia ct a l.. 20 10). lien ee. AIl( I-40 ) and ( 1-42) arc produ ced
under norma l ci rcu ms tances in ag ing brains wi tho ut deme ntia . but arc bel ie ved to be in
lower ratio and a ltered con fo rmat ion than o bserved in AD bra ins .
Abno rma l ac cumulat ion o f amyloid may lead to amy lo idosis res u lting in to xic ity.
Afl toxi eity induces ac ti n stress fi bre forma tion and is prop osed to inhibit ac tin dy nam ics.
tr igger ing actin pol ym erizat ion and d iso rgan izati on of ac t in fil ame nts in neurona l
de ndr ites (Me ndoza- Naranj o , Go nza lcz-Billault. & Maccioni, 20 07: So ng . Pcridc s,
Wa ng. & Liu , 20(2 ). Axo na l transpo rt in cultured neurons is inhibited by A[lthro ugh its
effe cts upon the po lymeri zat ion and agg reg at ion of intracellu lar ac t in (Hirum a. Kat akur a.
Ta ka has hi. Ichik awa. & Kawakami. 20OJ ). Intr acellu lar agg rcga tio n of act in has been
described previou sly in ncuru dc gc ncrat ivc d iseases as rod-like struc tures fo rmed in
hippocampa l neu ron s in respon se to stres s suc h as Afltreatme nt (M. T. Ma lone y.
Minarnidc, Kinle y. Bo yle . & Bamburg. 2(05) . Disrup tio n of the actin cytoskele to n can
lead to gro wth co ne co llapse and degene rat ion of ne uronal de ndr ites (Mobe rg &
Bamburg. 2000) . In itiall y. inves t iga tion into the toxic nature of AIll <lCused on the
inso lubl e fib rillar form found in the se nile plaq ues present in AD bra ins. T hese plaqu es
arc tho ught to be genera ted th rou gh hydrophob ic interac tio ns bet ween All fragments
wh ich assoc iate into rod-like structures , so-called fibri ls. Due to its mor e hydro phobic
natu re . A[l( 1-42) is the mo re aggre gate pron e fo rm o ft he pepti de (0 11ct a l., 20 II ).
While S I"s ar c the dia gnostic les ions o r AD neu ron al damage. the inso luble fibril lar AI\
assoc iated has be en prop osed as a rese rvoir till' sma ll o ligomc rs (cg. d imcr s) within the
plaque core . curo na l toxicit y has recent ly been assoc iated wi th the co nve rs ion of no n-
tox ic AI) monomers to toxic oligorncrs (dimcrs. trimcrs, ctc.), in addition to the fibrillar
form found in SPs (Selkoc. 2007: D. M. Walsh & Selkoc. 2(0 4). (.I. Hardy & Selkoc.
2( 02). These small oligo mcrs can diffuse to neighbouring neurons causing synaptic
injury (Shankar ct al., 2(08 ). Dendritic spine loss of -60'% is observed in hippocampal
pyramidal neurons after 15 days of exposure to sub-nanomolar concentrations of A[)
small o ligo rncrs , reflecting a loss o f excitatory synapses. Spine density returned to
almost normal levels with cessation of AI) treatment (Shankar ct ul., 2( 07).
AI) dimcrs extracted from human CSF have been shown to disrupt synaptic
plasticity (Klyubin ct al., 2( 08). Long term potentiation (LTP) is inhibited by so luble AI\
oligorncrs through excessive activation ofl MDA-receptors similar to inhibitio n of
glutamate rc-uptakc (W. L. Klein. Kraft!. & Finch. 200 I: Li ct al., 20 II : D. M. Walsh ct
al., 20(2). These results suggest that AI\ oligomcrs shin I :'v1DAR-dependant signalling
cascades towa rd pathways involved in the induction of LTD (long term depressio n) in
contrast to LTP (Sclkoc, 2(08 ). Chronic activation of these pathways by so luble AI)
oligo rncrs may underlie the synapse loss in hippocampus that occurs early in the disease
process in brains of AD patients (Masliah ct al., 200 1: Sclkoc, 2(08 ).
Recentl y. subnanomolar concent rations (0.5 nlvl)of so luble AI\ dimcrs isolated
frorn Al) cort ex have been shown to directly induce tau hyperphosphor ylation in
hippocampal neurons d isrupting the microtubule cytoskeleton and resulting in neuritic
degeneration (Jin, Shepardson. Yang. Chen. Walsh. & Sclkoc, 20 1Ib). This finding is
significant as it describes e ffects by endogenous levels o f AI\ on neuronal cells found
within the AD brain, in comparison to exogeno usly increased levels and presents
evidence o r direct influence on tau function hy Art Moreover. the isolated dimcrs were
principally composed o r A I~ ( 1-42 ) (Jin, Shepardson. Yang. Chen. Walsh. & Sclkoc,
20 II h). Finally. transgen ic mice that express only oligornc rs hut not plaques ( AI' I'I I>".II))
develop AD symptoms similar to mice engineered to convert oligomcrs into plaques
(A I' I' II>'>31)X I'S II\ E9) (Gandy ct al., 2( 10). Even though a growing amount ofevidence
is eme rging in regards to soluble A f~ oligo rncrs . this docs not discount the role or plaques
in neuron degeneration. There is evidence that peri-plaque Af~ asse mblies arc assoc iated
with neuritic dystrophy (Knowles ct ul., 1( 99). and local dendrit ic spine loss ((Koflie ct
ul., 2( 09). therefore placing soluble oligomcrs and insoluble fibri ls as co-co ntributors to
Al~ neuronal toxicity (Sclkoe. 2( 11).
A0 can be degraded by different systems. which include enzymatic degradation or
receptor-mediated clearance (R. E. Tanzi. Moir. & Wagner . 2( 04 ). Several pcptidascs
have been described to possess the ability to degrade All including insulin degrading
enzyme (IDE) (Qiu ct al., 1998: Vckrcllis ct al., 2( 00) and ncprylisin (Sastrc &
Gentleman. 20 10: A. J. Turner. Isaac. & Coates. 20( 1).
In addition. Afl can he cleared through phagocyto sis by activated microg lia and
via tran sport through the blood brain barrier (BBB) which can he enhanced by binding to
chaperones such as Apol. and «-macroglobulin (Suzuki & Nakaya, 20(8) .
1.5 Heat Shock Protein beta- I (HspB I) in the Brain
Heat shock proteins arc up-regulated in response to cellul ar stress including
elevated temperatures. expo sure to heavy metals. ethanol and anoxia (Lindquist. 19X6).
Induction of Hsps is regulated by heat-shock factors and a heat shock clement present at
the promoter region of the heat shock gene (Mori moto . Kline. Bimston , 8: Cotto. 1( 97).
Ileat shock proteins can be divided into two families based on size and function : classic
li sps such as l isp100. Ilsp90. Ilsp70. Ilsp60. and the sma ll heat shock family: uB-
crysta llin. HspB I. Hsp20. IIspB2 and IIspB3 (Kappc et 'II..2003; Wilhelm us ct 'II..
2(0 6). Hsps with a molecular weight o f60 kDa or more possess an ATP-binding site and
arc actively involved in the process of re iIIIding misfoldcd prote ins (Guscv et 'II..2( 02 ).
Small li sps. with a mo lecular weight of40 kDa or less. lack this AT I'-binding domain
and assist the larger li sps in their refo lding function (Mac k ac, 2( 00).
HspB I (also referred to as Hsp27/25) is highly expre ssed in muscle (Wilhclmu s et
'II..2(06) and glial cel ls. spec ifically react ive astrocytcs (Renkawck. V oortcr, Bosman.
van Workum , 8: de lon g. 1994: Shinohara. lnaguma, Goto , lnagaki. 8: Kato, 1( 93). In
the nervous system. HspB I expression is seen in spinal co rd motor neurons and
peripheral sensory neuron s. where it plays a key role in promoting neuronal survival and
axona l growth. particularly in adult neuron s (Cos tigan et 'II.. 199X; Dodge ct 'II..2006; S.
E. Lewis et 'II.. 1999; Williams. Rahimtu la, 8: Mcarow, 2005: Williams. Rahinuu la, 8:
Mearow .2(06). While HspB I is expressed in some areas of the brain such as cranial
nerve nuclei and hypothalamus (Armstrong. Krueger-Nang. Currie. 8: Hawke s. 200 1:
Plumier , Hopkins, Robertson, & Currie, 1997), it is not expres sed in cortical neuron s (M.
King, afar, Clarke, & Mcarow, 2(09). HspB I has been co- localized to post-synapt ic
structures in rat cerebellum and peri -synaptic glial proce sses followin g hyperthermia and
this incre ase was not seen in uns tressed animals (Bechtold & Brown. 20(0). li sps may
be secreted by astrocytcs and may be taken up by neighb ourin g neurons thus possib ly
pro viding a compen sato ry mechanism till' lack ofcortical expre ssio n (Ouy ang. Xu, Sun.
& G i fl ~mL 2006 : Taylor. Robin son. Gifondo rwa, Tytc lL 8.:Milligan. 2(0 7). Thc
common funct ions of Hsp B I arc chaperone activ ity, thcrmoto lcru ncc, inhibitio n o f
apoptosis, regulat ion ofcell development and cell di fferentiation, and interact ion with
cytos kc lcta l clements in ce ll growth (Arrigo , 2005 : Arrigo. 2007: Charette 8.:Landry,
2000a: Parccl licr ct al.. 2003: Varga s-Roi g, Fane lli, Lope z. Gago. Te llo, Aznar, 8.:
Ciocca. 1997b).
1.5.1 IIspBI as a chaperone protein
Heat shoc k proteins (Hsp) arc the cell ' s defe nce mechanism in timcsofstrcss and
arc thus termed "chaperones" , Chapero nes can be defined as protei ns that : I) have a ro le
in the intrace llular manage ment olmisfo ldcd prote ins, 2) induce conlormationa l changes
ofproteins, 3) act as a transport er of proteins (Hendrick & Hartl. 11)93: Wilhclmus, dc
Waa L& Vcrbcck.2(07). Hsps can bind unfolded protei ns and keep them in their nat ivc
state (Walter & Buchner, 2(02) . or recognize misfo ldcd proteins and transport thcm to
the protcosomc for degradat ion (Wilhc lmus ct al.. 2006 : Wilhc lmus ct ul.. 200 7).
Molecular chaperones work by recognizing and binding to hydrophobic amino acids
exposed to the surface ofthe substrate protein thereby preventin g unproducti ve
aggregation (Hartl, 19(6) .
IlspB 1 conta ins a highly conserved amino acid sequence. the u-cryst allin domain
at the C-tcrminus. which form s l~- shccts important for the forma t ion o f stablc dimcrs
(Van Mo nt for t, Slingsby. & Vierling, 2(0 1). The I -tcrminu s is essential for the
development of high molecular oligorncrs (Haslbcck , 2002: Theriault ct al.. 2( 04). which
exclusively have chaperone function ill vitro , These oligorncrs consist of stable dimcrs of
neighboring monomers (Guscv ct al.. 2( 02). Oligomeri zation o f HspB I depend s on
exposure to stress and its phosphor ylat ion state. Stress induces an increase ofex pression
(after hours) and phosphorylation (after several minutes) of HspBI. HspB I in unstressed
cells exis ts as large o ligomcrs, while upon phosphorylation HspB I dissociates into
smaller species, including dimcrs and monomer s (Lambert , Charette, Bernier, Guimond.
& Landry. 1999: Rouse ct ul., 1994: Williams ct al., 2(05) . Stimulation ofthe p]X MAl'
kinase cascade leads to the activation of MAPKAPK2 which is reported to directly
phosphorylate HspBI (Kyriakis & Avruch. 1996: Rogalla ct al.. I99(». HspBI is
phosphorylatcd on ] serine residues in the human HspB I (S 15. S7X.SX2) and 2 in the
rodent HspB I (5 15 and SS6 in mouse or S90 in hamster HspB I). Oligomcrization
appears to be connected to chaperone activity: aggregates of large oligorncrs have high
chaperone activity. whereas dimcrs have no chaperone activity (Gusc v ct al.. 2( 02).
li sps have hccn invol ved in rescue o f agg rega te pron c protein s inman )' ins ta nccs .
In Dem en tia wi th I.C\\)' Bodic s (DLl 3). u- synuc lcin prot e in inclu sion s ado pt a [i-shcct
struc ture leadin g to aggreg atio n suc h as oli gomeric assembly ill co rt ica l and limbi c arcas
(S pillant in i & Goedert. 2( 00). until it reache s a stahlc fibrill ar f(JrI11 (Conw ay ct al. . 2(0 0 )
s imila r to Afl in A D. Previ ou sly. Il spB I and uB -cr yst allin have been show n to protect
again st u-synuc lcin-i nduccd toxici ty and aggr egati on (Mel.c an ct al.. 2002: Rck as ct a l..
2004 : Wa udhy ct al. . 2( 10 ). Thi s has hccn furthe r indic at ed as evi de nce ofrccomhinanl
slls ps, inc lud ing HspB I. were sho wn to bind (though throu gh a weak and tran sicnt
intc rac t ion) to u-sy nuc lc in thus inhibiting mature u-sy nuc lc in fihril formation and
aggre gat ion ( Bruins ma ct a l., 2( 11). More o ver, mutant atax in- I tran sfcctcd HcL a cell s
disp lay large nuc lear aggreg ates that co- Ioca lizc with end ogen ou s Hsp 70. uhiqu itin an d
20S prot cosom c. suggest ing that thc ce ll's end ogenou s prote in dc grad ation systcm is
insu ffi c ient to suppress thes e aggre gate s . O ver-ex pres sion o f Hsp70 resulted in a
sig nifica nt reduct ion of nuc lear aggre gate s (Cummings ct al., 199X). showing that an
exog eno us ov er-express ion of Hsp was better ahlc to prote ct tha n an endo genous o ne.
Bip /GR P7X. part of thc II sp 70 fam ily found in thc ER. hinds directly to Al' Pswc
impa iring mat urat ion an d dec reasing sA Pf' . Afl ( l A O) and All ( 1-4 2) recove ry in
con di tio ncd med ium of hum an embryo nic kidn ey 293 ce lls (II EK 2(3 ) ('I' . Yang. T urne r.
& Ga ut , 199X), The mechanism hchind thc red uction in API' mctaholitcs in conditioncd
med ium may hc retention o f API' in thc ER thu s weaken ing thc chance ofll/y scc rctasc
cle av age and/or suhstratc depl etion .
HspS I may act to inhibit apoptosis through interacting with the outer
mitocho ndrial memb rane and interfer ing with the activati on ofthe cytoc hrome c/A paf-
l /dATP complex inhibit ing the activation ofprocaspasc-O (Brucy ct al., 2000:
Concannon. Orrcnius, & Samali. 200 I: Samali ct al., 200 I: Sar to. Binz, & Mocarclli ,
2( 00). The phosphorylated form of HspB I has been seen to inhibit Dax x apoptotic
protein and pre vent the association of Daxx with Fas and Ask I (Charette & Landry.
2000b: Charette, Lavoie, Lambert, & Landry. 2( 00). Apoptosis may also be stopped by
activa t ion of Akt or ERK and pro-survival transcription facto r, nuclear factor-« li (NF -
KB ) (K ennedy. Kandel, Cross. & Hay. 1999: Lcvrcs sc, Butterfield . Zcntrich, & Heasle y,
20( 0). all ofwhich HspB I has been shown to enhance thc activ ation of: thus acting in a
pro-survival natur e (Parccllicr, Gurbu xani, Schmi tt. Solary, & Garrido. 2003 ) .
A0 toxicity induce s actin stress fibre form ati on lead ing to inhibition o f axon al
transpo rt , growth cone collapse and degeneration of ncuronal ncuronal dend rites. Actin
stabilizat ion by sHsps has been shown throu gh their ability to act as an actin capping
protein thus promot ing survival (Gua y ct al., 1997: Guscv, Bogarchcva. & Marston.
2(02 ).
The pro-survi val and chaperone functions of HspB I may be potenti al mechani sms in
which HspB I can effect API' proce ssing or distr ibut ion withi n thc cell and influence thc
production ofA ji thcrcby impeding All oxidat ive damage,
1.6 Alzheime r 's Disease and IlspBI
IlspB I has been recog nized in 15% ofS l's in neocortical areas of AD pat ients brains
(Wilhclrnus ct al., 2006 : Wilhelmus ct al., 2(0 7). Whether this localization is an attempt
by IlspBI to ameliora te the detrimental effects or A[~ on ce lls or part or the disease
proce ss is unknown. however previous wor k hum our lab has observed increased
neurona l surv ival in ce lls ex posed to A r~ ( 1-42) when transfcctcd with Hsp B I (M. King ct
al., 200lJ) pointin g to a possible protective mechani sm. In support ofthis. Hsp131 can
decrease the level o I'phosphorylated tau and rescue tau-mediated cell death (Shimura et
al., 2( 04) and has been implicated in neurite gro wth and cytoskc lctul stability in DRG
neuro ns (Wi lliams ct a l., 2006: Williams & Mcarow, 2( 11).
Direct interac tion between uB-crysta llin and IlspBI with Ar~ has been
demon strated in vitro (Kudv a, Hidd inga, Butler. Mucskc, & Eberhardt. IlJlJ7: Liang.
2(00 ). Wilhcl mus ct al., 2006 investigated the roles or sl lsps on All cytotoxici ty. They
round IlspB I. Hsp20 and uB-er ysta llin. but not Il spB2Jn . bind to Ar~ (1-42) and
decrease its aggregation by reducing the propensity or Ar~ to limn [}.-sheet conformat io n.
Furthe rmore . IlspB 1. IIsp20 and uB-erysta llin inhibited cerebrovascular A r~ toxicity.
probably by reducing the accumulation o rAr~ at the cell surface (Wilhelmus ct ul., 2( 06).
A more recent study found Ilspl3l . API' and I3cl-2 limn a complex within mitochondria
ofserum starved N2a cells which is associated with apoptosis. This eff ect was increased
in cells con taining the Al' l'swe mutation and API' over-expressio n increased HspB I
presenc e in mitochondr ia. It is important to note that APP ovcr-cxprcssion aloncdid not
induce apo ptos is instead a second insult in thc form ofserum starvation was needed (I'.
T. Yang. Hsu, & Kuo. 2(09). "
Perhaps HspBI is recruited to thc mitochond ria under stress ful conditi ons to provide
chape rone activity and act ivates apoptos is through mitochond rial dysfunction or
converse ly, the sequestering o f HspBl inside thc mitoch ondri a impair it from bindin g to
thc cytoso lic cytochrome c. thus inhibitin g HspBl from providing its anti-apoptotic
effect s.
Whilc HspBl has been implicated in neuronal protectio n and reduction o fp rotein
aggr egation, thc question remains whether HspBI localized in SPs of AD brains is a
fa iled aucmpt to counterac t AI) aggrega tion or part of thc disease proccss.
1.7 Proposed Thera pies
Researchers in AD have identifi ed various areas as possible intervent ions against
amyloid aggregation given evidence for AI) toxicity (Citron. 2( 04 ):
I.) [)-sccrct asc inhibitors (c.g. Mcmap sin Z). These block thc first amyloido gcnic
cleavage of 1\1'1'. inhibitin g the forma tion of 1\/\ N-tcnninus (Chang ct al..
2(04) however these have been proven ineffective in clinical trials"
2.) Y- sccrctasc inhibitors (e.g. scmagaccstat). These block the second cleavage
o r API' in the cell membran e that would stop the formation or All C-terminus.
These have not been success ful to date as v-sccrctusc binds ligands ot her than
APP such as otch, hence inhibition has other negative effect s (Basi ct al.,
20 10: lmbimbo & Pcrctto, 2009: Shih & Wang. 2(0 7).
3.) Selective AIJ( 1-42) lowering agents (e.g. tarcn tlurbi l). These modulate y-
sccrctasc to reduce All ( 1-42) product ion in favour of shorter AIJversions,
Tarcnflurbil unfortunatcly was found to have no beneficia lly effects on AD
patients upon completion of the Phase III clinical tr ial (Gree n ct al., 200l)).
4.) Immunotherapie s. These stimulate the host immune system to recognize and
attack Allor provide antibodies that prevent plaque deposition or enhance
clearance of plaques. Unfortunately. AfJ immunotherapies can cause micro-
haemorr hages due to activation of matrix mctallop rotcinascs, MMI'2 and
MMPl) (Wilcock ct al., 2( 11).
5.) Anti-aggregation agents (c.g. apomorphine). These prevent AfJfragments
from aggreg ating or clear aggregates once they arc formed (Lashucl ct ul.,
2002: Parker et al., 20(2) . IlspB I may 1:11 1under this category as an
endogenous anti-aggregation agent through its chaperone activity.
I.X Summary
FAD is the genet ic form of AD accounting fi ll ' 4-5% of AD cases. Mutations. such
as the Swedis h mutation in the API' gene have been shO\\"I1 to increase All toxicity
through favouring the arnylo idogcnic pathway. hastening production of aggregate prone
AI\(1-42) (Citron ct al.. 1992; £3.Maloney & Lahiri. 20 I I). All can also assemble into
oligomcrs which appear to be the Iocus ofAli toxicity recently. Thcsc oligomcrs increase
apoptosis. d isrupt cell signalling and inhibit LTI' and synaptic plasticity (D. M. Walsh &
Sclkoc, 2(04). This has brought the focus of All research away trom clearing Sls to
disrupting amyloid oligomerization.
A possible mechanism fill' disruption ofmisfoldcd or aggregated proteins is through
the work of molecular chaperones. Exogenous HspB I protects neurons from cell deat h
caused by All treatment (M. King et al.. 2( 09). HspB I though not found endogenousl y in
cortical neuron s. is secreted by neighbourin g glial cells and may be taken up by adjacent
neurons to elicit its protec tive effect s, Throu gh its chaperone function. HspB I may
sequester mutated or misfoldcd API' tagging it for degrad ation before process ing occ urs
or sequester API' within the cell inhibiting its secretion into the extrace llular
environment. Since both All and IlspB I arc involved in the cell death pathway . IlspBI
could inhibit All activation ofapopto sis. The possibility also exists for IlspBI 10 exert
changes on cytoskcletul element s thus interfering with tau misfolding and inhibiting
production of FTs.
HspBI has many therapeutic possibilit ies in ncurodcgcncrativc diseases such as AD.
My focus on interact ions betwee n IlspB I and AI'I'/Aflexplore the potential effec ts ofthe
small heat shock protein on API' processing and distribution within the cell. As
mentioned previously. location of API' within the cell plays a role in the type of
processing that will occur and thus the production or Aft To further my iuvcstigar ion. I
compare the wild type API' against the Swedish mutated API' in regards to distribu tion
and release of proteolytic products (including i\f~I--IO and A I~ I--I2) to determine possible
modifications in the presence of HspBI.
1.9 Hypothesis
HspS I interacts with AI~ or its precursor API' and through this interaction is able to
alter API' processing and hence the distribution /release of toxic AI~ peptide.
l . tOObjcc t ivc
Investigate the correlation between HspBI and AI'I'/All
HspB I and AI~(1 -42)
Objective I : Is there an interaction between All and IlspB1'!
Objective 2: Can we manipulate the relationship between HspB 1 and All to
decrease the amount of released All'!
HspBI and API'
Objective 3: Is there an interact ion between HspB I and API''!
Objective 4: Can we manipulate the relationship between IlspB I and API' to
decrease the amount of AII production'!
Amyloid Cascade Hypothesis
Altered APP processing
•Increased A13(1-42)production and accumulation
•Oligomerization of A13(1 -42) and
deposit ion as diffuse plaques
•Neurotoxic effects of oligomeric and protofibr illar
A13(1-42)on synaptic projections
•Inflammatory response with activation
of microglia and astrocytes
Increasing synaptic a! neuronal inj ury
•Progressive ox idative injury signalling
(kinase and phosphatase activity)
Tau hyperPhOSPhOry!tion and tangle formation
•Extensive neuronal dysfunct ion ,
transmitter release def icits and cell death
•DEMENTIA
Fi:,:u rc 1.1 Proposed Amy loid Cascade Hypothesis (From (J. Hardy S: Sc lkoc. 2(02).
Reprinted with permi ssion from AAAS .
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(microglial activation/as trocy tosis)
Fi~u rc 1.2 Schema t ic oft he ma in hyp o theses impl icat ed in AD path o logy and the ir
interactions or de pen de nce o n each component for AD deve lop ment .
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Fi~lIrc 1.3 Schema tic otA l' P sho w ing the (A) A ll pepti de within the tran sm emb rane
region alo ng with the sc c rc tasc enzy me cleav age si tes . Not ice the a lte red y-sccrc tusc
cl eav age s ite used to produce A ll (1 -4 2) which is up -re gul ated in the A!'I' -swe mutation.
API' pro ce ssi ng occurs through (B) the non-arnyloidogcn ic (u-sccrctasc) pathwa y el udin g
the form ation o r Allor (e ) the am yloidogcni c (fl-see retase) pathway favouring the
forma tion o ft he All peptide. From (Thinakaran & Koo. 200X ). Reprinted w ith






Fig ure 1.4 Schemati c o f cellular trafficking of A!'!' from maturation within the golgi to
transport to the plasma membra ne via the secretory pathway and continuing through
recycling into the cndocytic /Iysosornal pathway for degradation . From (Thinakara n &
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Fi!-:urc 1.5 Sc hemat ic of possible Hsp effe cts o n ncurodcgcncrutivc disease .
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Neurite outgrowth Undefined (Mattson , 1997)
Synaptogenesis (S . A. Small &
Synaptic plast icity Gandy, 2006 ; D. H.
Neurona l excitabi lity Small et aI., 1999)
Regulator of (Ca ille, Allinquant,
neuronal stem cell Dupont, Bouillot ,
division Langer, Muller, &
Prochiantz, 2004 b;
P. R. Turner et al.,
2003)
Surface receptor Apo E (La Fcrla. 20m :
Ccll adhesion ECM Malison. 1997: D.
Neurite outgrowth Undefined H. Small ct al..
Rcgulator of C2+ 1999: 1'. R. Turner
homeost as is c t aI..200-')
Axo nal transport Kinesin,JIP (Bao et aI., 2007 ; G.
cargo receptor D. King & Scott,
Kinase mediated Shc/Grb2, HP 2004 ; Lazarov et al.,
signalling 2005 ; Tarr,
Gene transcription Fe65 , HP, Numb Roncarati, Pelicci,
Pelicci, &
D'Adamio, 2002 ;




Materials and Method s
2. 1 Cell Culture
Nafve Human Embryonic Kidney 293 (HEK293) and stable cell lines of wild-typc
Amyloid Precursor Protein (APPwt) and mutated swedish API' (A l' Pswc ) (a kind gill
from Dr. Paul Fraser - University o f Toronto) were grown in high glucose Dulbcccos
Modified Eagle's Medium (DM EM. Invitrogen. Carlsbad. CAl supplemented with I'/';,
pen-strep/L-glutamine (P/S/G). 10% Fetal Bovine Serum (Fe S) and 400 pg Gcncticin
Disulfate (G418. Gibco, Invitrogen. CA). to 80% confluency in IOml petri dishes. G4 18
suppleme ntation was used only for stable cell lines and stopped upon initiation of
experimen tal procedures. Cells were incubated at 37°C with 5% CO 2 supplementation.
2.2 I'lasmid s and Transfcction
As shown in Fig. 2.3 Experimental model. I performed experiments as lollows: i)
HEK 293 naive cells co-transfcctcd with APl'wt or Al'P swc construct. pmaxGFI'
(positive cont rol vector with enhanced gree n fluorescent protein) (VSC- IOOI. Lonza.
Basel
Switzerland) and pEGFI'-C2-HaHspl3l-W T fusion protein which has been previously
shown to be functional in I'C I2 cells (Mearow ct al., 20(2 ) or the control empty vector
(EVC2) and ii) Al' Pwt and Al' Pswc HEK 293 stable cell lines transfcctcd with pCIG-
HaHspl3 l-WT -IRES-EGFP construct. These experimental models were initially used
interchangeably. however. upon experimen tation it was noted the large EGFI' tag fused to
the IIspB I-Wt protein may cause int er ference in the normal metabolism oft he IIspBI
protein thus affecting the results obtained. In addition. interference in results may occur
fro m the stress of over-expressing two proteins (lIs pB I-Wt and AI'I') by transfcct ion
within the cell. Therefore, to address these discrepa ncies. the Al'Pwt /swc IIEK 293
stable cell lines tran sfcctcd with the smaller pCIG-l lallspB 1- WT-IRES-EGFP construct
was used for the majority of the experimentation unless otherwise noted.
Confluent HEK293 cells. Al' l'wt and APPswe stable cell lines were transiently
transfcctcd in low serum media using L ipo fcctami nc 2000 1 ~1 (Invitrogen. Car lsbad. CA.
USA) as per rnanulacturcrs protocol. Briefly. 20 p i Lipofcctaminc 2000 reagent was
added to an aliquot or 500 pi Opti-Mcm Reduced Seru m media (Gibco Invitrogen.
Carlsbad. CA. USA) while X.O ~ l g DNA was added to a second aliquot containing 500 ~ "
Opti-Mcm Reduced Serum media and incubated for 5 min. Since the Al'P wt and Al' Pswc
constructs arc not tagged proteins. it is imposs ible to visualize the tran sfccti on efficiency
ofthese proteins in comparison to the tagged IlspB I-Wt that was tran sfc cted . To
overcome this issue. I added pmaxGFP to the API' co-transfcction reaction in a ratio o r
1:4 since the pmaxGFP is transtcctcd at a much lower concentration than API' .
T here fore. if2 pi of pmaxG l-P yield. 50'% transfcction efficiency then I can assume Xpi
olAl'P will give at least 50%,tran sfcct ion efficiency. The Lip of cctumi nc solution was
added to the DNA slowly and incubated for 20 min upon which the solution was added to
the IIEK293 cells. Media was changed 4-6 hI'S post tr ansfcct ion !i'OIl1 the reduced serum
media to media containing DMEM with I'Yo I' /S/G. O.5'X, ITS. 0.5 X B-27 (Gibco.
Invitrogen. Car lsbad. CA. US/\ ) supplement and the A[{degradat ion inhibitor 0. 1 'Yc,
phosphoramid on disodium salt (17.7 mM. Sigma-Aldr ich. Oakville. Ont., Canada).
2.3 Protein and Conditioned Media Collection
Cell lysate and cellular conditioned medium were collected 24 and 4X hrs post
medium change. Cellular conditioned medium was collected on ice with addition or
protease inhibitor cocktail table t (Roche Diagnostics. Laval. Quebec, Canada)
immediately upon collect ion. Media was centrifuged at 14.000 g Ior S min at 4°C to
discard any cell debri s. HEK293 cells were co llected by adding I ml ice cold TBS with
200 mM sodium vanadate and scraping cells o ff the plate with a rubber policeman. Ce lls
were pclletcd for :; min at 4000 g at 4°C and re-suspended in ice cold protein lysis bu ffer
(I 'X, NP40. 10% glycero l. O-l{-thioglucopyranoside. protease inhibitor tablet. 200 mM
sodium vanadate. sodium fluoride and magnesium chlor ide in TBS) and stored at -20°C
until experimentation.
2.4 Western Blot Analysis
Western blot analysis was performed with samples oftotal cellular lysate and
cellular conditioned medium. Samples were thawed on icc and centrifuged at 14.000 g
ti ll ' 10 min at 4°C and supernatants were used to determine protein concentrations using a
BSA protein assay kit (Pierce Chemicals. Rockford, IL. USA). Lacmmli sample buffer
(10% SDS. glycerol. 1M Tris pH 6.X. dlleO. 0.0 I% Bromophenol blue) containing fresh
l{-mercaptocthanol (13MI:) was added to 50 pg or either cellular lysate or cellular
co nd itio ned medi a protein. boiled and separated on an pre -ca st 4-20%,gradi ent Tri s-
g lyci ne ge l using the X-Ccll Sure lock Sy stem ( Invitrogen, Carlsbad. CA. USA) at 120V.
300 A Ill!' ~ 1.5 hr. Protein from gel was then transferred to a nitrocellulose membrane at
100V for I hr at 4°C using a transfer tank and transfer buffer ( IM Tris base, glycine,
dll -O, McOIl) . Western blots we re stained with Ponccau Red tor as sess ment of
equi valent protein loading, Blots were washed with TBS -T (I M Tris base, 2.5M I aCI.
50%,Tween) to remove Ponccau Red stain and blocked with either 3'% milk or BSA
dependi ng on the primary antibody dilution conditions Ill!' I hr to pre vent non-spe c ific
binding. Once blocked, blots were incubated with the following antibodies overnight at
4°C on a shaking platform : anti-AI'I' nC 11 mou se monoclonal directed against the N-
te rminu s region s of AI' I' (Milliporc. Billeric a. MA. USA): 61:10 l~-amyloid (1-16) mouse
monoclonal (Covaucc , Emery ville, CA. USA): Cvtcnninal anti-AI'I' mouse monoclonal
(Zymcd, Carlsbad. CA. USA): anti-I-lsp25 rode nt (S I'A-~WI) rabbit polyclonal (Assay
Design s, Enzo Life Sc iences lntcrnat ional lnc.. Plymouth Meet ing , I'A. USA): anti-
sA I' I' I~- swc mouse monoclonal (IBL. Gunma, Japan): anti-actin rabbit polyclonal
(Sigma-Aldrich. Saint Louis. MI. USA ): all antibodies were used at a concentration of
I:1000, Blots were subsequent ly washed with TBS-T 3xl5 min til!' a total of45 min on
shaking platform. Protein was detected using horseradish peroxidase (fIRI' ) lab e lled
seco ndary antibod ics ( 1:5000 - 1:10000 in3 % milk) and Supe r Signal West Pico
chemilum inescence substrate (ECL: Thermo Scie ntific, Rockford, IL. USA) Ill!' 5 min
and exp osed to X-ray film. De nsi tomet ry analysis was performed using lmage,l soflwarc
and image s prep ared with Adobe Photoshop graphics software.
2.5 Co- Immuno prcc ipitat ion
Sy nthetic AI~ ( 1-42) peptide ( I ~l g . r-p cpt idc, Bogart. GA . USA ) wa s incubated
with reco mbina nt hum an his-tagged Il spB 1 (2 pg. Strcs smarq Biosc ic nccs Inc.. Vic toria .
Be. Canada ) in 500 p i olmcdia ( DMEM. ]'% P/S/G. 0.5'% FCS. 0.5 X 1327 supplement.
phosphora midon) on a nutator at 37°C overnight. The foll owin g da y. prote in A /G PL US-
ugar osc head s (40 p i per sample . Santa Cru z Biotec hno logy. Santa Cru z. CA . USA ) were
equilib rat ed with the above describ ed media and 20 ~d wer e ad de d [0 his- l lspls 1I A I~ ( 1-
42) sample on rotat ion Ill!' I hr at 4°C. Sa mple was ce ntr ifuge d at 3000g Ill!' 5 min to
pellet head s and supernatant wa s placed in a fresh ce ntrifu ge tube . 3 pi 01" anti- Hsp l! I
huma n (S PA-803) rahhit po lyc lonal (Assa y Desi gn s. Enzo Life Sciences Internat io na l
Inc.. Plymouth Mee tin g. PA. USA) wa s then added to supernata nt to detect the human
reco mbina nt his-ll spB I prote in on rotation at 4°C Ill!' 1 hr follo wed hy ad di tion 01" 20 p i
heads ove rn ight to co-immunoprccipitaic any AIH1-42) and his-H spB I co mplexes that
limned. T he above protocol was repea ted ad din g the 6E 10 r~-amylo id ( 1- 16) mou se
mo noclona l (Covancc, Emeryville. C A. USA) antibody to the superna ta nt to detect the
synthet ic Ar~ ( 1-42) peptide portion o f co -immunoprecipitatcd Ar~( 1-4 2) and his-H spB I
co mplex es. lmm unprcc ip itat ion o lhuman reco mbi nan t his-Hspls I us ing the anti -HspB I
human (SPA -803) rahhit pol yclon al ant ibo dy (Assay Des igns . Enzo l. if c Sc ience s
Internation al Inc.. Plymou th Mee ting. PA. USA) and sy nthet ic A I~ ( 1-42) usin g 6E I01 1-
amy lo id (1- 16) mo use mon ocl o nal (Co vancc, Emery ville, CA . USA) anti bod y were use d
as posit ive co ntro ls. All samples were centrifuged at 300 0 g ill!' 5 min to separate co -l!'
(A/G beads , antibody and any protein complexes att ached) from su pcrnatant with co -I l'
sa mp les subsequently was hed twice wi th DM EM to rid thc sam ple of no n spec ific
bindi ng. T he co- Il' sam ple was resus pe nde d with 40 pi o f2X lacmml i sa mp le bu ffer
with fresh DTT and e lectro phore sed as pCI'western blot protoco l. Blots were probed wi th
61: 10 [i-am yloid ( 1- 16 ) mou se monoclonal (Covancc, Emeryv ille, C A. USA) and anti -
IIspB I human (S PA-803) rabbit pol yclonal (Assa y Dcsigns. Enzo Lite Sciences
Intcrn ation a l lnc .. Plymout h Meeting , I'A . USA) primary antibodies .
Altc rnatc co- Il' expe rime ntat ion invo lving ce llular con d itioned med ia were
perf ormed si milarly to thc above protocol with thc exce ptio n o ft hc sa mp lc prcp aration
stcps . Initia lly. samp les were thawed and centrifuged at 14.000 g for 10 min. Protein
co nce ntra tion wa s determined and 200 pg of protein wa s uscd for co- lP cxpcrimcntat ion .
Magneti c A/G beads were used to replace thc agaros c A/G beads duc to magnet ic bcad s
bein g easier to usc and thu s mo re effic ient . Three sa mples were e lectrophoresed by
wes tern blot inc lud ing a crude sa mple "C" co ns ist ing ofthe bead s from thc initi a l
equilibrat io n incu batio n w hich co ntai n any non -sp ec ific bind ing to thc bcads be fore
antibo d ies were addcd to thc reac tion . a supcrnatant "S" sa mple co ns ist ing o f thc
d iscarded samp le left a fter centrifugat ion of thc II' and finall y thc co- If sa mple "II'''
co nsis t ing o fthc bcad s and bou nd his- Hspfs l /sAPI' complexes as de noted in Figure 3. 10.
Remaining stcps were as pCI'above protoco l.
2.6 ELISA
Invitrogen Ilum an Ar~40 and Ar~42 ELISA kits were used to quantif y the amount s
or Ilum an A r~40 and Human Ar~42 in ce llular lysate and ce llular conditioned medium or
APPwt and Al' Pswc, transfcctcd with or without pCIG-Hall spl3l-WT-IR ES-EGFP.
Ce llular lysate and cellula r co nditioned medium was collected 24 and 4X hrs post
translcc tion with pCIG-l-Iall spBI-WT-IR ES- EG FP on icc. Cellular lysate was co llected
and resuspended with lysis hurter (I 'x, NP40. 10'% glycero l. O-r~ thioglucopyranosidc.
protease inhibitor tablet , 200 mM sodium vanadate. sodium fluoride and magnesium
chloride in T I3S) and cellul ar conditioned media was colle cted with protea se inhibito r
cocktail tablet (Roche Diagnostics. Laval. Quebec . Canada) added immediatel y upon
co llection as described in section 2.3. Media was centrifu ged at 14.000 g for 5 min at
4°C to discard any cell debri s. Collected cellular lysate and ce llular conditioned media
was subjected to protein conccnrrations using a I3SA protein assay kit (Pierc e Chemica ls.
Rockford. II-. USA). Since 5 ml o f ccllular condit ioned media was co llected per 100 ml
d ish yet only II 0 ~d per \\l:1I was requ ired for the I:LlSA kit. collected media was
concentrated via a 3 kDa nanosep centrifu gal device (Sigma-Aldrich . Oakville. Ont..
Canada ). Through the nanosep omega filte r. the sample is concentrated by centrifu gal
force allowi ng biornolcculc s larger than the cutoffoft he membr ane (>3 kDa) to be
retained in the sample reservoir. Solvent and lower molecular weight molecule s « 3
klra) pass throu gh into filtrate . This a llowed a 500 pi sample or cellular conditioned
media to be concent rated to 50 pi without loss or Ar~ pept ide (4 kDa). Samples were
diluted in the dilut ion hu rter provided with the ELISA kit in a 70:30 dilution as per
manuf acture r ' s protocol. Media contain ing DMEM with 1'% P/S/G, 0.5'1..FCS. 0.5X 13-
27 supplement (Gibco, Invitrogen. Carlsbad. CA USA) and the Al~ degradation inhibitor
0. 1 % phosp hora mido n disodium sa lt ( 17.7 mM. Sigma-Al drich. Oakvi lle. Ont., Canada)
was diluted in a 70:30 ratio with the provided dilution buffer and used as the negative
control for the conditioned media while lysis buffer diluted 70:30 with the provided
di lution buff er was used for the cellul ar lysate negative control. A]] ( 1-40) and All ( 1-42)
standards were provided with the kit and diluted with 70:30 media/diluti on buffer in
serial dilution s from 100.000 pg/ml - 7.'11 I pg/ rnl . Standards 01'7. '11 Ipg/ml - 250 pg/ml
were measured with up to 125 pg/ml uscd to construct the standard curve , ImM of the
serine prote ase inhibitor 4-(2-aminoet hyl)-benzenesultilllyl fluoride (AE13SF) was added
to each standard and sample as recommended by the numuf acturcr due to the ability of
serine protcascs to degrade A l~ pcpt idcs. ELlSA ' s were performed as per manulac turcrs
protoco l through colom ctric assay . Upon 3 hr incubation with a l luman Al~ ( 1-40/1-42)
detec tion antibod y followed by detection using the supplied anti-ra bbit IgG IIRP
antibody. addit ion of stabilized chrom ogen coloured the samples blue reflecti ve o f the
amoun t of Al~ present. A react ion stop solution changed the co lomctric blue to yellow to
signify the cessation o f the assay. Absor bance of each well was read at 450nm. ELISA
Ar~ conce ntrations were lower than reported results (Fig ure 3.'11) , An explanation for this
d iscrepa ncy in values may be attributed to the masking of Al~ by 13SA found in the FCS
present in the media as select protoco ls cal l lor formic acid extractio n to measure Al~
amounts (Sw eeney. Darker. Neville. Humphri es. & Camilleri. 1( 93). i\ l~ extraction \\ as
not carried out in my experi mentation however FCS was dec reased as much as possible
to allow fo r ce ll viabil ity and co ncentra ted medi a All value s we re s im ila r to All value s in
non-concentrated media. Although the amo unt orBSA in the media was lo wered as
much as po ss ible to sti ll ens ure ce ll viabi lity. prese nce may have a ltered the All res ults
negati vely. Alternatively. minimal amounts or monomeric All pre sent in the medi a may
have passed throu gh the nano sep into the discarded filtrate. Gi ven the high vo lume o f
media that was colle cted per sample plate to the expected low percentage or All sec reted
by the ce lls in comparison to tot al sec reted protein, a sample or 500 !" may not be an
appro priate sa m pling to obtain a high concentration or All since theoretically only 10'% or
sec reted All would be co llec ted by this method. Therefo re using sma lle r surface area
pla tes such as o-wcll plate s wou ld a llow for a smaller sample ofcellular conditioned
medi a to be collected ye t a more All concentrated sa m ple.
1.7 Immunocytochemistr y
H EK19 3 ce lls were plated at 1.5 x 101' o n po ly- lysine coa ted l o-wc ll Lab -TeI';(I{)
chambe r slides (L ah-Tckuo). Cells were fixed in 4 '% paraforma ldch ydc in phosphate
buff ered sa line (PB S) for 15 min. washed with PB S and pcrmcabi lizcd with 0. 1'% Trit on
X and blocked with 10'% Hor se Serum for I hr . Prim ar y ant ibodies added incl uded ant i-
API' rabbit pol yclon al ( I : I00. Abeam 151 71. Ca mbridg e. MA . USA ): 61:lOl l-am ylo id
(1-16) mouse monoclonal ( I :100. Co vance. Emer yville. C A. USA): C-termina l anti -Al'P
mou se monoc lonal (I : I00 . Zymcd, Invitro gen. Carlsbad. CA. USA): anti-Golgi mouse
monoclon al ( I : I00. 17 043 Abeam. Ca mbridg e. MA. USA): Rab 5 rabbit pol yclonal
(ea rly endosome. I : I00 . 1 143 5 Cell S igna lling . I cw Eng land. USA ): Rab 9 rabbit
pol yclo nal (la te endo so me . I : I00.5 11X5 Cell S igna lling . I cw Eng la nd. USA ): a nt i-
LA M P- I (H4A 3) mou se mon o clonal ( I : 100. Hybrid om a Ce ll Ba nk ) ant i- II sp25 (S PA-
XOI) ra bb it pol yclon al (I : I00 . Ass ay Design s. Enzo Life Sc ienc es International Inc..
Plymouth Meet ing. PA. US A): a nti-Hs pB I goa t pol yclon a l (I : 100. Santa Cruz
Biot ec hno logy. Santa Cruz CA. US A ) . Cells wer e inc ubat ed in primary a nt ibo dies
ove rn ig ht (- 20 hr ) at 4°C. rinsed wi th PBS a nd inc ubated with seco ndary a nt ibo d ies fill'
I hr in the dark . Seco ndary a ntibo d ies incl uded : Alexa Fluor ,Hi5 55 goa t anti-mo use IgG
( II& L) ( I :250. Invitr ogen . Carlsbad . CA. USA). Dyc lig ht 1 ~1 549- co njugatcd A ffin il' urc
don key a nt i- mo use IgG and Dycli ght 649-co njuga te A ffin if' urc donk ey a nti-rab bit
( I :250 . Jac kso n Lab o ra tor ies. West Grove, PA. US A): Cy 2-co njuga te bo vine anti -go at
( I :250. Jack son Laborat ories, West G ro ve. Pi\. USA ). Ce lls were rinsed wi th T BS- y; r
(T ris-buff crcd sal ine wit h 0.25% Tween) and nucl ear stai ned wi th DA PI (Sig ma -A ldri ch.
St c inhc im.C lI ) in T BS fill' 5 min. Ce lls were ag ai n wa shed w ith T BS- Y:!Tand cov e r-
s lipped us ing pol yvin yl alcohol mounting medium with DAB CO " (Sigm a- Aldri ch .
S tc inhc im.C ll ). Images were o btained in four cha nne ls (40 5. 4 XX. 549. 64 7 nm ) usin g
con foca l sc a nning m icro sc o py w ith seque nt ia l Z-stage sca nning (O lympu s l luo vic w
1000 micro scop e ).
2.X Co- lo ca liza t io n A na lysi s
Co -loca liza t ion ana lys is was per formed o n confocal o ptica l z-s ta ckcd sect io ns
us ing Imari s 6. 1.5 wi th Imar is Co - loca liza t ion mod u le ( Bitp lanc ) to ex ami ne the co -
loca liza t ion o f th e bri gh te st 2'% o f p ixcis in eac h c ha nne l (pro te in of inIeI'est ) by us ing the
computer generated automatic thresholdin g option . This allows an unbiased threshold to
be set for each protein channel ruling out problems caused by variance between cell-to-
cell express ion and image brightness/exposure thus allowing direct compar ison between
cells/experiments. When analysing intrace llular locality. the masking option was used to
select only those pixels corres ponding to the intrace llular compartment channel. For
example . the Golgi channel was masked to identify API' iso lated within the golgi
compart ment there fore excludi ng the remainder of the cell. To further this. co-
localizatio n analysis was calculated on a user determined specific region of interest
(ROI). The ROI was used to isolate each cell individually for co-localization
measure ment. Together. this allows the user to zoom in and isolate a specific region such
as the golgi (through masking) within a specific cell (through ROI) and measure only the
staining found local ized within that region. An average 01'5 images compo sed 01'4 cells
in each totalli ng 20 cells per experiment were analysed for co-loca lization. Values
represent co- localization in the set ROI. Graphing and statistical analysis was per limn ed
using GraphPad Prism 4.0 using two-way ANOVA with Bonlcrro ni post-test. Statistica l
significancc was determined as * 1'<0.05 : ** 1'<0.0 I: *** 1'<0.00 I: **** 1'<0.000 I. The
range of co-localization was determined using the Pearson 's coeffic ient reference guide
which set the limits as follows: None < 0.09: Small 0.1-0..3: Medium 0..3-0.5: Large >0.5.
2.9 Statistica l analysis
Statistical analysis was perlimned in GraphPad Prism 4.0 (GraphPad
Software Inc.. La Jolla, CA, USA). Figures arc shown with mean values ±...SEM with
s ignificance determined by either one-way ANOV A testin g followed by T ukcy post -hoc
tests. two-w ay A O VA followed by Honf crroni po st tests or t-tcst s to compare two
gro ups. I(Jr example +/- Hspl3l . Signi ficancc was determined when p < 0.05 unle ss
ot herwis e stated.
3.0 Co nstruc ts
Co nstructs empl oyed f(JI' tran s feet ion of II EK293 wer e : pEG FI'-C2-lI all spB 1-
WT with subsequent EVC2 (empt y vect or) used as a control (Mcarow ct al. , 2002 :
Willi am s ct al., 2( 06 ) or pC IG-lIall spBI-Wt-IR ES- EGFI' and Al'Pwt or Al'P swc in
co mb ina tion with pm axGFI' .
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Figul'c 2.2 Sc hema tic or API' ant ibody recognit ion sites . Sta ndar d API'
ant ibo d ies were empl o yed incl udin g the an ti-A PI' rabbit polyelon al (Ab eam
15272 . Ca mbridg e. M A. USA) reco gn iz ing the N-te rminus o ft he API' prot ein.
n C I I mou se mono clo na l (M ill iporc , Billerica. MA. USA) ant ibod y d irected
against the N-terminus o lAl' P and th us recogn izing the solu ble forms of API' as
well , the 61:I0 f{-amyloid (1- 16) mo use mo noc lonal antibody (Covance.
Emeryv ille. CA. USA ) which will a lso detect lull leng th A PI' and so luble uA 1'1'
and finall y the C- ter minal an ti-A PI' mou se mon oc lona l (Zy mcd, invitro gen.
Carls bad. C A. USA) anti body wh ich wi ll detect the C-termina l fiugmcnt a long
wit h lull len gth Al' P, I a lso em ployed the anti-sA l' l'f{-swe (6A I) mou se
monoc lona l ( IHL. Gunm a, Japa n) whi ch speci fica lly detect s the so luble IIAI'I'-
swc fragm ent .
API>" t + IIspBIWt / EVC2
APPs\\l' + IIspBIWt /EVC2
Figure 2.3 Experimental Mode ls. IIEK 293 naive cells were co-trunslcctcd with Al' Pwt
or Al' Pswc plasmid along with IIspl3l-Wt or Empty vector (EYC2). Alternative ly,




HspB I has been localized in 15%,of the A~ senile plaques associated with AD
(Wilhclmus ct al., 2(06) . In addit ion. work fi'OI11our lab has shown Ilsp B I exogeno usly
expressed in cort ical neuron s ameliorate s cell death caused by Af~ (1-4 2) (M. King ct al..
2(09) . More widely studied member s of the heat shock protein famil y, HSP70 and 90
have also been shown to inhibit early stages of Ar~ ( 1-42) aggregatio n and this effec t was
thought to be chapero ne based (Evans. Wiscn, & Gcst wicki, 2( 06).
Previous research has shown that while API' is con stitutivel y expressed in cell
types. HspBI may not operate under detectable endogenous levels in all cell types
including cortical neurons (M. King ct al., 200<») . II EK 2<)]ce lls arc a human ce ll line
that expresses huma n HspBI although in relat ively low levels in non-stressed conditions.
Due to the availability of the HEK 2<)] APPwt and Al'P swe stable cell lines and their
case oft rans fcc t ion yie lding an efficienc y of 70-XO'%. I opted to usc the HEK 29] cells as
my cxpcri mcntul modc l. HEK 2<)] cells proved to be a rel iab le model as they allowed 1(11'
the analysis o ft rans fccted rode nt HspBI without endogen ous human Ilsp l3l interference.
HEK 29] cells have been used in API' processing and A~ studies previou sly (Bclyacv.
Kellett. Beckett . Makova, Revert. Nalivacva, 1looper. & Turner. 20 lOb: Citron ct al..
1<)92: Henrique s ct al., 2009: Stcin hilb, Turner. & Gaul. 200 I: Stcinhilb, Turner . & Ga ul.
2002 : Sullivan ct al., 2( 11). Consequently. my first aim was to investigate both the
endoge nous and exoge nous expression of HspB I and A P P/A~ in naive, stable and
transfcctcd HEK 293 cells,
3. 1 Endogenous/exogenous expression of HspB I. APPwt and Al' l'swc in HEK 293 naive
cells
To examine the expression of HspBI and API' in HEK 293 cells in culture. naive
and API' stable cell lines with and without HspB I transfcct ion were plated on collagen
coatcd 100 ml dishes and grown to XO%.conllucncy. Protein Iysatcs were extracted fill'
Western blot analysis. Figure 3. 1 shows the translcct ion efficiency of co-transfcctcd
APPwl. APPswc and EGFP-HspB I-Wt in naive HEK 293 cells. HEK 293 cells were co-
transtcctcd with either APPwt or Al' Pswc and HspB 1-Wt fusion protein or EVC2 (empty
vecto r). A transfcction efficiency of 70-XO% was observed when API' or HspR I were
singly or co-transfcctcd. Column I displays IIEK 293 cells under transmittcd light ("1"1.)
to show the total number of platcd cells, Column 2 displays the transfcctcd cells (green)
under the fluorescence filter (FL). EGFP-HspB I-Wt appears green due to the fused
EGFP tag. API' translcctio n is shown indirect ly by observing the grccn oft he pmaxGFP
construct which was addcd to the transfcction in a 1:4 ratio to the AI'I' construct,
Column 3 is a merged image showing the high ratio oftrans fectcd to non-transfcctcd
cells (Merge), Expression ofco-transfcctcd APPw\. APPswc and HspRI-Wt fusion
protein in naive HEK 293 cells is shown in Figure 3.2 through western blot. Trunsfcction
of EVC2 alone was used as a negat ive control while single translccrions ofeach HspB 1-
WI. Al' l'wt and Al' Pswc were used as positive controls ( lanes 2-4). Al' Pwt, Al' Pswc and
HspB1-Wt arc express ed well w hen co- tra nsfcctcd . Endogenous level s of HspB I arc
undetectable as HspB I is only observed in HEK 293 ce lls tra nsfcct cd with the rodent
HspBI construct and probed with the roden t se lective anti-HspBI (SOl ). T he EGFI' tag
has a molecular weight 01'29 kDa similar to the HspBI protein (27 kDa) causing the
fused protein to appear at the 5() kDa molecular weight. To further confirm the ability to
co-t ra ns fcct and thus exo gen ou sly ex press both the Al' Pwt /swc constructs and HspB 1-
Wt, I employed immuno cytochemistry (Figure 3.3) . Cells were stained with the anti-All
6E I0 (1-16) antibod y shown in red which is a standard antibody used lor de tection ofnot
on ly All but also soublc API' alpha and full-length API' . HspB I expression is evident in
green due to the fused EGFI' tag on the transfcctcd HspB I construct. A merged co lumn
is shown to ide ntify the ce lls ex pressing both proteins, Ce lls ex pressing both API' and
IlspB I proteins (w hite arrows) do not appear to show increased API' sta ining (red) in the
presence of HspB I (green) in comparison to cel ls not trans fcc ted with HspB I (arro w
heads),
3 .2 So luble API' (sAI'I') is sec rete d into the ce llu lar co nditio ned medi a ofco-tra ns fcctc d
IIEK 293 cells.
The detriment al effects ofA~ and Sls on neuronal cells is believed to occur
cxtraccllularly therefore it was pertinent to determine ifdetectable levels ofx Al' !' were
being released into the media of liE K 29 3 cells. Ce llular lysate and cellular conditioned
media from HEK 293 cells transfcctcd with the AI'Pwt and Al' l'swc constructs were
co llected over 12-72 hrs and analysed thro ugh Western blotting (Figure JA ).
Immediately following transfe r. membr anes were stained with ponccau red as a protein
loading contro l (bottom panels). An increase in both expression (A-cellular lysate ) of
APPwt and Al' Pswc and secret ion ofxA l' Pwt and sAPPswe (Bvconditioncd media) was
observed when probed with anti-All 6E l 0 (1-16) antibody. Detection with rodent anti-
Hsp131SOI antibod y revea ls undetect able endogenous IIspl3l levels as a negative control
(Fig. JA ).
J .J Endogenous/exogenous express ion o f Hsp B I in IIEK 2<)J APPwt and Al' Pswc stable
ce lls
Tra nsfcct ion ofpCIG-HspB I in APPwt and Al'P swc stable cell lines is shown in
Figure J.5 . Endogenous levels of API' arc detected in control lanes 1-2 since the anti-All
6E IO(1-16) antibody recognizes human API' fio rn the human ce ll line however a clear
ove r-expr essio n o f API' is ev ide nt in the stable ce ll lines (lanes J-6 ). pC IG-HspB I is
on ly dete ctable in transfcctcd samples (lanes 2.4.6 ) due to the specific ity of the anti-
IIspB I antibody SOI for rodent HspBI. Ponccau red staining used as an indicator of
protein loadin g disp lays equal amo unts o f protein acro ss samples confirmin g that
differen ces observed on the weste rn blots arc due to differences in protein exp ressio n and
not discre pancies in protein loading. Expression o f HEK 2<)JAPPwt and Al' Pswe stable
cell lines transfcctcd with pCIG-HspB I was further confirmed by immunocytochemi stry
(Figure J .6). Unlike the fused EGFP-HspB I-Wt protein. posit ive sta ining tor EG FP in
cells trausfccted with pCIG- HspB I docs not necessarily correla te to posit ive HspB I
expressio n the re fo re sta ining for Il spl3l us ing the rode nt ant i-Hspl3l SOI ant ibod y was
required . As ev ident in the EGF I' (green) and HspB I (red ) image s. cell s were po siti ve
till ' both sig nify ing a success fu l tran slcction and working con struct. AI'I' staining wa s
perform ed us ing the ant i-A ]! 6 E I0 ( 1-16) antibo dy (cya n). Cells exp ressin g both API'
and Hspl3l (white arrows) may show sligh t ly incr eas ed API' stain ing (6 E lG-cyan) in the
presence of Hsp B I (re d) in co mparison to ce lls not tran s fcct cd with Il spl3l (arro w head s )
however thi s is difficult to determ ine from the lo w magn ificat ion and den sel y populated
cel ls.
AI' I' sta ble cell s transfcctcd with pCI G-HspBI appear to express high er level s of AI' I'
tha n the A l' Pwt and Al' Pswc sta ble cel ls a lone (Fig . 3.5) . T his is not seen in the 293 +
Al'Pwt /A l' Pswc + Hspl3l-Wt co- tra nsfccrcd sa mples (Fig. 3.2) lead ing to the qu est ion
whet her the large EGF I' tag on the I-Ispl3l -Wt fusio n prot ein is interfer ing in norma l
ce llular pro tein met aboli sm.
3.4 Absence ofA]! ex press ion in cellul ar lysat e o fA l' Pwt and Al'Pswc sta ble cel l line s
Figure 3.7 Western blot o f ce llular lysate shows A PI' expre ssio n in the Al' Pwt
and Al'Pswc stab le cel ls in co mparison to na ive H EK293 ce lls . As expect ed. Al' Pwt and
Al' Pswc sta ble cel l lines ex presse d much high er leve ls of API' co mpa red to I I EK 293
ce lls as seen in Figure 3.5 . Sy nthetic AB (1-4 2) peptid e was used as a positive control for
AB however AB levels were undetect able throu gh We stern blot in the cellular lysat e.
While fai lure to dete ct A r~ in the cellu lar lysate may see m to que st ion the relia bi lity of the
II EK 293 cell s as a model. it sho uld be noted tha t much co ntroversy ex ists in the Ar~ lic ld
as to whether the All fragment exists intraccllularly or on ly as a secreted peptide. Many
investigators believe previous intracellular staining by 6EI0 of what was thought to be
All may actually be the All fragment within the uncicaved AI'I' protein and not free AI\ as
our technology for visualization ofcellular components advances ( : :294 Winton. M.J.
20 11:: . If this is the case. a high presence or the 4kDa All peptide would not be
expected in the cellular lysate.
3.5 Increased secretion o f A~ (1-42) in cellular conditioned media a llcr4S hrs is
decrease d in thc prcscncc nfHs pls l
Due to undetec table levels o r A~ in cellular lysate via Western blot and the
present controvers y surrounding its presence intraccllularly, I turned my atten tion to the
more sensit ive ELISA. ELISA kits specific for each A~ ( 1-40) and A~ (1-42) were
purchased from Invitrogen. ELISA or All (1-42) was first carried out on 24 and 4S hr cell
lysate ofstable APPwt and APPswe cell lines transfcctcd with Ilspl3l-p CICI. All ( 1-42)
was undetectable in cellular lysate samples. This experiment was carried out once in
duplicate therefore further experimentation is needed to concl ude the absence or All
within cellular lysate however coupled with the negative western blot data I decided
against additional lysate testing for All. I ext. ce llular condi tioned media from 24 and 4S
hr stable APPwt and APPswe samples transfcctcd with Hspl3l -pCIG was measured lor
secreted All ( 1-40) and (1-42) levels. Results from three biological samples in duplicate
were statist ically analysed as shown in Figure 3.S. APPwt cell media disp layed increased
levels of A~ (1-40) over A~ (1-42) suggest ing that the APPwt cells arc undergo ing non-
amyloidogc nic process ing mor e readi ly than amyloidogcnic proccssing as ex pec ted . Ap
(1-40) levels re ma ined fairly constant over 411 hrs in both APPwt and Al' Pswc ce ll medi a
with and without Ilspl3l express io n sugges t ing that Hspl3l docs not have an e ffect on the
non-amyloidogcnic AP (1-40) . In contrast, Ap (1-42) protein levels show a significa nt
incrcasc aflcr dS hrs in thc Al' Pswe ccll mcdia as ex pected. yet this incre ase is not
observed when HspB I is presen t. These result s ind icate Hspl3l may have an effect on thc
lcvcls o fA f (1-42) bcing relea sed into the medi a. thus I explore d a plau s ible rclationship
between HspB I and Ap (1-42). Statistical analysis was perf ormed using a two-way
Anova with Bonfcrroni post-hoc tcst. n=3: F=0.04 and p=0.91170 (A[{( 1-40)) and n=3:
1=4.49: p=O.OI11 I (AI{( 1-42)).
3.6 Synthet ic Ap ( 1-42) pept ide and recomb inant lI is-Hspl3l pept ide co-
imrnunoprccipitatc.
To investigate a relationship betwe en Ilspl3\ and AP (1-42). I employe d a co-
immunoprccipitation technique. Thro ugh incubation of human recombinant his- l lspBI
protein and synthet ic AP (1-42) pe ptide with antibody-bound magnetic A/G beads, I was
able to demonstrate that human recombinant his-l lspB I and synt he t ic AP (1-42) co-
immunoprccipitatc, suggest ing a direct interaction , T he anti-A]!6 1 ~ I0 [{-amyloid ( I- I(I )
mo use monoclonal (Covancc, Emeryv ille. CA. USA) was used I(lr thc II' and thc blot
probed with thc anti-Hspl3l human (SI'A-1I03) rabbit polyclonal (Assay Dcsigns. Enzo
Lite Sc ience s lntcrnutional lnc.. Plymouth Meet ing , I'A. USA) and vice versa (Fi gure
3.9) through Western blot analysis to confirm an interaction . If IIspB I is able to directly
bind to Ap ( 1-42). it may be able to bind to APP. This led me to consider a potential
relat ionship with HspBI and thc full length API' .
3.7 Recombinant His-HspBI co-immunoprccip itatcs with so luble AI'P alpha
I repeated thc co-immunoprccipitat ion technique this timc using 4Xhr sample 01"
cellular conditioned media fro m stable AI'Pwt and Al' l'swc cell lines incubated with
human recombin ant his-l lspBI. Similar to my findings with Ap. these data suggcst a
direct interact ion between his-HspB I with secreted sAl' l'u 01" Al' l'wt and Al' Pswc
indicated by the high molecular weight band (AI'P- I I0 kDa) when immunoprccipitatcd
with anti-A]!61:10 f)-amyloid ( 1- 16) mouse monoclona l (Cova ncc. Emeryville, CA.
USA) and probed with anti-lIs pBI human (SPA-XOJ)rabbit polyclonal (Assay Designs.
Enzo Life Science s Intcrnationall nc.. Plymouth Meeting, I'A. USA) (Figure 3.10). Since
HspBI co-immunoprccipitatcs both APPwt and Al'Pswe soluble alpha fragment s. it is
plausible that HspB I is interacting with thc Ap sequence within sAl' l'u: however this is
speculation at this point.
Fij:u rc 3.1 T ra ns fcct ion efficiency of Al' l' wt, A l' l' swc, EC F I'- lI sp BI- W t
a nd EGFI'-EV C2 in nai ve IIEK 293 ce lls. A transfcction efficien cy of
70-80% was observed when API' and I lspB I we re sing ly or co-transfcctcd.
Colu mn I consists ofpl atedH EK 29.1cellsunder transmi lted ligh t tll .)
microsco py with out the flou rcscc nce IiIter. Co lumn 2 displ ays the
transfectcd ccll s underthe fluore scen ce lilte r (FL ). EFG P- l lsp B I-Wt appea rs
green due to the fused EGF P tag . Al' l' trantection is shown ind irectly by
observing the gre en o ft he pmax-GlP construct which was added tot he
transfcction ina 1:4 ratio to the A1'1'co nstruct. Therefore, if 21t!of
pmax-G FP yie ld 50% transfcct ioncflicicncythcn lcan assumc8plofAP P
wi ll giveat lcast 50%transl'ectioncl"l icie ncy. Column Lis a merged image
showing the high ratio of trans fcc ted to non-tra nstcc ted ccl ls tMer ge) .
29.1 , HspBI -W T
293 + 1\PPwt +
plllaxGFP
293 + A PPswe +
plllaxGFP
29.1 + A PPwt +
EVC2
29.1 + A PPsw e +
EVC2

























Fi!:un ' 3.2. Express iuu of cn-t ra ns fec ted '\ " " \\ 1.A1'1'"" , a nd EG FI'- II, p UI- WI fusion p ro tein iu nar ve II EI-.:
293 cells. H EK 29.1 cells were co- tra nsf cc tcd with either Al'l'wI o r Al' Pswe and EGF I'- Hsp BI -WI fusio n protei n o r
EG FI'-E VC2 (em pty ve ctor ). Transfccti on of EGFI' - EVC2 a lone wa s used as a negat ive co ntro l w hile s ing le trans-
tcct io ns o f each EGF I'- Hsp B I-WI , A l' Pwt and Al'P swc were used as po sitive con tro ls ( lanes 2-·1). A l' Pwt , Al'l'sw e
andEG FI'- lI spB I-Wtare c, prcsscd wcllwhc neo-lra nsleet ed (la ncs 7-8) . Endo gcn o us lcvcl s o fH sp ll l are uude -
tccrab lc as Hspli l is o n ly o bse rved in II EK 29.1cc lls tran s fccted with the rodc nt EG FI' - l lspl j l -Wr co nstruct and
pro bcd with rhc rodent Hsp li l detec tab le antibo dy 80 1. T he EG Fl' lag has a molecular wei ght o fZ' J kUa sim ila r 10
the Hspl s l pro le in (27 kD a ) ca usi ng the fused prote in 10 appear at the 56 kDa molec ular wei ght
6E10
801
Fi~lIr('3 ,3E\pr('ssin ll()fcn-lransf('Cli() nnf na iH' IIE k: !') 3 n'II,wil h H;F I'- II,pB I-Wland
APP",. ur A I)Ps \\"l' cunst r urt s hy inuu unucvtuchemistrv, II EK ~ 9J na ive ce lls \ \ "(' 1'(' co- trans-
fecledw ilhe ilher Al' l'lVlnr AI'PslVeand pEGFI'-C2- lIsplll -WI fusion protein. Cells were stained
wilh lhe al1li-AIl 6EIO( I- 16) anlihody shown in red which is a standard antibody used fo r detection
of noI only AJ\ bill also sOllbk APP alpha and most importantly torthi s workful l-lcugth A!' I'
IIspB I expression is evident ill green due to the fused EGFl' lag oll lhelra nsfecred l lspll l construct
A merged column is shown 10 identify the cells expressing both proteins Cells expressing both APP
and I l spl ~ I constructs (white arrows) do not appear to show increased APP staining I(l l: lu-red) il1 111l'








Fi!:Url' 3A Level s or A I' I' exp ress ion in cel lu la r lys at e a nd co nditio ne d med ia or naive II EK 293 ce lls t ran s-
recte d wit h A I' I' wla ndA I' I's weco ns t ru ctonr72 h rs . Cc lllliarlysa tc andcclllliarcondi tioncd mcdia from
II EK 29 3 cc lls tran sfectc d with thc Al'P wt and Al' Pswc co nstructs we rc co llcc ted ovcr 12-72 hrs and ana lvsc d
throu gh Western blot tin g. Immediately fol lowin g transfer. me mbr anes were sta ined wit h ponCC3 U fed asa·
protein load ing con trol (bo tto m pa nels). An increa se in bot h ex pression (A -cel llliarl ysa le la nd secre lion( ll -
co ndi tioned med ia ) o f' A l' Pwt a ud Al'P swe wa s observed when probed with allli-A J16 E IO ( I- 16)alllihody
Detec tion w ith rodc m a nti-l lspl l l SOl alllihody resea ls llnde tec tab le endoge nolls i lspll i les elsas a lwga lis e
control
A 293 t Al' l'w! 293 + Al' l'swc
B 293 \ Al'l'w! 293 + Al' l'swc
l $ -5 s -f .:: l $ $ .f f -f;; ~ :t s ;:::, ~; :R :t ;:::,
Figllrr3.5. E' prrss illn nf lransf,'ctl·d pC IG- lIspll l in Al'Pwt and Al'P swestnhl ecell lim's.
Endog eno us leve ls o f A PP are detec ted in co ntro l lanes !-2sincc the ant i-A p 6 E I0 ( 1- 16 ) am ibo dy
recognizes human APP from the human cell line howeve r a clear ove r-ex press io n ofA PP is evident
in the stable cell lines {lanes 3-6) . pC IG -lI sp B I is o n ly detectable in tran sfeci ed samp les (lanes
2.4 .6) d uc to the specificityo ft hc am i-Hspff l antibody 80 1 for rod e m ll spB I . A PP sta b le rc lis
tra ns fec ted wit h pClG -l lspB I appear 10 express h igher leve ls of A PI' tha n the APP wt a nd AP Psw e
slab le ce lls alone . Th is is not seen in the 293 I Al ' Pwt/A l' Pswe I II spB I-W t co -trans fec ted
samplcs lcnd ing the q ucslion as lll whcther thc largc EG r P tag on thc l lsp B I-Wt fus ion pro tcin is
interfe ri ng in the no rma l ce llu lar metabol ism . POl1ccaur cd swining uscd as an indicatoTofp rolcin
load ing d isplays equal amounts ofprotei n across samples confirm ing rhat diffcr cn ce s obscrvcd on




Fi\: lIn' 3,6 E' pn'ss iollo r llE K 293 sl a hle Al'l 'wt a nd A l' Pswesta bl« cel l lincs tr ansfect cd wi th
pCIG-lI all spll' -W" ~IH ES- EG FI' hy im m unucyt or hem istry, HEK 2l)J stab le ce ll lines ofA l' Pwt and
Al' Pswe were tran sfcctcd wi th the pC IG-ll spll l co nstruc t and subjec ted 10 immunoc ytoche mis try. Cel ls
cxp rcss ing both A t' P and Hspln (a rro ws) may show slightly increase d API' stai nin g (6EI0-cyan) in the
prcsc ncc o tH spls l ( red )in compa ri sonlo eell snoltranst~cledwilh Hspll l (arrow heads) how ever this is
ditli eulttodetermin e! r omlhel owmagniti eati on and denselypopulaled ee lls . Sincc Hspll l is not fused
10 EG FI' (gree n) in the pCIG con struct as it is in the EG FI'-Il sp ll l WI, sta ining for HspB I using the
rodentanti- Il sp ll l SOl wa s require d (re d ). As evi den t in the EGF I' (gree n) and IIspll I (redj image s. cell «
werep ositi \'cforh oth signifyi nga successfultt ransfection andw orkingcon slTuct
APPwt + pCIG-HspB1
EGFP HspB1 APP Merge
APPswe + pCIG-HspB1
EGFP HspB1 APP Merge
Figurt.· 3.7 Ahsl'n{"f.' of A ~~ ('\llrl'Ssion in cellu la r I~ sal l' of AIIP"1 and AI-IIs\\(' stab le cc ll lin rs ,
\Vcstcrn hlot o f cclllllar lysatc shows APP c\ prcssion in thc Af'Pwt and Al' Pswe stable cells in compari son to
naive II EK29.1cells . As expected, Ap Pwt and Al'P swe stable ccli lincs expressed much higher levels of AI'I'
compa red to II EK 29.1cells as seen in Figurc J .5. Synth cticA P II -.J2) pcpl idcwasn scdas aposit i\ ·c cont rollllT
A]] howe ver A]] levels were unde tectable through W CSlCTI1 blot in the cel lula r lysate , Th is may be due to lowe r
than dc lcc lablea mo nntsof All throngh wcslcrn blolor Ap bc ing abscnt from cellular lysate and only prcscnt in
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Cellular Lysate
Figun' J.N In creased prot ei n e xp ression of All ( I · .H) a fte r ~N hr s is not " " ' U iu the pn'.. -nce of
II spHI. l)ue to the llndetec tabl e levels ofA~ in lhe ce li ula r l ysate \' iawes tem blot , the more sens itive
ELISA wa s used . A: A~ ( 1--12) wa s fi rst ca rried out on 2~ a nd ·IS hr cellular lysa te o f stable APPwt
and A l' Pswe ce lls tran sfccrcd wi th pClG -Hsp B I. A~ (1 ·~2) was dcctablc within the cell ular lysa te
through ELISA but docs not appearto vary significantly betwee n APPwt and APPswc with
pC IG-Hsp B I tran sfec lion how everthi s is an N=2 lhere fo re further tesling isn eeded to con f rm valu es
B: Ce llular co nditione d media from 2~ and ~S hr stable A PPwt and A l' Pswc samples transfccted wit h
pC IG-HspB I was mea sured for secre ted Ap (1 -40) and (1-42) leve ls. A PPwt ce lls d isplayed increased
le\' els of AII ( I-40) o\' er AII(I -42) sugges ting tha t AP PWIce lls arc undcrgoing non -a my loido gcnic
processing mor e rea dily than amyloidogenic as ex pec ted. Ab ( 1-40 ) level s rema in fair ly constant over
4S Iu s in both the APP wt and A l' Pswc ce lls w ith a nd w ithout HspB I express ion suggesting that
Hsplll docs not affect thc non-am yloidogcni c Ah t l -a n) I n cont ra st .A~ ( 1 -4 2 )prote i n level is
significantly increased in the A l' Pswe ce ll line at 4S Iu s co mpared 10 all other co nd itio us
Interestin gly, th is increase is not detectable in the Al' Pswc ce lls tra nsfc ctcd wu h Hsp BI . ·p <O.O)
Lysat e An (1-42)
: -~; ~;:24 IlfS + pC I~HspB 1





24hrs+ pC I~HspB 1




24hrs + pC I~HspB 1
_ 48hrs + pCIG- HspB 1
Figun'3.9Syn lhe lirAf! ( I- I2) l' el' lideiseu-i1n lllu nu l' redl'i la led wilh recnmbinant human his-Iaggl'd 11s111l1
in vi t ro , Synthetic Af! ( I--I~) and recomb inant human his-I IsI'Il I were inc ubated overnight at ] T" in PIIS. The
followin g day, coo rc lative rever se IP's were performed using ami -human I Ispll I antib od y XO] or anti-A]! 6E 10
( 1-16) with magnet ic dynabcads. Western is probed with XO] and 6EIO . Synthetic All (1 -4~) and recombinant
his-I lsp lll wer e run as positive control s as wel l as immunoprccipit atcd his-l lsplll and AJI (1 -4~ ) . Presence or
both protein s when co-iped with XO] or 6 E I0 suggest s a direct interaction between Il spll l and AJI ( 1 -4~ ) . Th e
lowe r ofthe two hands in the SO) blot is be lieved to he non-specific binding as itappears 10 correspond to Ig( i \
mo lecu lar weight.
;\1\(1 -42)
his-l lsl' 27 -
I I' - ~03
11' - 61010
- - _ ........ -12 kDa
Figun 'J. IOlIsp BI Sllfft.'ssfully( 'o-immullo))n't.·ipit:th's \\'ilhsu lllhlt.'A I)P i11t.'t.'lIularflmditiollt.'d nu-d i..
Conditioncd mcdia from A PPwt and A PPswcc clls wasinc ubatcd with recol1lhinant hul1lan his-l lspB I
o vcrn i g h t atJ 'Zv d c g rcc s . 6E I Owas uscd toi mmlillOprecipitatc sAPPu with magncticb cads. Three s a m p l e s
were electr op horese d by we stern blot inclu din g a crude samplc t'C 'l co nsistin g o ft hc bcads fro m the ini tia l
l'q uilibralio n inl'ubal io n w hil'h wo uld l'Onlai n any no n-s pl'c ifk bind ing bl'fo rl' a lll ibod il's wl'rl' addl' d lo lhl'
reaction: a supernatant samplc "S" consisting of the discarded samplel ctt aftcr ccntri fllgation oft hc co-IP
and fi na lly thc co- H' sa mplc co nsis ting ofthe bead s a nd bound Hsplli /sAl'Pu comp lcxe s . Hsplll is
co-il1lmunoprecipitated withs APPa as secn by thc ballds corrcspond ing to 27 kl.ra whc n probed with
alll i-huma n lls p B I803 (bollom ) and imm llnoprl'l'i p ilOll'd w ilh 6 E I0 . WeSlern was probe d wilh6E I0 (A PP)
and 803 (lI spB I) 10 sho w the pre sen ce o fbo th prote ins . Wesle rnblol o f 6 E I0(lOp)wasnol strip ped
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3 .X Does Hsp l3l decr ease the ac c umul ation of A I' I' prod uct s with in ce lls?
Studies inves t igat ing th e ro les o f fami liar hea t sho ck prot ein s suc h as Hsp 70.
I Isp90 and atax in-2 . fo cu s prim aril y o n their c hape ro ne ab ility as the main effe cti ve
fu nct io n in inhi b ition of prot e in aggr egatio n ( Eva ns et a!.. 20(6). T his lea d me to
q ues tio n w he ther there are diff er en ces in A I' I' accumulati o n in H EK 293 Al' Pwt and
Al ' Pswc sta ble ce lls when Hsp l3l is presen t. Using imm uno cyt ochemistry , H EK 293
A l' l'wt an d A PPs\\, e stable ce lls tra ns fcc tcd wi th pEG FI' -C2-ll aH sp BI - WT wer e plated
at 1.0 x 10' de nsi t ics o n l o-wc ll s lides . As see n in Fig ure 3 . 11. cel ls negat ivc fo r HspB I
sho w accumulat io n of A PPIAp sta ining (red-6 E I0 ) th rou gh out the cyto sol. Aga in. th is
ant ibo d y not o nly de tect s the fu ll- lengt h AI' P. but a lso the im ma ture A I' I' . -t run carcd
fo rms as we ll as the Ap region as it reco g nizes the ami no acids 1-1 6 o f A PI' . Hsp l3l is
sho w n in gr ee n and as expected. appe ars cyt o sol ic : the eD NA co nst ruct used result s in a n
EG FI'-Hs pB I fusio n pro te in. T he merged image sho ws HspB I pos it ivc ce lls (green-
EG FP) do not appea r to have s im ilar sta ining o f A PP/A P in the Al'P swc ce lls in
co mpa r iso n to A I' Pwt. In fact, local izat ion of the A PI' sta ining o f the A PPswe ce lls
a ppears to cha ng e in the pre sen ceof ll spBI .
3.9 Do es HspB I a ffe ct the produ ction a nd release ofamyloi do gc n ic prot eol yt ic produ ct s
o f'A l' Pswc ?
O nce I determi ne d that Il sp B I is ab le to bind di re ct ly to sy nthet ic Ap (1-4 2)
a lo ng with sA I' I' . I wa s inte res ted in w hethe r HspBI eli cit ed any effects d irectl y o n
processing of API' or on the API' proteolytic product s. Since the A~ pept ide is a product
or API' proteo lytic processing, it cannot he released ir API' is not cleaved hy enzymes
13ACE and v-sccrctasc.
3.9. 1 Expression o fma ture and immature API' remains unchanged in the presence o r
Hsp13I in both Al' Pwt and Al' Pswc cells.
The novel finding ofHsp131interacting with sAl' l'u , the decrease seen in A~
amounts present in the media o r Al' Pswc cells when HspBI is present. taken with the
undcctablc A~ levels intraccl lularly. lead me to question whether HspBI influences the
maturation process of API' thereby decreasing the availabilit y of API' for cleavage and
A~ production. Employing western blot analysis, I characterized mature and immatu re
API' by antibody recognition ofthe I -tcrminal region (22C I I) in the cellular lysate or
Al'Pwt and Al'P swc cells transfcctcd with pCIG-ll sp13l . Although the western blot data
shown appears to show some variations in expression, upon analysis oftrip licate samples
no statistical difference s were found in total levels ofmat ure or immature API' whether -
wt or - swc. concluding Hsp13I having an influence on maturation of API' to he unlikely
(Mature AI'I'1>95 n=3. 1'=0.27, F=I .9: Immature AI'I\ "5 n=3, 1'=0.17. F=2.S - Figure
3. 12A&C ). Endogenous levels of API' were also measured which did not show any
significant diffe rences in API' levels between Al'l'wt and Al'Pswc stable cells (Mature
AI'I'7711 751n=3. 1'=0.6 I. F=0.67: Immature A1'1'770175I n=3, 1'=0.9S. F=0.06 - Figure
3. 1213).
3.9.2 CTF~ level s remai n co nstan t whcn Hsp ls l is expressed in H EK 293 Al' Pw t/swc
stable ce lls.
To test whether prote ol yti c produ cts of API' processi ng are affected by Il spBI
ex press ion. I probed the ce llular lysate we stern blots with an antibody which detects the
C-termina l fragme nt of API' that is detected after a or ~ - sec ret ase cleavage . When I
employed densi tometry ana lys is. a lthoug h a s light ele vati on in the CIT-~ frugmcn t or the
fragment cleaved by ~-secretase. was seen in the A f' Pswc ce lls in the pre sence ofll spB I.
thi s was not significant when stat ist ica l anal ysis was emp loyed . Simi larl y. CT F-a d id not
show a lte rnat ing level s ( CI'F-r~ n=3 . 1'=0.95. F=O. IO: c n :-a n=3. 1'=0 .1':1':. F=0 .22 -
Figure 3. 12D) . HspBl-pCI G app ear s to have better transfcct ion efficiency in the
Al' Pswc cell s ac counted by the den ser band in the we stern blot data tor Figure 3. 12.
3 .9 .3 Is Releas e o f so luble API' influenced by the pre sence ofHspB 1 in Al'P swc ce lls'!
Next I co ns ide red Il spB I influencin g the relea se o f so luble API' from the cell s
into the media . Media conditioned from the ce lls used in the abo ve experiment was
co llec ted in add it ion to the ce llu lar lysate and asse ssed usin g we stern blo t anal ysis
(Fig ure 3. 13A ). Secret ion levels of sAl' I' were unchan ged in the presen ce o fH spB I and
alt ho ugh sli ght variat ion in total sA PP protein was ob ser ved. sta tist ica l analys is sho wed
no difference between tr iplicate matched timcpoint samples with and withoutl lspBI .
Stea dy sAPl' a level s were seen in Al' Pswe medi a samples and ag a in varia t ion ob served
was insignifica nt when trip lica te experimentat ion was ana lysed. S imi lar to CTF~ level s.
sA I' I' ~-swe level s remained con stant in the presence of HspB I. Overall. result s from the
ce llu lar co nd itio ned med ia co inc ide with the correspond ing cellular lysate dat a o f API'
pro teo lyt ic produ cts concluding I-1 spl3l doc s not appear to have an effect o n the
matur ation or pro ce ssin g otAl'Pwt or Al' Pswc in vitro as evident by the steady level s of
API' and API' proteol ytic products o bserved (Tot al sA 1'1' n=3. I'=O.XX. F=O.22: sA PPa
n=3. 1'=0.57. F=O.75: sA I' I' ~-swe n=3. 1'=0.<)0. F=O. I<)- Figure 3. 13(3).
3. 10 Cellular locali zati on of API' and I-1 spB I
Investi gation into the effect s o f HspB l on A I' P/A ~ accumulation requi red further
investigat io n into the ce llular local izat ion of the two prot e ins thus pro vidin g insig ht into
po ssible areas of intera ct ion. 24 and 4X hr sa mples of ce llul ar lysate were take n fro m
Al'Pwt and Al' Pswc cell line s plated o n 5c m co llag en coa ted cell cu lture d ishes
transfcctcd w ith the HspB l-p C IG con stru ct. Prote in wa s run and western blot ana lysis
was subjected to antibod ies agai nst earl y cndosomcs (Rab5 rabbit pol yclon a l 214 35 Ce ll
Signa lling) . late cndoso mcs (R ub <)rabbit pol yclon al 511 X5 Ce ll Signa lling ) and
lysosomcs (LAM P-I 114A3 mou se monoclon a l Hybr idoma Cell Ba nk) to determin e if
there were cha nges in the intracell ular co mpartments where API' is known to und ergo
process ing . Leve ls o f a ll three ce llu lar co mpartme nts we re s im ilar in samples with o r
w ithout I-1 spB 1 pre sent ( Figure 3. 14 ). Th is s igni lies that the pre sence o f I-1 spl3l doc s not
affec t the con cent ration of the intracell ular compartments yet did not answe r my qu estion
o I'whet her Hsp131 and API' were inter actin g within the se co mpa rtments o r whether
distribution of API' pro teo lytic products between these com partments wa s alte red by the
presence of HspBI. To explore these questions I employed immunocytochemist ry along
with computer so ftware generated 3D-rendering and co-localization analysis to visually
conceptuali ze possible areas of interaction and distribution changes between API'
products and HspB I with in specific intracellular compartments. Pairing of the antibodies
was chosen based on the recognized API' product and hypothesized intracellu lar location
as well as the ant ibody species to ensure visua lizatio n of all antibodies used. API' is
known to mature within the golgi compartment where it becomes glycosylated there fore
theant i-golgi mouse monoclonal antibody was used with the anti-Al' P rabbit polyelonal
15272 Abeam antibody. Likewise. early and late endoso mes arc both thought to be sites
of secretase cleavage and thus the 6E 10 [i-umyloid (1- 16) mouse monoclonal was
employed with both the early and late cndosomal markcrs Rab 5 and Rab l) rabbit
polyclona l to not only recognize full length API' but also A I~ and soluble API'. Finally.
due to the recent evidence that Al' Pswc undergoe s trafficking to the lysosomc s, the C-
terminal anti-API' mouse monoclonal (Zymcd) was paired with the lysosom al marker
anti-LAi'v1 P- 1 H4A3 mouse monoclonal (Hybridoma) to identify API' and the C-tenninal
end product of' y-sccrctasc cleavage to determine if this change in traffick ing would be
evident in the Swedis h mutated API' cells. Figure 3. 15 displays both
immunocytoc hemistry as well as images generated through the co-localization so tlwarc
ofa representative cell fro rn thc Al' Pswc and Al' Pswc + pCIG-l lspl3l groups to visually
represent the collection of data. Panel L 2. and 3 show immunocytochemistry of API'
using the anti-A l' P rabbit polyclonal 15272 Abeam antibody (red) . golgi staining using
the anti-go lgi mouse monoclonal 27043 Abeam antibody (cyan) and a merged image also
displaying HspBI tr ansfcction using the anti-l lspB I goat polyclonal Santa Cruz antibody
respect ive ly, l'a ncl4 is a 3-D surface rende ring image ofthc thresho lds set by the
brightest pixels o f staining cancelling out the backgrou nd. Additio nally, the region of
interest (ROI) is shown as a white outl ined box surro unding the ce ll to be measured.
Finally. panel 5 is an image o ft he co- localization shown in violet. This rep resent s only
the pixels con taining both the red (API') and cyan (Go lgi) after co-localization
ca lculat ion has been performed . This proc edu re was repeated tor 20 ce lls o fe ac h group
and the generated co- loca lization avcragc values were plotted in Figure 3.16. Figure
3. 16A displa ys co- localization of Al' Pwt and Al' Pswc with Hspl3l in specific cellular
compart ments to address the question o f which cellular area has the highe st co-
local ization o f API' and HspB I. Data displayed in 3. 16B answers the question o f
whether changes in distribution o f API' products occur when Hspl3 l is present. This
looks particularly at localization o f API' in ce llular compartments with and without the
presence of Hspl3l . Neither Al'Pwt nor Al' Pswc were strongly co- loca lized with Hsp131
given the Pearson ' s co e ffi cient values for co- localization in any o f the intracel lular
co mparuuc nts. This is not surprising since HspB I is a cyto sol ic pro tein and theref ore
any binding action would be expected cxtraccl lularly as seen with Arl. Interesting results
eme rged whe n the distr ibution o f API' was measured in the cel lular compart ments with
and without HspB I. Al' Pswc is sig nificantly decreased in all compartments whe n
measured in the presence of Hspl3l . This co rres ponds to earlier ICC data whe re API'
accu mulat ion appeared to decre ase in the presence of ll spl3l in thc Al' Pswc cc lls (F ig.
3.11).
Figun ' 3. 11 lmmunucytorh cmi str y d ispht~'ing differ en ces in cel lu lar accumu lat io n of A 1)11in
AI'P,,\!' stab le cells Ir ansf,','(",1 .. ith pEG FP-C2-lI sl'III -Wt.
Us ing immunocytochem ist ry, IIEK 29 3 A l'Pwt and Al 'P swc stab le cells tran sfcctcd wi th pEGFI'-C 2-
Ha l isplt l- WT were plat ed at 1.0, 105 den s it ie s o n 16-well s lides It spll l is show n in g ree n an d as
expected . app ears cy rosol ic: the c DNA co ns truc t used result s in an EG FI'- Hspll I fusion protein . Cells
negative for Ilsplll (w itho ut green I s how acc um ulatio n of AI' I'/A n sta in ing (red-o li l Oj throu ghout thc
cytoso l in the A l'P swe ce lls . Th e mer ged ima ge sho ws It splll posit ive ce lls (green -EG FI' ) do not appe ar






Fil:lln· J . 12 I' ru cess illl: o f A I' I' in II Eh: 29JA I' I' '' land A I' I'S\\ esla blecell lines rr an sf ect ed with pC 1(; -
II splll co ns t r uct, II EK 2l)J APP"l and APP s"e stab le ce ll line s we re gro wn to 80~ o co n tl uency and tran s-
fec tcd with the ptKi -Hspli l co ns truc t. PrOle in and co nd itio ned med ia we re co llec ted 24and 48 hrs post
transfection. A: Employing western hlot analysis. I characterized mature and immature APP in cellular lysate by
antibody reco g ni tio n usin g the Nvterminal regio n an lihod y22C I I (Mi llipore)and lhe C-ter mi na llragmelll swere
recogni zed using the Al ' Pu mi -Cucrmi na l antibody tZy med ). Ce llular Iysa tc s ho ws var iauo n in expre ss ion o f
the different fonn s o tA l' P pres cm thou ghout proc essi ng wi th and wit hout pC I(;- Il sp ll l ovc r 48 hrs . Red arrow
matur c i\PP770 I7SI ;blw..· a rro\\,: mat ure 695 ; green arrow : I111lIIat ure 770175 1; yellow arrow: llll lllature 695;
lilac arrow: (' -Ienni na! lkaqua arrow..: C-(cnni nal u . B: Den sitometry analysis on endogen ou s level s ofAPP770
form s in the pres ence o r pClG -l ls p ll l . Il spBI does not appear to al ter over a ll exp ression of mature or
immature APP770 as there arc no significa nt changes in level s regardless o f pC IG-l lspB I expression. C:
Alth ou gh the we stern blot dat a sho wn appea rs to sho w so me var iations in expressio n, upo n analysis o f tripli cat e
samples no statistical differences were found in total levels of exogenousmatur e or immatu re APP695 whether
-wt o r - swe , co nc lud ing Hspll I hav ing an influence on maturat ion of A !'!' 10 he unlikel y. I) ; Weste rn blot
sho ws intrace llu lar C T Fu and CT Fp remai ns fairl y con sistan t amo ng co ndi tion s when pC IG -H spll l is pre sent
Differ ences see n in pC IG -Hsp ll I le vel s bel ween A p Pwl and A PPswe ce lls are indic ative ofa stronger transfcc-
tion within the Al 'P swe ce lls
No re: A P I)", . and A Pl's'H' cell lines ovcrc xprcs » the 695 isufurm : 77 U175 1 is l'lId()~ l'n()lI s In
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mID 48 + Hsp27
Figlln ' J . I3 Solllb lr AI' I' lr , 'r1s iIl I'C IG-11sI, II I I, o, il is r r o nd it ionr d nH·d ia. A:\Vestern blot o fco ndi tioned
mediacollecled lromccll s sI1O\\·ninfigurc3.12 showingthc\'ar iation ofr e lease ofso luble Al' P tonu s into
media with and wilhontI' C IG-l lsl' lll : ' sArr total , ··sAr Pa . II: Densitomet ry analys is on relea se 01"so luble
APP forms in the presence of IIspB I. Secretion o fs APPu and s :\ p pr~-s \\'c foll ow s similar trend 10 CTFu and


















mID 48 + Hsp
Fi~ lI n' 3.1-1. lntra r ellul ar markers, Western II10t of'A l' Pwt and Al'P swc ce ll line lysate wi th an d with out
pC IG· Hspll l over 48 hrs probed with intracellula r marker s for lysosom cs (LA i\IP I) , early cndo so rncs (Ra b5) and
l a t c cndosol11cs (Rab9 ) . ~o sign i licantd i tlcrcnccs can bc sccn ll cross samp lcs
24 48
Rab 5 ------~----
Fi~urc3. IS Co- l."ra l i l.a t i"u aual) , cs "r"PI '"t . """ s" c and IIsplll within int race llular
com par t ments Co-localization analysis was applied to immunocytochemistry of APPwt, Al'P swe
and Hsplj l ill variolls ccll ular compartm entsi ncludingth e golgi apparatlls, eariyandlate clldosomcs
and lysosomcs to determi ne if Hspl! I is co-loca lized to the same re,:ion as "l'l' and if A1'1'
loca lil.alionwi lhin lhecellc han,:cswhcn ll spll l is present. A: lmnum ocytochem ist ry was appli ed
10 label cells with the \'arious amih odie s.:\I'I' (an li-Ah6E I0( 1-16) mo usc monoclonall. l lspll l
(anti-l lspBl goat polyc lona l), and Go igi (anti-go lgi mouse monoclona l) arc shown as an cxample
Auto matic threshold s were ca lculated for eac h color channel as seen in panel -I. The white box
surround in,: a sin,: le celi represellls the selected re,:ion of imerest (ROI). These thresho lds and the
ROlwcrclhcn uscdtocalcul atclhc co-locali l.alionusin,:lhe soliw arcp ro\' idcdwithlmaru s
Co- loca lization is shown in purple in panel 5. Purple co- loca lization is isolated to the ROI and is
calculaled using lhe pise lsonlyselccled hy lhe lhresholdse s cluding the backgro und staining and
remaining cells. Through selecting lhe specili c il1lracellular compa rtmen t tmnskingj . jhe
co-locali zalion ofA PPand l lsp ll l was measurcdi neac h compartm cm . A slighl co-Iocalizalionis
seen in APPswe and Ilsp£31 in thc golgi however duc to the low co-Iocalizatioll , "alucsthrou ghoul
lhecompartmcllls. lhis is lhoughl lo hc ncg ligihlc . Il : l.ocalization ofA l' Pwt and Af'P swe was
analysed in cach cellular compartm elll wilh and wil hoUI I lspll l Iranste ction aud compared. Il spll l
signili calllly dccreascd lhc APPwl localizcd wilhin lhc golgi. Most intcresrinply. Al' Pswe shows
signilicanl dccrease in localizalion throu,:ha ll ce llular compartmellls lesled when i lspll i is presclll
Correlation values : Nonc <O. I, Smali 0.1-0.3, ~lcdium0.3.0 . 5 . l.a r,:c 05-1 .0
A
B• APP wt t HspB 1
.6. APPs'¥\€tHspBl
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4 .1 The Significance of th is Study
Hsps arc uprcgul atcd under en vironm ent al strcss ors such as alco ho ls. heavy
meta ls, elevated tempe rature s (H ight ower . 1991 : Lindquist. 19X6) and arc thou ght to
preve nt cell death thro ugh prote cti ve mechani sms such as chapero ne acti vity.
thcr moto lcra ncc. inhibi tion ofapoptosis. enhancement of surviva l pathw ays and
cytos keleto n stabilizat ion (Arrigo. 2005: Charette ct 'II.. 2000: Hargis ct 'II.. 200 4:
Mcarow, Dod ge. Rahimtul a. & Ycgapp an. 2002 : l' arccllicr ct 'II.. 2003 : Vargas - Roig.
Fanelli. Lo pez. Gago . Tello. Aznar. & Ciocca. 1997'1).
While the we ll known Hsps such as Hsp90 and IIsp 70 have been extensively
studied in regar ds to the stress respo nse (B uch ner . 1996: Guscv ct al.. 20(2 ) the c lass of
sma ll heat shock protein s is emerg ing as protector s in pro tein agg regatio n diseases such
as AD ( Kudva ct al.. 1997: Liang. 2000: Shimura ct al., 2004: Wilhclmu s ct al., 2006 : T.
T. Yan g ct al., 2( 09 ). AD is a progress ive. degenerat ive disease o f the brain
characterized by spec ific neur onal death in areas within the front al and temp or al lobe s
(Ma ttso n. 2(04) assoc iated with NlTs and extracellular se ni le plaque s (Price . Tanzi.
Borchelt. & Sisod ia. 199X: Son g ct al., 2002 : R. E. Tanzi & Bertram. 200 1: R. E. Tan zi ct
a l.. 2(04) . The se amyloid containing plaqu es deri ved from the proce ssing of the API'
protein also co ntai n vario us other pro teins. nam ely HspB 1 (Wi lhc lmus ct ul., 200(1).
Eleva ted HspB I levels arc ofte n fou nd in indiv idua ls with ncuro dcgc nerativc disorde rs
fo r example Pa rk inso n ' s di sease. AL S. and A D (Rcnkawck et a l., 1994 : Rcnkawck,
Steg e. & Bo sman . 1999 : Vlcminck x ct a l., 2(02) . It is pro bable tha t increased Il sp B I
ex press io n is par t ora protective res pons e mount ed by neu ron al suppo rtive g lia l ce lls .
ac ting as a chaperone in an atte mp t to pro mote ce ll survi va l (D . E. Rea d & Go rma n.
200 % : Sherma n & Go ldber g. 200 I) . Co nversely . I lspB I ma y be released as an
in flam mato ry resp on se by acti vated micro glia under cytotoxi c s tress ors . Whether HspB I
is found in SP s as a protective mech an ism o r pa rt ofthe di sea se process is unknown.
My thesi s sou g ht to inv es tiga te whethe r possib le inte ract ion s be tween Il sp l3 l and
A ll o r its precursor A PI' affec t the prod uct ion and d ist ribut io n or the 1\ ll peptide fro m
bo th A l' Pwt and the Afl (1-42) producing A PPswe cell s. First ly. I inves t iga ted the effect
or IlspB 1 on All relea se into the extracellular e nviro nment. se co nd ly. the inter actions
be twee n Il spB I. All ( 1-4 2) as well as APP. th irdl y. if I Isp131 a ffec ts APP processin g. and
fina lly the d istribution or Hsp B I and A PP throu gho ut the cellular en viron ment and if an y
cha ng es in ce llu lar local izat ion ofA l'P produ ct s o ccur in the presen ce o f' Hsp l] I .
4 .2 H EK293 Ce lls Lac k Endog e no us IIspB 1
l Isp s arc con served pro tei ns who se express ion is dependent o n ce ll type
(Rcnk awck et a l., 1994: Sh ino hara ct a l., 1993 : Stet ler . Gao . S ig nor e. Cao. & Che n. 2009 :
Wilhelmus et 'II..2(06) . Hsp B I has bee n fou nd in the ner vo us sys te m in spina l co rd
mo tor neurons and peripheral se nsor y neurons (Costi gan ct 'II.. 1998 : Dod ge ct a l.. 2006 :
D. E. Read & Go rma n. 2009a: Williams ct al ., 200 5: Will iam s ct a l., 2(06) as well as
specific brain areas such as cranial nerve nuclei and hypothalamus (Armstrong ct al..
200 1: Plumier ct al., 19lJ7). HspBI is not found in cortical neurons (M. King ct al.. 2( 09)
howev er Bcctold and Brown (Bechtold & Brown. 2000; Bechtold & Brown. 2( 03 ) lound
HspB I localized to peri-synapt ic glial processes and specifically expressed in neuronal
supportive astrocytcs when induced by hyperthermic stress. This localizat ion could allow
secretion of HspBI from ustrocytcs into the environment surrounding neurons thereby
providing a compensatory mechanism for lack of cortical expression .
While it may be suggested that primary cortical neurons may have been a better
choice lor this study. the usc of primary cells is not ideal lor the exper imentation
performed. Studying the effects of HspB I required both cellular transfcction along with
collect ion of large amounts of cellular lysate for protein analysis through western blot
and co-immunoprccipitation. Cortical neurons have consistently shown a translcct iou rate
of only 30% therefore collecting HspBI positive neurons for lysate samples would prove
difficult . In order to mimic the lack of cortical endogenou s expression ofHspl! I. it was
import ant to choose an in vitro model which allowed lor study of only exogenous HspB I
expression. My study shows that rodent HspB I is not present in IIEK293 cel ls except
upon transfcction of my constructs and this exogenous expression remains consistent
when API' is ovcrcxprcsscd, This enabled me to study the effects of addition of rodent
IlspB I without interference . In addition. I examined the collected media from my cells
to ensure adequate presence o lA l' P as it is known to be a secreted protein. This provided
me with initia l evidence that by expressing HspB I I was not affecting the normal API'
secretion process from the cell. Also. access to AI'Pwt and Al' Pswc stable cell lines of
HEK293 cells influenced my decision to usc these cells as my experimental model.
4,3 Decreased Release of A[{ ( 1-42) ti'OI11 Af'Pswc Cells with IIsp 131
When API' undergoes arny loidogcnic enzymatic processing. the soluble -
terminal fragment and the freed Af{peptide arc transported and released into the
extracellular milieu although the mechanism for release remains to be elucidated. All ( 1-
42) is perceived as the predominant toxic species produced from API' processing since it
is shown to fibrillize. aggrega te and genera te oxidative species contributing to neuronal
death (.I. Hardy & Sclkoc , 2002: Harper. Wong. Lieber. & Lansbury. 1999: Mattso n.
2004: Price ct al.. 199X). While I was able to detect solub le form s of API' via western
blot analysis. A[{ appeared to be released in undetectable amounts in the cellular
conditioned media althou gh this is contradictory to the published amount s of released A[l
seen previously (Cai ct al.. 1993: Citron ct al.. 1992: Wang. Sweeney. Gandy. & Sisodial.
1996: T. T. Yang ct al.. 2( 09). For this reason. I turned to the more sensit ive ELISA
which also enab led the distinct analysis of All (1-40 ) and A[{(1-42) species in both APP-
wt and APP-swe cells. ELISA A[{concent rations were undetec table in cel lular lysate and
lower than reported results in cellular conditioned media. An explanation for this
discrepancy in values may be attributed to the masking of Al{ by BSA found in the Fe S
present in the media as select protocols call for form ic acid extraction to measure All
amounts (Sweene y. Darker. Neville. Humphries. & Camilleri. 1(9 3). All extraction was
not carried out in my experi me nta tio n ho wever FCS was decreased and concentrated
mcdia sho wed s im ilar values. Althoug h thc amount of BSA in the media was lowered as
much as po ssible to sti ll ens ure ce ll via bility. prese nce may have a ltc rcd thc AI\ resu lts
negat ivel y. Discr ep anc ies in pro toco ls between repo rts ma y also contribute to thc
perceived lowe r AI\ amo unts . T hough ImUlY stud ies have reported leve ls or Af\ rc lcasc .
lew arc co nsis te nt in the type o r AI\ measu red (sy nthet ic versus endog eno us). the
procedure used (ELISA vers us Ma ss Spec tro me try ) and thc ce ll type (neurona l ce ll lines
vers us non -neuron al) (B atem an , Mel . aurin , & Cha kraban ty, 2007: Bcl yac v, Kellett.
Becket t, Mako va, Rcvctt , Na livucva. Hooper, & T urner, 20 1Oa: Gouras ct ul., 199 X:
Sweeney cr a l., 1993: Wan g ct a l., 1( 96) . Any ofthese inco ns istenc ies may co ntribute to
the variance in Af\ release in the literature . Rele ase or AI\ ( 1-40 ) rem ain ed stea dy
throu gho ut time poi nts in both ce ll types inde pe ndent or HspB 1 expres s ion . T his result
suppor ts the lite rature as AI\ ( 1-40 ) is not believed to be a harmful spec ies to cel ls and is
readil y found in t issues wit ho ut det riment a l effect s (Bai ley ct al ., 201 1: Bogoyc vitc h ct
a l., 200 4 : Gand y. 200 2; lgbavboa ct al., 2009 : Lahiri & Ma loney, 20 10: Sos cia ct ul.,
2( 10 ). Expeeted ly. A l' l'wt ce lls re leased insignifica nt amounts or Af\ ( 1-42) into the
med ia suggcs t ing these ce lls do not readil y produ ce the toxic spec ies . In co ntra st. Af\ (1-
42) amo unts significantly incr eased at 4Xhrs in Al' Pswc ce lls. Evidently. the Swed ish
mut ati on docs indeed result in a g rea ter amou nt or the aggregate prone AI\ ( 1-42 ) known
to correlate w ith toxicit y (CaiIIL:. Allinquant. Dupont. Bou illo t. l. angc r, Mul ler, &
l' rochiantz, 2004a: Caillc. Allinquan t. Dup on t. Bouill ot , Langer. Muller, & Prochi ant z,
2004h: C itro n ct a l., 1992: M. Mull an ct al., 1992h : Sc hcu ncr, Eckma n, Jen sen. So ng.
Citron. Suzuki . Bird. Hardy, Hulton. 8: Kukull . 1996: Sinha 8: Lichcrbur g, 1999). The
high qua ntity or released A r~ ( 1-42) is lower when co-exp ressed with HspB I at 24hrs and
significantly decreased at 4Xhrs. This lead to two possibil ities: I ) IlspB I is binding \0
Ar~ (1-4 2) perhaps throug h chapero ne activi ty and inhibiting its release into the med ia or
2) IIspBI is affecting the processing of APP-swe to preven t the production orAr~ (1-42) .
Since IlspB I and other sl-lsps have been shown to bind to Ar~ (Clarimon . Bcrtrunpctit .
Boada . Ta rruga, 8: Comas. 2003: Kudva ct al., 1997: Muchowsk i 8: Wacker. 2005 : Perrin
ct al., 200 7: Wilhclmu s ct al., 2006 : T. T. Yang ct al., 2009 : Y. Yang ct ul., 199X) I
decided to explore the first option or HspBI binding to Ar~ ( 1-42).
4.4 I lspB I Directly Interac ts with Ar~ (1-42)
Ilsp BI has been reported to both interact with synthetic forms or A r~ (C larimon ct
al., 2003: Go ldste in ct al., 2003: Liang. 2( 00) inhibit aggrega tion and toxicity ofcerebral
Ar~ (Kudva ct al., 1997: Wilhclmus ct al., 20(6) and rescue already aggregated protein
(Perrin ct al., 2( 07 ). To investigate a possib le interaction betwee n IlspB I and AI\ ( 1-42).
I employed the co- Il' technique . By selecting an antibody to a known protein in the
solution (1lspBI) that may be in a comp lex with another protein or interest (A]! ( 1-42)). it
is possib le to pull the entire protein com plex out of solution and thereby ident ify both
proteins as interacting. Co- II' was performed with antibodies spec ific fill- human Ilsp BI
since the recombinant human his-HspBI protein was used as well as the co rrelative
reverse IP using anti-A]! ( 1-42) to ensure probabilit y of an interaction . Results fium co-
II' using IlspBI and Afl ( 1-42) antibodies hoth suggested a direct interaction between the
recombinant his-l lspBI protein and the synthetic AI~ ( 1-42) peptide, This is promising in
that HspB I is able to hind to the harmful All ( 1-42 ). In theory, if inhibi tion of All (1 -42)
release occurs. a greater pool of AI~ ( 1-42) would be found within the cellular lysate .
Since I did not observe i\r~ (1-42) present in the cell lysate in the presence of HspB I
either through western hlot or ELISA. it appeared more likely that any effect Hspl3l is
having on extrace llular AII(1-42) concentrations is upstream o fre lease via production.
Further investigation into the contents of the cellular lysate using ELISA is needed to
d ismiss IlspBI inhibiting the release of A r~ through direct interaction as the performed
cell lysate ELISA was with one biological sample in dupl icate there fore not conclusive
whereas the cellular conditioned media ELISA was replicated with three biological
samples, i\ potential di rect interaction between IlspB I and i\ [~ ( 1-42) presents insight
into how Hspl3l may become incorpo rated in amyloid plaques in AD. Perhaps through
its chaperone activity. HspBI recognizes increased levels of A[I ( 1-42) released into the
extracellular space and interacts in an attempt to seques ter thc harmful prote in however is
unsuccessful in abolishing the plaque for mation . The presence of l lspl) I in Sls may be
explained by the cross-talk between activated microglial and activated astrocytcs.
Micoroglial activation promotes phagocytosis ofdamagcd neurons and Sl s which is
thought to contribute to the neuronal loss associated with AD (De Witt. Perry. Cohen,
De ller. & Silver, 199X: Gahtan & Ovcrmicr, 1( 99) . Microglial activation in turn
stimulates astrocytcs which secrete li spS I and arc able to inhihit phagocytosis (Smits ct
al., 20()\ : Tichaucr. Saud. & von Bcrnhardi. 200 7: von Bcrnhardi & Eugcnin. 2(04)
leaving SPs present when both cell types arc co-cultured (Dewitt et al., 199X: Liu ct al.,
2( 11).
4.5 IlspB I Directly Interacts with Soluble Amyloid Precursor Protein
Given that HspBI intcracts with A r~ it is conceivable that IlspBI may also bind to
the precursor protein API'. A binding to API' would introduce the probability or IlspB I
eliciting effects on API' before All production. Thro ugh co-II' I again saw an interact ion.
this time betwee n HspBI and soluble API' in both - wt and - swe forms. Given that API'
is constitutivel y expressed and holds many biological roles necessary for survival. it
seems unlikely that HspB I would be targeted to the wild type form unless it recognises
the A r~ sequence within the soluble protein and is able to bind to that portion. Whether
IlspBI interacts with the AI~ portion or sApl' or recogn ises a different sequence within
the protein product is speculation at this point. To my knowledge. IlspB I direct ly
binding to sApp is a novel idea which warrants further examination. The ability or
HspBI to bind to sApp presents therapeuti c possibilities ofsequestering API' mutated
proteins before A r~ is produced through processing.
4.6 HspBI docs not Affect Processing or Al' l'swe
A I~ results [rom the processing or API'. therefore changes in the release or
production or Ar~ may be attr ibutable to changes in the processing or API' caused by
I lspBI. Proteins that have been found to bind to API' and decrease Al~ secret ion arc
thought to do so by blocking the maturation proce ss (Stcinhi lh ct ul., 200 \: Y. Yang ct
al., 1(98). Mature and immature API' were classi fied using antibody recognition and
molecular weight as cited in the literature (Frigcrio ct al.. 20 I0: Henriques ct a l., 20()l): E.
POI1c1ius ct al., 20 1Oa: E. Portc lius ct al., 20 1Ob). Contrary to this view, HspB I did not
appear to influen ce the maturation process of API' when analysed throu gh western blot as
similar co ncentrations ofmature and inunaturc Al' P were seen acros s time point s and
conditions. Changes in processing did not occu r with IIspB I in the APPwt or Al'P swc
ce lls as seen by fair ly cons tant levels o ft he CTF and sAPP fragm ents, While co nsta nt
CTFI~ and sA PPswc- l~ levels may seem contradictory to the decrease seen in AI~ (I --C), it
can be explained by the amylo idogcnic processing sequence ofevents. sAp pswc- r~ and
CTFI~ arc cleaved from each other by I~-sccrctasc theref ore levels of both fragment s
should be constant . CTFI~ is composed of the Ar~ portion and the AICI) bef ore v-sccrctasc
cleavage frees both fragmen ts. Therefore, steady CTFI~ and sAPPswc- l~ levels may be
ex plained by norm al [l-sccrctasc act ivity. but a defic it in y-sccrctasc abi lity to further
cleave CTFI~ resulting in a decrease in A I~ production without decrea sing overa ll CT FlI or
sA pp r~- swc leve ls. Plausible explanations may be the binding of HspBI to the All ( 1-42 )
region of API' would inhibit y-sccrctnsc abilit y to gain access to its Ar~ clea vage si te.
Alternatively. disruptio n in Al'Pswc traffickin g by HspB I may have varying effec ts on
the proteo lytic product s of Al' Pswc as it is thought to undergo processi ng in various
compartments o fth e cel l.
4.7 Ce llular Co- Localization o fHs pfl I and API' Products
My hypothesis that li spS I may alter API' processing or distribution of API'
products required investigation into specific cellular compartme nts where API' may he
found and examine possible effec ts due to HspB I. I proposed to answer two questions.
Firstly. arc HspSI and API' found co-local ized in a specific cellular area where a
possible interaction between the two proteins is plausible'! Seco ndly. docs the
distribution of API' within specific cellular areas change in the presence of HspBI'! To
explore this I employed image analysis software and a cellular co localization module
(lmaris, Bitplane Corp) to assess the co-localization of API' and HspS I in the golgi. early
and late cndoso mcs and lysosomcs of the cell. Through selecting each cellul ar
compartme nt individuall y. I was able to analyse the API' and IIspB I present in the
isolated region (ROI). Al' Pswc and HspB I were slightly co- localized in the glogi
compartment however this value was not considered a strong co- localizat ion given the
Pearson' s coefficient values fill' co-localization. I either Al' Pwt nor Al' Pswc showed
strong co- localization with HspB I in any of the cellular compartments analysed. This
may be explained by HspB I and API' binding in the extrace llular enviro nment as seen in
my earlier results and not having this binding effect intraccllularly. Interesting results
emerged when the distribution o f API' was measured in the cellular compartment s with
and without IIspB I. Al'P swc is significantly decreased in all compartments when
measured in the presence o fHs pl] I. This corresponds to ear lier ICC data where API'
staining appeared to decrease in the presence o f HspB I in the Al' l'swe cells. Given all
the results thus far, I lspBI appears to alter the amount of Al' Pswc and its toxic A!{ (1-42)
produc t. It may be thcoriscd that disruption in the normal amyloidogcnic processing of
Al' Pswc results from the addition of l lspBI into the intracellular environment. Such a
disrupt ion in the trafficking of Al' Pswe would coincide with changes in the processing of
Al'P swc and thus the proteolytic products limned . Since the detai ls regarding the normal
arnyloidogcnic processing ofmutated API' including Al' Pswc arc unknown. it is diffic ult
to predict where HspB I may be enforcing its effects on Al' Pswc, However, it is evident
lrom thc decrease in A]! (1-42) secretion. the binding to sAI'P and A[{(1-42). and finally
the decrease in intracellular API' in all cellu lar compartments when HspB1 is present that
IlspHI is eliciting an effect on the A[{(1-42) prone Al' Pswc.
4.X Future Directions
This study has investigated the role of IIspHI with Af{ (1-42) and the A!{(1-42)
producing
Swedish mutated API' with respect to its effects on Af{production and release. It has
addressed the hypothesis that l lspl! 1 interacts with A[{and sAPP and is able to alter
release of the toxic A[{(1-42) peptide. It was shown that HspBI is able to modify the
release of Af{ (1-42) without affecting the maturation process of API' or abolishing API'
processing altogether yet also appears to disturb cellular localizat ion of Al'Ps wc,
However. a number of questions remain concerning the mechanism by which the
alteration of A]! release occurs as well as the binding kinetics ofl lspll l with sAPP/AII(1-
42). Furtbcrmo rc, it is unclear . although appears promising. whether HspB I is act ing
through its chapero ne activity and in a protective measure against A[{toxici ty.
Giv e n the o bserva t io ns mad e here, it would be inte restin g to inve sti gate the
enzy ma t ic acti vity o ft he sccrctasc s in the pre sence of Il spB 1 especiall y the v-sec rc tas c to
lo o k Ill!' a ltera t ions in its ahi lity to proce ss A l' l' swc . Fur ther inve stigatio n into the
traffic kin g o f mutated AP P prote ins and their pro ce ss ing is under inve sti gat ion a nd wo uld
highl ight areas in which HspBI may intercept . Noteworthy as well is that while H EK 293
ce lls hav e bee n used to inve sti gate All and ot her agg regat ing prot ein s in vitro . a mo re
neur on al ce ll line wou ld o ffe r greater benefit s. Disc rep ancies mo st likel y e xist in the
natu re of A PI' processin g. trafficking and Afl acc umu lation between II E K293 ce lls and
neu ron al ce lls, Hsp l3l has been s ho wn to be up -reg u lated in g lia l ce lls exposed to stre ss
(Bid mo n ct al ., 2005: King ct a l., 2(09 ) and our lah ha s sho w n robu st I lsp13\ pre sence in
the me d ia ofcu ltured as trocyt cs (K ing ct a l.. 2(09 ). T hus . ha ving an en v ironment mo re
s im ilar to an in vivo sce nario whe re as troc ytcs arc the ma in ge nera to r o f Hspl3l in the
ex tra ce llu lar mi lieu a nd mea suring the effect on All would further validate the se resul ts,
References
Akiya ma . I L Bar ger , S.. Barnum, S .. Bradt. B.. Bauer, .I.• Co le, G. M... . Wyss-Co ray.
T. (2000). Inflammation and alzhcimcr's disease. Neurobiology ofAgi l/g. J /( J) . J XJ -
42 1.
Altsticl . L. D.. S: Sperber, K. (1 991 ). Cytok incs in alzhcimcr's di sease . Pro g ress in
Ncuro- Psvcho phurmacologv & Biologica! Psychiatry. / 5(4) . 4X1-4 95.
Alzhe imer's Disea se Co llabo rative G ro up. (199 5) . T he structure of the prc scnilin I
(S IX2) ge ne and identifi cati on o f six nov el mutations in earl y onset AD families. Nat
(;CI/ CI . / /(2).2 19-222 .
Arm st ro ng, C. L.. Kru eger- I aug. A. M.. Currie, R. W.. & Hawk es, R. (200 I).
Co nst itut ive ex press io n of heat sho ck protein HSP25 in the central nerv ou s syst em of
the developing and adult mou se . TheJournal ofComparative Ncu rolog v. 434 (J ),
262 -27 4.
Arna ud. L.. Rob akis, N. K.. & Figue iredo- Perei ra, M. E. (2006) . It may tak e
inflammation, phosph or ylati on and uhiqu itin ation to 'tangle' in a lzhci mcr' s d isease.
Ncuro- Dcg cucrat ivc Diseases. 3(6). J l J -J I9 . doi : 10.1 I59/000095 6J X
Arrigo . A. P. (20 05) . Heat shock proteins as molecular ch aperones. [Chaperons
mo lee ulairesetrepliement des pro te ines : I'exe mplc de eeI1aines prote ines deehoe
thcrm iquc] Mcdccinc Scien ces : MIS. J /( 6- 7). 61 9-625.
doi: 10.105 1/medse i/20052 16-7619
Arrigo. I\. P. (200 7). The cellu lar "networkin g" of mam malian Hsp27 and its functions in
the contro l of prote in fo ld ing, redox state and apoptosis. Adva nces in Experimental
Medici ne and Biolog v, 5')4. 14-26. doi: I0. 1007197X-O-3X7-399 75- 1_2
Ashle y. L Packard . M.. Ataman, 13.. 8.:. Budnik. V. (2005) . Faseiclin II signa ls new
synapse forma tion through amyloid precur sor protein and the scaff o lding protein
dX I I/Mi nI. 111C Journal ofNcuroscicncc : The Official Journal oft lu:Societyfor
Neu rosci ence. 15(25). 5943-5955 . doi: IO.1523/.INEUROSC I. I I44-05 .20()5
Bailey. M. E.. Wang. A. C; Hao, L Janssen. W. G.. Hara, Y.. Dumitri u, D...
Morri son. J. II. (201 1). Interactive effect s of age and estrogen on co rtical neurons:
Implication s for cognitive aging. Neuroscience. l v l . 14X-15X.
do i:I O.IOI6 /j.neuroseienee.201 1.05.045
13'10. L Cao, C; Zhang. X.. Jiang. F.. Nicosia. S. V.. 8.:. Bai, \Y. (200 7). Suppression of
beta-amyloid precursor protein signaling into the nucleus by estroge ns med iated
throu gh comp lex forma t ion between the estro gen receptor and Fe65. Molecular and
Cell ular Biologv, 17(4 ). 1321-1333. doi: IO.112X/MCB.OI2XO-06
Basi. G. S.. Hemphill. S.. Brigham. E. F.. Liao, /L Aubclc. D. L.. Baker . L . . Schenk.
D. (20jO) . Amyloid precursor protein se lect ive gamma-se eretase inhibitors Ior
treatme nt of alzheimer 's disease. Alzheimer's Research & ThC/'{/{J1', 1(6). 36.
do i:I O. II X6/alm60
Bateman. D. A.. lc Laurin. 1.. & Chakrabartty, 1\. (200 7). Req uirem ent of aggregatio n
pro pe nsi ty or a lzhci mc r amy loid pcpt ides fill ' neuronal cell sur face binding. UMC
Neuroscience, 8.29. doi : 10.111'\6/1471- 2202- 1'\-29
Baue r. .I.• Gan ter . U.. Stra uss . S.. Stadt muller. G .. Fro mmbcrgcr, U.. Bau er . H...
Ber ger. M. (1992). The part ic ipat io n ofintcrlcukin-o in the path ogenes is of
a lzhei mer's d isease . Resea rch i ll lmmunolog v. 143(6 ). 650-657.
Bec hto ld. D. 1\.. & Brown . I. R. (2000) . lI eat shoc k proteins Hsp27 and Hsp J 2 local ize to
syna ptic sites in the rat cerebe llum following hyp erth ermi a. Brain
Rcscarch.Molccu larHrain Resea rch, 75(2). J09-J20.
Bech told . D. 1\.. S: Bro wn. I. R. (200J). Indu ctio n of Hsp Z? and Hsp J 2 stre ss protei ns
and viment in in glia l ce lls oft he rat h ippocampu s fol lowin g hypertherm ia.
Neurochemical Research, 28 (1'\). 116J -Il n.
Bclyacv, N. D.. Kell ett , K. A.. Beck ett . c.. Mako va, N. Z.. Revert. T . 1.. Na livacva. N.
N..... Turner. 1\. .1. (20 1Oa). T he transcri pt iona lly ac tiv e amy loid prec urso r prot e in
(1\1'1') intracell u lar dom ain is preferent ial ly prod uced from the 695 isoform or 1\1'1' in
a [beta] -sccrctasc-dcpcnd cn t pat hway . 111C Journal ofB iolog ical Chcmistrv, 285( 5J) .
4144J-4 1454 . doi : 10.1 074/jo dvlI1 0.14 U 90
Bclyuc v. N. D.. Kell ett . K. A.. Beck ett, c..Ma ko va, N. Z.. Revert. T. 1.. Na liva cva. N.
N.. .. Tu rner . 1\. .1. (20 10b). T he tra nscri ptiona lly active amylo id precursor prot ein
(1\ 1'1') intracellular do mai n is preferentiall y prod uced from the 695 isoforrn or 1\1'1' in
a [bcta l -sccrctusc-dcpcndcnt pathway. The Journal ofBiologic a! Chcmisu v. ':85(53).
4144 3-41454. doi : I0 . 1074/jbc .M II 0. 14 1390
Bidm on . H. J.. Gor g. B.. Palom cro-Gallaghcr. N.. Sc hlicss, F.. Go rji, A.. Spcckma nn, E.
1.. & Zillcs, K. (2005). Bila te ra l, vasc ular and perivascular g lia l uprcg ulation ofheat
shoc k protcin-27 a lter rep eat ed ep ileptic se izures . Journal ofChemical
Ncuroanatomv. 30( I). 1-1 6. do i: I0 . 10 16/j .jc hc mncu.200 5.m.()()9
Bogo ycv itch. M. A.. Boehm, I.. Oa kley. 1\.. Kett erm an , A. .I.. & Barr. R. K. (20 04 ).
Targeting the JNK MAP K cas cade for inhibit ion : Basic sc ience and therapeutic
po ten tia l. Biochim ica Et Biophvsica Acta . 109 7( 1-2). X9- 10 1.
do i: I0 . 10 16/j .bb ap ap .20m .II .0 16
Boi sso nnea ult, V.. Fila li. M.. Lessa rd, M.. Rc lton. 1.. Wo ng. G.. & Rivest, S. (200 9) .
Po wer ful beneficial eff ects o fmacro phage co lo ny-s timulat ing fac tor o n beta-am ylo id
dep osit ion and cogn itive impa irment in a lzhc imcr's d isease, Brain . A Journ al o]
Neurology, / 3.:'( Pt 4) . I07X- I092 . doi : I0 .1093 /brai n/aw n33 I
Br ucy. J. M.. Du cassc, C .. Bonni aud . P.. Ravagn an , L.. Susin, S . A.. Diaz-La to ud . C.. .
Garrido . C. (2000) . IIsp 27 negat ively regul ate s ce ll death by inte rac t ing w ith
cyt oc hro me c. Nature Cell BiologF, 2(9 ). 645 -652. do i: I0 . 1mX 13502J595
Bruins ma . I. B.. Bru ggink , K. A.. Kin ast , K.. Vers lc ijcn. I\. A.. Scg crs-N o ltcn. I. M..
Subru muniam, V.. ... Ve rbec k, M. M. (201 1). Inh ibitio n ofa lpha-synuc lc iu
aggregatio n by small heat shock proteins. Pro tei ns. 71)( 10). 2956-2967.
doi: I0.1002/prot.23 152: 10.1002/prot.23 152
Buchner, J. ( 1996). Supervising the fold : Functional principles ofmo lecular chaperones.
Tlu: FiI S/:"B Journal : 0flicial Publica tion oithc Federation ofAmeri can Societies/ill"
Expcrimcnto l Biology . I()( I). 10-19.
Buckner, R. L.. Andrews-Hanna. J. R.. & Schecter. D. L. (200X). The brain's def aul t
network: Anatomy. funct ion. and relevance to disease. /111I /lds oft he Nc»: York
Acadcmv ofSciences. 1124. 1-3X. doi: I0.1 I96/annals.1440.0 I I
Buckner, R. L.. Scpulcrc, J.• Ta lukdar, T.. Kricncn. F. M.. Liu, H.. Hedden. T . .
Johnson. K. A. (2009). Cortical hubs revealed by intrinsic functional connectivity:
Mapping. assessment of stability. and relation to alzhcimcr's disease. J1/('Jou rnal or
Ncuroscicncc : J1/('Off icta lJournat ottlu: Societyfor Neuroscience. 29(6). IX60-
IXn. doi: I0.1523/JNE UROSCI.5062-0X.2009
Buckner, R. L.. Snyder, A. Z.. Shannon. B. J.. LaRossa. G.. Sachs. R.. Fotcnos. A. F.. .
Mintun. M. A. (2005). Molecular, structural. and functional characterization o f
alzhcimcr's disease: Evidence lil!' a relationship between default activity. amylo id.
and memory. The Journ al otNcuroscicncc : The 0 fl icial Journal oftlu: Socie ty/ill"
Neuros cience. 25(34).77 09-77 17. doi:10. I523/JNEUROSCI.2 I77-05.2005
Cui, X. D.. Golde, T. E.. & Younkin. S. G. (1993). Release ofexcess amylo id bcta
protein from a mutant amyloid beta precursor protein. Science. 251)(5094). 514-516.
Cai lle. I.. A llinquant. B.. Dupon t. E.. Bouillot. C.. La nger. A.. M uller. U., 8.:Proch ia ntz,
A. (2 00 4a ). So luble limn of am yloid precurso r pro te in regul ates proli fera t ion of
progenitors in the ad u lt subv cntricular zo ne . f) C1'C!OPIII C/l t , /3 / . 1 173-1 1XI.
Cai lle. I.. Allin q uan t. B.. Dupont. E.. Bou illot , c.. Lan ger. A.. M uller. U.. 8.: I' roch ian tz.
A. (1004h). So luble limn of amyloid prec urso r protein regu lat es pro life rat io n of
pro ge nitor s in the ad ult subvc ntr icu lar zo ne . /) C\'('/ OpIII C/l t (Camb ridg«. /:'/Ig !w /{/) ,
/ 3/(9). 1 173 -1 1S I. do i: I0 . 114 1/dcv .0 II OJ
Ca o , X.. 8.:Su d ho f, T . C. (2 00 1). A tran script ion all y [correcti on o f' tra nsc ript ivc ly] ac tive
com plex of A PI' wi th Fe65 a nd histon e acc tyltra ns fcrasc T ip60 . Scie nce (New York ,
N l'.) . 1Y3(5517 ). I 15-1 10. do i: I0 . 1 I16/s c ienc e. I05 S7S:;
Chakrabarty, 1'.. Jansen -West. K.. Bcc card , A.. Ccba llos - Diaz. c.. Lcv itcs, Y.. Vcrbccck.
c.. . . Das, 1'. (101 0) . Ma ssive g lios is ind uced by int crl cu kin-o suppresse s aheta
de posi t io n in vivo : Evi de nce agai nst infl ammati on as a drivin g force for amy lo id
dep ositi on . 1!/(' /·:·/S/:B Jo urnal : Oiticial Publication oftlu: Federation otAmcrica n
Societiesfor Expcri nicnta! Hiolog », 14 (1 ), 54S- 55 9. do i: I0 .109 6/ tj.09-14 1754
C ha ng . W. 1'.. Koelsch . G .. Won g . S.. Dow ns. D.. Da, II .. Wccr asc na , V.. . .. Ta ng. J .
(1004 ). In vivo inhib it ion o f ab eta produ cti on by memap s in 1 (bc tu- sc crc tasc)
inh ib ito rs. Journ al ofNcurochcmis trv. 8 Y(()). 1409-141 6 . do i: 10.IIII /j .1471 -
4 159 .1 004 .01 451 .x
Charett e. S . .I.• & Land ry. .I. (2000a). T he inte ract ion of HS pn wit h dan ide ntities a
pot en tia l reg ula tor y ro le of HS pn in la s- ind uced a po ptos is. Annals oft lu: NCl I' r o d
AcademyofScience s, 1.)26. 126-I JI ,
Charette. S. .I..& Land ry. .I. (2000b) . T he inter ac tion ofHS l'Z? w ith daxx ide nti fies a
potentia l regu latory ro le of Hspn in fas-i nduccd apoptosis, AI/I/a /s otthc NCII ' York
Acadcmv ofSciences. 916. 126- 1J I.
Charette. S. .I.• Lavo ie. J. N.. La mbe rt . II .. & Landry. J. (2 00 0). Inhibition o ldaxx-
medi ated upo pto sis by heat sho ck protein Tl . Molecular and Cellular !?i% gy ,
1()(20 ). 760 2-76 12.
Che n. K.. Huan g. .I..Gong. W.. Zhan g. L.. Yu. P.. & Wang. .I. M. (2006). C D40/C'D40 L
d yad in the in lla m ma tory and immune res po nses in the cent ra l nervo us sys te m.
Cellular & Al o /cc/I /al" / III III /I//II /og.l', 3(J ). 16J -1 69 .
C he n. W. .I..Go ldstein . .I. L.. & Bro wn. M. S . (1 990) . N PXY. a se q uence o ften found in
cyto plas mic tai ls. is req uired fill' coated pit-med iat ed inte rnali zat ion of the lo w
den sit y lipoprotein rece ptor. Tlu:Jo urnal oiH iological C!l<'lI/iSII" I' , ':6 5(6 ). J I I6-J 12J .
C hen. '1'.. & Bodies. A. M. (2007) . A my lo id prec ursor prote in modul at es bctu-cat cnin
de gra da tio n. Jo urnal ofNeuroinflanunation, 4.29. doi: 10.11 X6I1742 -2094-4-29
C irr ito . .I. R.. Dea ne. R.. Faga n. A. M.. Spinner. M. L.. Par sad unian , M.. Finn. M. B.. .
Holt zm an. D. M. (20 05) . P-glyco pro tein deficiency at the blood-brain bar rier
increases amyloid-beta deposition in an alzhcimcr disease mouse model. Tlu:Journal
ofClinica l Investi gation, 115( II), 32R5-3290. doi: 10,1 I72/JC I25247
Citron, M. (2004) . Strategies for disease modification in alzhcimcr 's disease. Nat ure
Review s.Neuroscience, 5(9). 677-6R5. doi:10.103R/nrIl 1495
Citron. M.. Diehl. T. S.. Gordon. G.. Bicrc, A. L.. Seubert. P.. 8.:. Sclkoc, D. .I. ( 1996).
Evidence that the 42- and 40-amino acid form s ofamyloid beta protein arc generated
ti'OI11 the beta-amyloid precur sor protein by different protease activities. Pro ceedin g»
oftlu: National Academy ofSciences oftlu: United Stat es ofA merica, 93(23). 13170-
13175.
Citro n, M.. Oltcrsdorf T.. Haass. C.. McCo nlogue. L.. Hung. A. Y.. Seubert. P.. .
Sc lkoc. D. J. ( 1992). Mutation o ft he beta-amyloid precur sor protein in famili al
alzhcirncr's disease increase s beta-protein production . Nature. 30()(6405). 672-674.
do i: I0. 103RI3606 72aO
Citron. M.. Tcplow, D. B.. 8.:. Sclkoc, D. .I. (1995). Generation ofamylo id beta protein
from its precursor is sequence spec ific. N ell roll . 14(3).66 1-670.
Clarimo n, J.. Bcrtranpctit , J.. Boad a, M.. Ta rrugu . L.. 8.:. Comas. D. (2003) . HSP70-2
(HSPA I B) is associated with nonco gnitivc symptom s in late-onset alzhcimer's
disease. Journ al ofGeriatric Psvch iatrv and Ncuro log». 10(3) , 146-150.
Co nca nno n. C. G .. O rrcnius, S.. 8: Sama li, A. (:~001) . Hsp 27 inhihit s cyt o chro me c-
medi ated caspasc activation by seq ues tering both pro-caspasc -J and cytochrome c .
GeneE xpression, 9(4-5). 195-20 1.
Co nway. K. A.. Lee . S. 1.. Rochct , J. C.. Din g. 'I'. 1'.. Williamson. R. E.. 8: Lan sbury, 1'.
T ..Jr. (2000). Acceleratio n o f o ligo meriza t io n. not fibrilli zation , is a sh ared propert y
o f bo th a lp ha-sy nuc lc in mut urion s linked to earl y- on set park inson 's di se ase :
Implications for pathogenesi s and thera py . I'rocccdillgs oltlu: National Acadcmv of'
Scien ces ofthe United States ofAmerica. 97(2).5 71-5 76 .
Costiga n. M.. Mannion. R. 1.. Kendall. G .. Lew is. S. E.. Ca m pag na. J. A.. Cogges ha ll. R.
E.... . Wo ol f: C. J. (19 98) . Ile at sho ck protein 27: De velopment al regul a tio n a nd
ex pr essio n after peripheral ner ve injur y. Tlu:Jo urnal ofNeuroscience : nil' O{/icial
Journal olthc Societyfor Neu roscience. 18( 15).5891 -5900.
Cumm ings . C. 1.. Ma ncini . M. A.. Anta llTy. 13.. De i-runco . D, 13.. Orr. H. L , 8: Zo g hbi .
II. Y. ( 199 8) . C hapero ne suppres s io n of aggre gation and a ltered subce llu lar
protcasornc local ization impl y pro tein mi sfokling in SCA I. Nat ure Geneti cs. 19(2 ).
148 - 154 . do i:10 . 10J 8/502
Dak ocha- Souto . 13.. Scotton. T . c.. Co ma. M.. Scrrano-Po zo, A.. Hashimoto. '1'.. Sereno .
L.. ' .. Go mez - Is la, T . (20 11). Brain oligomeric beta -am yloid but not total am yloid
plaqu e burden correlate s with neuronal los s a nd astro cyte inflammator y re sp on se in
amyloid precursor protein/tau transgenic mice. Journal ofNeuropathology alit!
Experimental Ncurologv, 70(5). 360-376. doi:10.1OlJ7/ \ EN.ObO13c31 8217a 118
De Stroopcr, B.. Cracssacrts, K.. Dcwachtc r. I.. Mocchars . D.. Greenberg. 8 .. Van
Lcuvcn, F.. S: Van den Bcrghc, H. (l lJlJ5).Basolatcral secret ion of amyloid precur sor
prote in in madin-darby canine kidney cells is disturbed by alterat ions o f intracellular
pH and by introducin g a mutation asso ciated with familial a lzhcimcr's disease. n i l'
Jo urnal ofHio logica ! Chcmistrv. 1 70(8 ). 4058-4065.
DeWitt. D. A.. Perry. G.. Cohen. M.. Dollcr, c.. S: Silver. J. (llJlJ8) . Astroc ytc s regulate
microglial phagoc ytosis o f senile plaque cores o f alzhc imcr's disea se. Expcri nicntal
Ncurologv. / 49(2). 32lJ-340. do i: I0.1006 /exnr. l lJlJ7.6738
Dodge. M. E.. Wang. 1.. Guy. C.. Rankin. S.. Rahimtula. M.. & Mcarow, K. M. (200(1).
Stress-induced heat shock protein 27 expre ssion and its role in dor sal root ganglion
neuronal survival. Bra in Research. /OM,( 1). 34-48.
do i:I O.1016/j.brainre s.2005 .11.00 8
Eckert, A.. Marque s. C. 1\.. Kcil, U.. Schussc l. K.. S: Mulle r. W. E. (2003) . Increased
apoptotic cell death in sporadic and genetic alzhc imcr's disease. / / 111/1111/ Nc»: rod
I I C(/( /CII/ Y ofSciences. /0/0 . 604-60lJ. doi:10.1 1lJ6/annals. I2lJlJ. I 13
Eckert . 1\.. Steiner. B.. Marque s. C.• Leutz. S.. Romig. H.. Haass. C.. & Muller. W. E.
(2001 ). Elevated vulnerability to oxidat ive stress-i nduced cell death and activa t ion of
cas pas c-J by the swed ish am yloid precursor prot ein mutation. Journal o]'
Neuroscience Research. 04( 2). IX3-192 .
Eva ns. C. G .. Wiscn , S.. & Gcstwicki, J. E. (2 00 6) . Heat shock proteins 70 and 90 inhibit
earl y stag es of amy lo id het a-( 1-42) agg rega t ion in vit ro. fill ' Journal ofHio logica !
Chemistry. ':8 / (44 ). 33 1X2-33 191. doi :10. 1074/jbe .M606 192200
Ferre ira. A.. Caceres. A.. & Kos ik. K. S. (1993). Intr aneu ron a l co mpart ment s of the
amylo id precur so r protein. The Journal ofNeuroscien ce : Tlu: (Jjll cia / .Iournal 0(1 /1£'
Societyfor Neuro science, / 3(7 ). 31 12-31 23.
Fillit. /-I.. Din g. W. II.. Bucc , L.. Ka lman . 1.. Al tstic l, L.. Law lor . 13.. & Wo lf- Klein . G .
( 199 1). Elevated circu lati ng tumor necro sis factor level s in azhcimcr's d isea se .
Ncurosci l.ct t.. / ':Y(2). 3 IX-320 .
Fischer. D.. Mukrasch , M. D.. Bierna t. 1.. Bibo w, S.. Blackledge. M.. Grie singer. C .. .
Zwccks tcttc r, M. (2 009) . Co nfo rma tio na l ch ange s spec ific tor pseudophosphorylation
at serine 262 se lect ively imp air binding o f tau to mic rotuhulcs. BiOc! l£'lII iSIJT . 48(4 2) .
1004 7-10055. doi :10. 102 1/b i90 ImOm
Frank-C anno n. T . C.. A lto. L. '1'.. Mc/v lpinc, F. E.. S: Ta nse y. M. G. (20m). Docs
ncuro inflamm at ion Ian the flam e in ncu rod egen erat ived isease s'? i\!o/ccu/a r
Ncu rodcg cncra tion, 4. 47. doi :l 0.II X6/1 750-1 326-4-4 7
Frigcrio . c.. Fadccva, 1. Minogue. A.. Citron. M.. Van Leuven. F.. Staufcnbicl. M...
Walsh. D. (2010) . b-sccrctusc cleavage is not required for generation of the
intrace llular C-terminal domain of the amylo id precursor fami ly of proteins. 1-"I:'8S
Jou rnal. :277. 1503-1503- 151X.
Gahtan. E.. 8:.. Ovcrmicr, J. B. (1999) . Inflammatory pathogenesis in alzheimer's disease:
Biological mechanisms and cognit ive scqucli. Neuroscien ce and Hiobchavioral
Review s. 13(5).6 15-633.
Gandy. S. (2002). Molecular basis fill ' anti-amyloid therapy in the prevention and
treatment of alzhcimcr's disease. Neurobi olog y Ii / Ag ing. :23(6). 1009-1016.
Gandy. S.. 8:.. Petanccska. S. (2000). Regulation ofalzheimer beta-amyloid precursor
trafficking and metabolism. Hiochimi ca HI ll iophysica A CIa . /5():2(1).44-52.
Gandy, S.. Simon, A. .I., Steele. .I. W.. Lublin. A. L.. Lah. .I. .I.. Walker. L. c.. . . . Ehrlich.
M. E. (20 10). Days to criterion as an indicator o f toxicity assoc iated with human
ulzhcimcr amyloid-beta oligomers. Annals oiNcurologv. 68(2 ).220-230.
doi: IO. 1002/ana.22052
Goatc, A.. Chartier-Harlin. M.. Mullan. M.. Brown. 1. Craw ford , F.. Fidani, L.. . .
Hanl y. J. ( 1991). Segregation ofa missense mutation in the amylo id precursor protein
gene with familial alzhcimcr's disease. Nature. 349. 704-706.
Goedert, M.. Crowther. A. R.. & Spillant ini, M. G. (199X). Tau mutations cause
fronto tempo ral dcmcntias, Neu ro n, :!I. 955-95X.
Golde. T. E.. Petrucelli. L.. & Lewis. .I. CW I0). Targeting All and tau in alzhcimcr's
disease. an early interim report. Expcrinu -nta! Neurology . 223(2).252-26(1.doi:DOI:
10. 1016/j.expneuroI.2009.07.035
Goldgabc r, D,. Harris, H. W.. Hla, T.. Maciag. T.. Donnelly. R. J.. Jacobsen, J. S...
Gajdusck, D. C (19X9). lntcrlcuk in I regulat es synthesis of amyloid beta-prote in
precursor mRNA in human endothelial cells. Proceed ings o( II/(' National Aca dcmv o(
Scien ces oft lic United Sta tes ofAmerica , Sti( 19). 7606-76 10.
Goldstein. L.. Ashford, J. W.. Busciglio. .I.• Crutcher. K.. Gouras. G.. Kinoshita. .I.•.
Sudol. M. (2003). Live discussion. from here to there : Abctal'l' as an axonal transport
receptor-cho w could this explain neurodcgcncrat ion in AD. 15 july 2002, Journal ot '
Alzheimer's Disca sc: .fA D, 5(6). 4X3-4X9.
Gouras. G.. Xu. H.. Jovanovic , J. N.. Buxbaum. .I. D.. Wang. R.. Grccngard, 1'.• . .
Gandy. S. ( 199X). Generation and regulation ofb -amyloid peptide var iants by
neurons. Journal ofNcurochcmis uv. 7/ (5 ). 1920-1 925.
Green. R. C . Schneider. L. S.. Amato. D. A.. Bcclcn, A. 1'.. Wilcock. G.. Swabb, E. A.. .
. . Tarcnflurbi l Phasc 3 Study Group. (2009). Eff ect of tarentlurbil on cognitive
decline and activit ies of daily living in patients with mild alzhcimcr disease : A
random ized controlled trial. .lAM /I : The Journal oftlu:Am erican Med ical
Associatio n, 30](23 ). 1557-1564. doi:10.100 I/jama.1009. 11166
Greenfield. 1. 1'.• Tsai, 1.. Gouras, G. K.. Hai, 13.. Thinakara n. G.. Ched er. F.. .. Xu. H.
( 1(99) . Endoplasmic ret iculum and trans-go lgi network generate dist inct pop ulalions
o fal zhcimcr beta-am yloid pcpt idcs, Proc Nail Acad Sci USA. c)fJ. 741-747 .
Griffin. W. S.. Stanley. L. c.. Ling. c.. White. L.. Macl.cod, V.. Perrot, L. 1.. . .. Araoz,
C. (19 119). Brain intcrlcukin 1 and S- I00 immunoreact ivity are elevated in down
syndrome and alzhcirncr disease . ! ' ro cccd il/ gs ofthe National Aca clcntv ofSciences 0/
tlu: United SIlI ICS ofAmerica, SfJ( 19). 76 11-76 15.
Gu, '1'.. Oyama. F.. & Ihara. Y. (199(1). Ta u is widely expressed in rat tissues. Journal 0/
Ncu ro chcmi strv, fJ7(3 ). 1235- 114 4.
Guay. 1.. Lambert. /-I.. Gingras-Breton. G.. Lavoie. 1. N.. Hunt, 1.. & Landry. 1. ( 1997).
Regu lation o f actin filament dynamics by p311 map kinase-med iated phosphorylation
o I'heat shock protein 17. Journal ofCell Sci ence. 110 ( 1'13) (1'13 ). 357-36X.
Guscv, N. 13.. Bogatchcva, N. V.. & Marston. S. B. (1001). Structure and properties of
small heat shock proteins (sHsp) and their interaction with cytoskeleton proteins.
niochc lI/is lr F.!ho khi ll/iia. fJ7(5 ). 5 11-5 19.
Haass. c.. Hun g. A. Y .. Schloss ma c hcr , M. G .. Tc plow, D. B.. & Sc lko c, D. .I. ( 1993) .
Be ta-a mylo id pep tide and a 3-k Da fragment arc deri ved by di stinct cellular
mechanism s. ./ ltiol Chcm, 208. 302 1-3 02 4 .
Il aass. C.. Hun g, A. Y.. Sc lkoc , D. .I.• S: Tc plow, D. B. (1 994 ). Mut at ion s asso c ia ted with
a locu s fix familial a lzhc imcr's di sea se result in alternati ve proc essin g o f amy loi d
beta-prot ei n precur sor. The Jo urnal ofB iological Chcmistrv. 20 9(26 ). 1774 1-1 774 X.
Il aass. C.. Koo , E. II. . Mellon. A.. Hun g , A. Y .. & Sc lko c, D. .I. (19 92) . T arget ing of ce ll-
surface bet a- am yloid prccursorprot cin to lyso somcs: Alternati ve pro ce ssin g into
amy lo id- hear ing fragm ent s. Nature, 35 7(637X). 500 -5 03 . doi : 10 .1 03X135 750 0aO
Haass. C .. Sc h lo ssmac hcr, M. G .. Ilun g. A. Y .. Vi go-Pcl frcy, C .. Mell on . A..
Os tasz ews k i. B. L.. . . . Tc p low, D. B. (1 992) . Am yloid bet a-peptide is produced hy
c ultured cell s during normalmetahol ism . Natu re. 35 9.322-32 5.
Ham pel. H.. Shc n, Y .. Wal sh . D. M.. Ai scn , P.. Shaw. L. M.. Zetterherg . II .. .
Blcn now. K. (2 0 I0) . Biol ogi cal mar ker s of a my loid [l-r clatcd mech ani sm s in
ulzh ci mer's dise ase . Experimental NCllro{o~y. 22 3(2 ). 334-3 46. doi :DOI :
10 . 10 16lj .e xp neu roI. 2009 .()l).024
Hard y. .J..& Sc lkoc, D. .I. (200 2) . T he am yloid hypothesis o f a lzhe imer's di sea se :
Prog ress and probl em s on the ro ad to ther apeutics. Sci ence. 2 9 7. 353-356.
Hardy. J. A.. & Higgins. G. A. (1992). Alzheimer's disease: The amylo id cascade
hypothesis. Sci ence (NClI' York, N.n .156(5054) . IX4-1X5.
Hargis. M. '1'.. Storck. C. W.. Wickstrom. E.. Yakubov, L. A.. Leeper. D. 8 .. & Coss. R.
A. (2004) . IIsp27 anti-sense o ligonuc leotide s sensitize the microtu bular cytoske leto n
of chinese hamster ovary cells grown at low pH to 42 degrees Cvinduccd
reorganization . tntcrn at ional Journal oft lvp crthcrm ia : The q flicial.J olIl'llal ol
European Societyfor I Ivpcrth crm ic Oncology . North America n l Ivpcrthcrmia Gronp .
111(5), 49 1-502. doi:10.1OX010265673041000 1699 I00
Harper. J. D.. Wong. S. S.. Lieber. C. M.. & l. ansbury. 1'. T..Jr. (1999) . Assemb ly of A
beta amylo id protofibri ls: An in vitro model til!' a possible early event in alzhcimer's
disease. Biochcnti strv, 38(2X). X972-X9XO. doi: I 0. 1021ibi9904 149
Hartl. F. U. ( I(96) . Molecular chaperones in ce llular protein fo ld ing. Natur e. 381(65XJ).
57 1-579. doi:10.I OJX/J XI57I aO
Hartmann. '1'.. Bicgcr. S. C.. Bruhl. B.. T icnar i, 1'. .1..Ida. N.. Allsop. D.. .. . Unsickcr. K.
( 1997). Distinct sites of intracellular product ion for alzhcimcr's disease A beta40/42
amyloid pcptidc s. Na t Mcd, 3. 1016- 1020.
Hasegawa. M.. Smith. M. J. , & Goedert. M. ( I99X). l'au proteins with FTDI'- 17
mutatio ns have a reduced ability to promote micotub ulc assembly. FU? S Leu ..
./3 7(J ).207-21O.
Haslbcck, M. (2002). sl lsps and their role in the chaperone network . Cellular and
Molecular Uli' SciCII CCS : C \l IS 59( 10). 1649-1657.
Hc. X.. Li. F.. Chang. W. P.. & Tang. J. (2005) . GGA protei ns mediate the recycling
pathwa y ofmcmapsin 2 (BACE). ./ Biol C h ClII, 28IJ. 11696-11 7OJ.
Hendrick . J. P.. & Hat11. F. U. (199 3). Molecular chapero ne functions of heat-shock
protein s. Annual R C1'i c I I' oiBiochcmistr v . 02. 349-3X4.
doi: I0. 1I46/annurcv.hi.62.070 193.002025
Henrique s. A. G.. Vieira, S. I.. Crespo-Lo pez, M. E.. Guiornar de Oliveira. M. A.. da
Cruz c Silva. E. F.. & da Cruz c Silva. O. A. (2009) . Intracellular sAPP retention in
rcsponsctoahctaismappcdtocy!oskclcton-associatcdstruclu rcs. .lournal o]
Neuroscience Research, 8 7(6). 1449-1461 . doi : IO.I 002/jnr.2 1959
Hernandez, F.. Gome z dc Barreda . E.. Fustcr-Mata nzo. A.. Lucas. J. 1.. & Avila. J.
(2010). GSK 3: A possib le link between beta amyloid peptide and tau protein .
Experi mental Ncurolog v. 223(2).322-325. doi:10. 10 16/j.cxpncuroI.2009.()l).0 11
Heyser, C. 1.. Mas liah. E.. Samimi. A.. Campbell, I. L.. & Gold. L. II. ( 1997).
Progress ive decli ne in avo idance learning paralleled by inflam matory
ncurodcgc ncrat ion in transgeni c mice expressing intcr leukin 6 in thc brain.
Proceedi ngs oftlu: National Academy ofSciences ofthe United States otAmcricu.
9</(4). 1500- 1505.
Hickman. S. E.. Allison. E. K.. 8.:EI Khoury. J. (200X). Microglial dysfunct ion and
defecti ve beta-amyloid clearance pathwa ys in aging alzhcimcr's disease mice. Tlu:
Journal ofNeuroscience : The O/licialJollmal oft he Socictvfin Neuroscience.
.?8(33). X354-X360. doi: 10. I523/.INEUROSCI.0616- 0X.200X
II ightowcr, L. E. (1( 91). Heat shock. stress proteins. chaperones. and protcotoxicity.
Ccll. M (2). 19 1- 197.
Hiruma, H.. Katakura. T.. Takahashi. S.. Ichikawa. T.. & Kawakami. T (2003) .
Glutamate and amylo id beta-protein rapidly inhihit fast axonal transport in cultured
rat hippocampal neurons by different mechanisms. The Journal ofNeuroscience : The
OfficialJournal oft lu:Societyfor Neuroscien ce. .?3(26). X967-X977.
110. A.. & Sudhof, T. C. (2004) . Binding ofE -spondin to amyloid-beta precursor protein:
A candidate amyloid-beta precursor protein ligand that modulate s amyloid-beta
precursor protein cleavage. l 'ro« Natl Acad Sci US/I. l Ul , 254X-2553.
Holmes. c.. Bochc. D.. Wilkinson. D.. Yadc garfar. G.. Hopk ins. V.. Bayer. A. . .
NicolL J. A. (200X). The Lancet, IY(372). 216-23 .
Hutton. M.. l.end on, C. L.. Rizzu, 1'.. Baker. M.. Froelich. S.. Houldcn, H... . llcutink .
1'. ( 199X). Association ofmissense and 5'-splice site mutations in tau with the
inherited dement ia FTDI'- 17. Na ture, 3Y3(66X(1). 702-705.
lgbavb oa, .. Sun . G . Y.. Wei sman. G. A.. He. Y.. & Wood . W. G. (2009). Am yloid
beta-protein stimulates trafficki ng of cho lestero l and cav co lin- I fro m the plasma
membrane to the go lgi compl ex in mou se primary astro cytes . Neu roscienc e. !o ]( 2).
328 -338 . doi : 10. \0 16/j .ncu ro scicnce.2009.04 .049
lmb imbo , B. P.. & Pcrc tto , I. (2009). Semagacestat. a gamma-secretase inh ibitor fill ' the
potent ial treatment o fa lzhcimcr's disea se . Current Opini on ill Invest igational Drugs
(London, h"lIg !wu ! : ] ( 00). !O(7). 72 1-130.
Jancl sin s. M. C.. Mas trange lo. M. A.. Park . K. M.. Sudo l. K. L.. Nar row. W. c.. Oddo,
S.. . . . Bowers. W. .I. (2008) . AI//..l.Pathol.. ! 73. \ 768-8 2.
Jho, Y. S.. Zhulina. E. B.. Kim. M. W.. S: Pincu s. P. A. (2010). Monte carlo s imulat io ns
o f tau prote ins: Effect of phosphorylat ion. Hiophvsi cal Journal, 99(X). 238 7-23 97.
doi :IO.10 16lj.h pj.20 10.06 .056
Jin, M.. She pardso n. N.. Yan g. T.. Chen. G.. Wa lsh. D.. & Sc lkoc, D. .I. (20 11'1). So lub le
am yloid bet a-protein dimer s isol ated from a lzheimer cortex direct ly indu ce tau
hypcrphos phory lation and neuritic dege neration . Pro ceedings oft lu: Nati onal
Academv ofSciences oft lu: United Stall'S ofA merica. ! OS( \4 ). 58 19-5824.
doi : I0.1013/pnas. 10 17033 108
Jin , M.. Shepardso n. N.. Yan g. '1'. Chen. G.. Wa lsh. D.. & Sc lkoc , D. .I. (201I h). So luble
amyloid bet a-protein dimer s isolated from alzheimer cort ex direct ly induce tau
hyperph osph or ylation and neuriti c degeneration. Pro ceedings oftlu: National
Academy ofSciences oft he United Slates oiAmcrica . IOS( 14). 5X19-5X24.
doi:10. 1073/pnas.10 17033 1OX
Johnston. 1-1 .. Boutin. 1-1 •• & Allan. S. M. (201 1). Assessing the contribution of
inflammat ion in models of alzhcimcr's disease. Biochemical Socictv T ransactions.
39(4). XX6-X90. doi: I0.1042/BST0390XX6
Kuether. C.. Haass. C.. & Steiner. H. (2006). Assembly. traffick ing and function nf
gamma-sccrctasc. Ncuro-Dcgcncra tivc Diseases. 3(4-5). 275-2X3.
doi:10. I 159/000095267
Karncnct z, F.. Tomita. T.. Hsieh. II.. Seabrook. G.. Borchelt. D.. lwatsubo. T.. .
Malinow, R. (2003). API' processing and synaptic funct ion. Neur on. 3 7(6). 925-937.
Kang. J.. Lemaire. H. G.. Untcrbcck, A.. Salhaum. .I. M.. Masters. C. 1... Grzcschik. K.
11. ... Muller-Hill, B. (19X7). The precursor o f ulzhcimcr's disea se amyloid 1\4
protein resemble s a cell-surface receptor. Nature. 325(6 1(6) . 733-736.
dni:10.103X/325733aO
Kappc. G.. Franck. E.. Verschuurc. 1'.. Boelens. \Y . c.. Lcunisscn. .I. A.. & de .long. \Y.
\Y. (2003). The human genome encodes 10 alpha-crystallin-related small heat shock
proteins: HspB I-I O. Cel/ Stress eliChapero nes. S( I). 53-61.
Kar. S.. Fan. J.. Smith. M. J.. Goedert. M.. & Amos . L. A. (2003) . Rep eat motifs of tau
bind to thc ins ides ofmicrotu buics in the absence oftuxo l. Tlu: /:'M80 Jo urnal. ]]( I).
70-77 . doi : 10. 1093/cmbo jlcdgOOI
Kaw ahara . M.. & Kurod a. Y. (2000) . Molecu lar mec hanism ofncurodcgcncrat ion
induced by a lzhc imcr's beta -amyloi d protei n: Channcl forma t ion and disruption of
calcium homeo stasis , Brain Resea rch Bulletin. 53(4 ). 389-397 .
Kenned y, S. G.. Kand el, E. S.. Cross. T . K.. & Hay. N. (1999). Akt/Pro tc in kinase B
inhib its cell deat h by pre vent ing the release ofcytochro me c fi'OI11 mitochondri a.
Molecu lar and Cellular Biolog v. N(8) . 5800-5810.
King. M.. Nafar, r.. Clarke, 1.. & Mcarow , K. (2009) . T he small heat shock protein
IIsp27 protect s cortic la neurons against the toxic effec ts ofbeta-a myloid pcp t idc.
Journal ofNeurosci ence Research . do i: I0. 1002/j nr.22 145
King. G. D.. & Sco tt. T. R. (20 04 ). Adaptor protein inter act io ns: Mod ulator s of amy lo id
precursor protein metabol ism and ulzhcimcr's disea se risk"!Exp Ncurol, 185.208-2 19.
Klein . c.. Kramer . E. M.. Cardinc. A. M.. Schravcn, B.. Brandt. R.. & Trotte r, J. (200 2 ).
Process o utgro wth o fo ligodcndrocytcs is promot ed by interact ion of fyn kinase with
thc cytos kclcta l pro te in tau . The .Iournal ojNcurosci cncc : The (J{licia/Jo/ll"I/a/ oit!«:
Societyfor Neu roscience, ] ] (3).698-707.
Klein. W. L.. Krafft. G. A.. 8.:Finch. C. E. (200 I). Targeting small abcta oligorncrs: The
solution to an alzhcimcr's disease conundrum'? Trends ill Neuroscien ces. ':4(4).2 19-
224.
Klunk. W. E.. Engler. H.. Nordberg. A.. Wang. Y.. Blomqvist. G.. Holt. D. P.. .
Langstrom, B. (2004). Imaging brain amyloid in alzhcirncr's disease with pittsburgh
compound -B. Annals ofNcurologv, 55(3).306-319. doi: I0. 1002/ana.20009
Klyubin, I.. Betts. V.. Wclzcl, 1\. T.. Blcnnow, K.. Zcttcrbcrg, II.. Wallin. 1\.• . . . Rowan.
M. J. (2008) . Amyloid beta protein dimcr-containing human CSF disrupts synaptic
plastic ity: Prevention by systemic passive immunization. Tlu :Journal of
Ncuroscicn cc: Tile Oiiicial Journal otthc Societyfor Neuroscience. 18( 16).423 1-
4237. doi:10.1523/.1NEUROSCI.5161-07.2008
Knowles. R. B.. Wyart, c.. Buklyrev, S. V.. Cruz. L.. Urbane, B.. Hassclmo. M. E.. .
Hyman. B. T. (1999). Plaque-induced neurite abnormalities: Implications tor
disruption of neural network s in alzhcirncr's disease. Proceedi ngs oftlu: National
Acadcmv ofSciences oftlu: United States ofAmerica , Yti(9 ). 5274-5279 .
Koffic, R. M.. Mcycr-Luch mann, M.. Hashimoto. T.. Adams. K. W.. Mielke. M. L..
Gurcia-Alloza, M.. . .. Spires-Jones . T. L. (2009). Oligomeric amyloid beta associate s
with postsynaptic densities and correlates with excitatory synapse loss near senile
plaques. l 'rocccdin gs oft lu: National Acad emy ofSciences oft lu: United States o(
America . f()ti( IO). 4012-4017. doi:10.107J /pnas .081 1698 106
Koo, E. 1-1 .• & Squazzo. S. L. (1994) . Evidence that production and release of amyloid
beta-protei n involves the cndocyt ic pathway. Tlu:Journal o/Biological Chcm ist rv,
2t5Y(26). I73X6- 173X9.
Kudva. Y. C . I-liddinga. 1-1 . 1.. Butler. 1'. C . Mucskc, C S.. & Eberhardt, ' . L. (199 7).
Small heat shock proteins inhibit in vitro AllI-42 arny lo idogcncsis. FU/S Lett ers .
.f/(j( l ). 117-121. doi:DOI: 10.10 16/S00 14-5793(97)0 1IXO-0
Kurt. M. A.. Davies. D. C . & Kidd, M. ( 1999). Beta-amylo id immunoreactivity in
astrocytcs in alzhcimcr's disease brain biopsies: An electron microscope study.
I:~rpcrill/cl/lal Ncuro logv, 158( I ). 22 1-22X. doi:10.1006/exnr.1999 .7096
Kyriak is. J. M.. & Avruch, J. ( 1996). Sounding the alarm: Protein kinase cascades
activated by stress and inflammat ion. 711 c Journal ofBio log ica l Chcm ist rv. 2 7 / (40 ).
243 13-243 16.
LaFeria. F. M. (2002) . Calcium dyshomeost asis and intrace llular signa lling in alzheimcr's
disease. Nature Review s.Neuroscience. 3( I I). X62-X 72. doi:10.103X/nrn960
Lahiri. D. K.. & Maloney. B. (20 I0). Beyond the signaling effect role of amyloid-ss42 on
the processing of AI'1'. and its clinical implications. Exp erim ental Ncurolog v, 2.?5( I).
51-54. doi:10.10 I6Ij.expneuroI.20 I0.04.0 IX
Lam bert , H.. Charette, S. 1.. Bern ier, A. F.. Guimo nd. A.. 8: Landry. J. ( )999) . IISp n
mult imcri zati on medi ate d by phosph orylat ion- sen siti ve inte rmo lecular interac tions at
thc amino terminus. The Journ al o( !ho logiCilI Chcmistrv. 174( 14).937X-93X5.
Las hucl. H. 1\.. Hartl ey, D. M.. Balakh anch. D.. Aggarwal. A.. Tci chbcr g. S.. 8:
Ca llaway . D. J. (2002). New class of inhibito rs ofamyloid-bcta fibril form ati on.
imp lica tio ns ti ll ' the mec han ism ofpat hoge nesis in alzhci mcr 's disease , Tlu:Journal o(
ll iolog ica l Chcmistrv , 277(45). 42XX1-42X90. doi : 10.1074/jbc.M206593 200
Laza rov , 0 .. Morfin i, G . A.. l.cc, E. 13.. Fara h. M. II .. Szodorai. 1\.. DcBocr. S. R.. .
S isodia, S. S. (2005). Axo na l tra nspo rt. am ylo id prccurso r protein , kincsin- l , and thc
processing appara tus: Revisited. The Journ al otNcuroscicncc : The Of!icia l Joumal
ottlu: Societyfor Neuroscience, 25(9 ). 23 X6-2395 . doi : I0 . 1523/JN EU ROSC U OX9-
04.2005
Lee, V. M oo 8: Troj anowski . J. Q. (200I a) . Transgenic mou se mod els o l' tauo pathics:
Prospe cts for animal mod els o f pick 's disease, Ncurologv. 50( II SuppI 4 ). S26-30 .
Lee , V. M.. 8: Tro ja no wski. J. Q. (200 1b). Transgenic mo use model s o f tauo pathics:
Prospect s fo r anima l model s of pick 's disea se . Neu rology. 50 ( II SuppI 4 ). S26-30 .
l.cvrcssc . V.• Butterfield, L.. Zcntrich. E.. 8: Heasle y, L. E. (2000) . Akt negativ ely
regu lates thc d un N-tcrminal kinase pathw ay in PC 12 ce lls, Journal otNcurosci cnc»:
Research, 01(6 ). 799-XOX.
Lcvy - Lahad. E.. Wijs ma n. E. M.. Ncmc ns, E.. Ande rso n, L.. Go dda rd. K. A.. Weber . .I.
L.. ... Sc he llenbe rg, G . D. ( 1( 95). A familial alzh cim cr 's di sea se locu s o n
chro moso me I. Science. 20l)(522 6 ). 970-97:. .
Lewi s. .I.. Dick son . D. W.. Lin. W.. C hisho lm. L.. Co rra l. A.. Jone s, G.. . . McGow an. E.
(200 I) . Enhanced neurofibrillary degeneratio n in tra nsgen ic m ice ex pres sin g muta nt
tau and API' . Science. 2l)3( 1487) doi: 10. 112Mscic ncc .1058189
Lewis, S . E.. Manni on . R. .I.• Wh ite , F. A.. Coggesha ll, R. E.. Beggs, S.. Cos t iga n. M.. .
. Woolf c. .I. (1 9l)l)). A rol e till' IISI' 27 in sensory neuron surv iva l. The Journ al 0/
Ncurosci cncc: Tlu: Offi cio! JOUri/O! oft he Socictvfor Neuroscience. fl)(20) . 89 45-
8l)53 .
Li. S . F.. Wu, M. N.. Wang. X. II .. Yu an. L.. Yan g. D.. & Qi. .I. S. (20 11). Requ irement
ofa lpha 7 nicotinic acet ylcholine recept or s for amy loi d bc ta protein-indu ced
depre ss ion o fh ippoca rnpa l lou g-tcrrn potcntiation in CA I region o f rat s in vivo .
Syna pse (New York, N.n , 05( II ). 1136- 1143. do i: 10.1 00 2/sy n.209 5 1:
10. I002/syn .20951
Liang. .I. .I. (2000 ). Intc ract ion betwee n beta-amyloid and lens a lpha B-c rys ta llin. FU/S
Letters , 484(2). 98- 10 1.
Lindq uist. S. ( 1( 86 ). Th e heat -sho ck res ponse, ·IIIIII/a! Review ofHiochcmisttv. 55 . I 151 -
1191 . do i: I0 . 114Mann urcv.b i.55.070 186 .00 544 3
Lindwall, G.. & Cole. R. D. (Il)S4) . Phosphorylation affects thc ability o f tau protcinto
promote microtubule assembly. .I !No! Chern. 159(1\).5301-5305.
l.iu, Y. II.. Han. Y. L.. Song. J.. Wang. Y.. .ling. Y. Y.. Shi, Q .. . . . Dong. X. P. (20 11).
Heat shock protein 104 inhibited the tibrillization of pI'ion peptide 106-126 and
disassemb led prion peptide 106-126 fibrils in vitro. 711 e lntvrn ational Journ al of
Biochemist rv & CeI! Bio logv , doi: I0.10 l6Ij.bioceI.20 11.0 1.022
Lorenzen. A.. Samosh. J.. Vandcwark, K.. Anborgh, P. II.. Scah, c.. Magalhaes. A. C .. .
. Pasternak. S. II. (2010). Rapid and direct transport of cell surface API' to the
lysosome defines a novel selective pathway. Molecular ltrain. 3. II .
doi:I O.1 IX611756-6606-3-1 I
l.uc , L. F.. Kuo, Y. M.. Roher. A. E.. Brachova, L.. Shcn, Y.. Sue. L... . . Rogers. .I.
(Il)l)l»). Soluble amyloid beta pept ide concent ration as a predictor of synaptic change
in alzhcimcr's disease. 711e American Journal ofPatholog v. !55(3). S53-S62.
MacRae. T. II. (2000) . Structure and function of small heat shock/alpha-crystallin
proteins: Established concept s and emerging ideas. Cellular and Molecular l.ilc:
Scicn ces : CM!.S. 57(6). Sl)l)-l)13.
Magalhac s. A. C.. Silva. .I. A.. Lee. K. S.. Martins, V. R.. Prado. V. F.. Ferguson. S. S.. .
. Prado. M. A. (2002) . Endocytic intermediates involved with the intracellular
traffickin g of a fluorescent cellular prion protein. nil'Journal ofBiologica !
Clicmistrv , 1 77(36). 333 11-333 1S. doi:10. I074/jbc.M 20366 I200
Malo ney, B.. & Lahiri, D. K. (20 I I). The alzhcimcr's amyloid beta-pept ide (ahcta) hinds
a specific DNA ubcta-intcructing domain (Abc tulD) in the API'. BACE I. and APO E
promoters in a sequence-specific manner: Characterizing a new regulat ory moti f
(;CI/('. 488( 1-2). 1-12. doi:10.I OI6/j .gcnc.201 1.06.004
Maloney, M. T.. Minamidc, L. S.. Kinley. A. \Y.. Boyle, J. A.. & Bamb urg. J. R. (2005) .
Bcta-sccrctasc-c lcavcd amyloid precursor protein accumulates at act in inclusio ns
induced in neurons by stress or amyloid beta: A fccd forward mechan ism for
ulzhcimcr's disease. The Journal otNcuroscic ncc : 'I11C OI/icia!Jol/m a! oft lu:Soci i-tv
forNeuros cie nce . 25(49). II J IJ -II J 21. do i:10.1523/JN EUROSCI.371 1-05.2005
Mandc lkow, E. M.. Schweers, 0 .. Drewes, G.. Biernat . L Gustkc, N.. Tri nczck. B.. &
Mandclkow, E. ( 1996). Structure, microtubule interactions. and phosphorylat ion o f'
tau protein. Annals otthc New York Academy ofSciences, 777. 96- 106.
Marquez-Sterling, N. R.. Lo, A. Co.Sisodia, S. S.. & Koo, E. H. ( 1997). Trafficking o f'
CCIl-Surt~ICC beta-am yloid precursor protein: Evidence that a sort ing iutcrmcdiatc
parti cipates in synaptic vesicle recycl ing, The Journ al ofNeurosci ence : Tlu: Ol/icia!
Journal oltlu:Societyfor Neuroscience. ! 7( I). 140- 15 1.
Masl iuh, E.. Rockcnstc in, E.. Vcinbcrgs, I.. Sugura, Y.. Mallory. M.. Hashimoto. M.. &
Muckc, L. (200 1). Beta-amyloid pcptidcs enhance alpha-synuclcin accumulat ion and
neuronal defic its in a transgenic mouse modcl linking alzhcimcr's discasc and
parkinso n's d iseas e. Proceedings oftlu: National Acadcm v ofSciences oftlu: United
States otAmcric«. 98(2 1). 1224 5- 1225 0. do i: I0. 1073 /pnas .2 114 12.19X
Master s. C. L.. Sim ms. G.. Weinman . N. A.. Multhaup. G.. McDonald . 13. L.. &
Bcyrc uthc r, K. ( 19X5). Amy lo id plaque core pro te in in a lzhci mc r d isease and down
syndro me. Proc Natl Acad Sci US/ I. 8.7(12).4245-4249.
Ma ts ui. '1'.. lngclsson , M.. Fuku moto . I I.. Ramasam y, K.. Kowa, H.. Frosc h. M. 1'.. .
Hyman . B. T. (200 7). Express ion of AI' I' pathway mR NAs and proteins in
a lzhei mer's di sease. Bra in Research . // 01 . 116-1 23 .
doi : I0 .10 16/j .hrai nres .2007.05 .050
Matt son . M. 1'. ( 1997) . Cellu lar act ions o fheta-amyloid precurso r prot e in and its sol ub le
and fibrillogcnic deriva tives . l 'hvs iol R(,\" 77. IOX1-1132.
Mat tso n, M. 1'. (20 04 ). Pathwa ys towa rds and aw ay from a lzhe imer's di sease . Nature,
4311(7000).63 1-639 . do i: 10.103X/natu re026 2 I
Maw yer . B.. Zago , L.. Meller. E.. Bricognc, S.. Etard , 0 .. Houd e, 0 .. . . . Tzo ur io-
Ma w yer. N. (2001) . Co rt ical networks for wo rki ng memory and exec utive functio ns
sustai n the co nscious rest ing stat e in man . ltrain Research Hullcti n, 54(3). 2X7-29X.
Mel.ca n, 1', J.. Kawamat u, II.. Shari ff: S ,. Hew ett. .I..Sharma. N.. Ucdu, K... . . Hyman .
13. T. (2002) . Torsi nA and heat shock pro teins act as mol ecul ar chapero nes :
Suppress io n ofa lpha -sy nuc lc in agg rega t ion. Journal oiN curo chcmistrv, 83( 4). X4(1-
X54.
Mcarow, K. M.. Dod ge. ivI. E.. Rahimt ula. M.. S: Ycgapp an , C. (2002). St ress- media ted
sig na ling in PCI 2 cell s - the role of the sma ll heat shoc k protein. It sp 27. and akt in
pro tectin g cell s from heat stress and nerve gro wth factor withdrawal. Jou rnal ot
NCl/roc !Icmislrl'. 83(2 ). 452-462.
Moberg , P. 1.. & Bamburg. 1. R. (2000) . Increase in neurite out growth mediated by
o vc rcxprcssiou o f act in dcpol ymerizin g factor, TheJournal oiNcuroscicncc: The
Officia! Journ al oftlu:So cietyfor Neuroscience. ]1!(7 ). 2459 -2469.
Mend es. C. T .. Mu ry, F. B.. de Sa Moreira. E.. Alberto , F. L.. Fo r lenza . O. V .. Dins-Nero.
E.. & Ga llaz. W. F. (20 09 ). Lithium red uces Gs k3 h mR NA lev els : Impli cati on s fill '
alzhcimc r d ise ase. Europea n Archives ofPsychiatrv and Clinical Neuroscience.
] 5Y( 1). 16-22 . doi : 10. 1007 /s00406 -00X-OX2X-5
Me ndo za -Naranjo, A.. Go nza lez -Billa ult. c.. & Maccio ni, R. B. (200 7) . Ahcta 1-42
st imula tes ac ti n pol ymerization in hipp oc amp al neu ron s thro ug h Rac l and Cdc 42 rho
G'l'Pasc s. Journ al ofCell Sci ence, / ]1!( l't 2 ). 27 9-2XX. do i: 10 . I242 /jcs.03323
Mori , c.. Spoo ner. E. '1". . Wisnicwsk, K. E.. Wi sniewski. T . M,. Yamagu ch , II.. Sa ido, T .
c.. . . Lemere. C. A. (200 2) . lntrancuro na l Abct a4 2 acc u mulat io n in down sy nd ro me
hra in. Amyloid. Y.xX- 1m .
Morimoto. R. I.. Kline. M.P.. Bimston . D. N.. & Cotto. J. J. (199 7). The heat-shock
respo nse: Regulat ion and function ofheat-shock protei ns and molecular chaperon es.
lissays in Biochcmistrv , 32. 17-29 .
Morri s. J. c.. Heyman. A.. Mohs. R. c.. Hughes. J. 1'.. van Belle . G.. Fillenha um. G.. .
Clark. C. (1989). The consort ium to estah lish a registry for Alzheimer ' s disease
(CERAD). part I: Clinical and ncuro psycological assess ment of Alzheimer's d isease .
Neurology , 39(9 ). 1159- 1165.
Muchowsk i, 1'. 1.. & Wacker, J. L. (2005) . Modulation ol' neurodegeneration by
molecular chapero nes. Natu reReviews.Neuroscience. 0( 1). 11-22.
do i: IO.I038/nrnI58 7
Mullan. M.. Crawford, F.. Axc lman, K.. l lou ldcn, H.. Lilius. L.. Winbald. B.. & Lann fc lt ,
L. ( 1992a). A pathogenic mutation til!' probable alzhe imer's disease in the API' gene
at the Nvtcrminus of beta-a myloid. Na t G CI/c/ . /(5) . 345-347.
Mullan. M.. Craw ford, F.. Axc lman, K.. Houlden. H.. l.ilius , L.. Winblad. B.. & Lunnfclt .
L. ( 1992h). A pathogenic mutation fill ' probable alzheimer's disease in the API' gene
at the N-terminus of beta-amyloid . Nature Genet ics, /( 5). 345-347.
doi: I0. 1038/ng0892 -345
Murcsan, Z.. & Murcsan, V. (2004) . A phosphorylated. carboxy-termina l fragm ent o f
beta-amyloid prec ursor protein localizes to the splicing factor compartment. l luman
Molecu lar Geneti cs, /3 (5).475-488 . doi: I0. 1093/hmg/ddh054
Nagele. R. G.. D'Andrea. M. R.. Lee. II.. Vcnkatararnan, V.. 8.:.. Wang. II. Y. (200:1).
Astroeytes accumulate A beta 42 and give rise to astrocy tic amyloid plaques in
alzheimer disease brains. Bra in Research. 1)7/( 2) . 197-209.
I itsch, R. M.. Farber. S. A.. Growden , J. IL 8.:.. Wurtrnan. R. J. (199:1). Release of
amyloid beta-prote in precursor derivat ives by electrical depo larization of rat
hippoca mpal slices. Proceedin gs oft lu: Nationa l Academy ofSciences oftlu : United
Stat cs oiAmcrica, I)()( I I). 5191-5 19:1.
Oddo , S.. Caccamo. A.. Smith. I. F.. Green. K. N.. 8.:.. LaFeria. F. M. (2006). A dynamic
relationship betwee n intracellular and extrace llular pools ofabeta. AII/.! l 'atho l, I tiS.
11\4-194.
Ott. S.. Henkel. A. W.. Henkel. M. K.. Rcdzic. Z. B.. Kornhuhcr. L 8.:.. Wiltfang. .I.
(20 11). Pre-aggregated Abetal-42 peptide increases tau aggregation and
hypcrphosphor ylation a ller short-term application . Molecula r and Cellular
Biochcmi str v , 341)( 1-2). 169- 177. doi:10.1007/sI 1010-010-06 71-7
Ouyang. Y. B.. Xu. L. L Sun. Y. L 8.:.. Giffard, R. G. (2006) . Ovcrcxprcssion of
inducible heat shock protein 70 and its mutants in astrocytcs is associa ted with
maintenance o f mitochondr ial physiology during glucose deprivation stress . C,,1/
Stress & C!WI} cro I/CS. 11(2). IXO- I1\6.
Parccllic r, A.. Gu rbuxa ni. S.. Schmitt. E.. Solar y. E.. & Ga rrido. C. (2003). I-Ieat shock
prot ein s. cellu lar ch apero nes that modulate mitochondrial cell de ath pathways.
Biochem ical and Biophysical Resea rch Communications. 304(3) .505-51 2.
Parccll icr, A.. Schmitt. E.. G urbuxani. S.. Scigncurin-B crn y. D.. Pancc. A.. Cha ntome,
A.. . .. Garrido, C. (200 :;). IISP 27 is a ubiquitin-binding protein involved in 1-
kap paBa lpha pro tcaso rnal degradation. Mol ecular and Cellular Biologl' . .73( 16).
5790-5X02.
Parker. M. 1-1 .• Che n. R.. Conway. K. A.. Lee . D. II.. Luo , C.. Boyd . R. E.. . . Re itz. A.
B. (2 002). Synthesis of (- )-5.X-dihydroxy-3R-me thyl -2R -(dipro pylamino )-1 .2.3.4 -
tctrahydronaphth alcne: An inhibitor ofbcta-a ruyloidt 1-42) aggregation. Bioorganic &
Medicinal Chcmistrv. IO( I I l. 3565-3569.
Past ern ak. S. 1-1 .. Callahan. 1. W.. & Mahuran. D. J. (20 04). T he role of the
cndosom al/lysosornal sy stem in am yloid-beta production and the pathophysiolo gy of
a lzhc imcr's di sease : Reexamining the spat ia l paradox from a lysosomal per spective.
.Joul'lla l o/ AI::hcim Cl"sDiscasc :.JAD ,6(I).53-65 .
Perez. .I. L.. Carrero. I.. Go nza lo. P.. Areva lo-Se rra no . .I..Sanz-A nqucla. 1. M.. Ortega . .I..
. . . Gon za lo- Ruiz. A. (20 10). So luble o ligo mer ic forms ofbcta- umy loid (A I\) pept ide
stimula te AI) pro duc tion via as trog lios is in the rat brai n. I:'.rpcrimclllal Neurology.
213 (2 ). 4 10-42 1. doi :DO I: 10. 10 161j .expneuro I.2009 . 10.0 l..l
Pere z. R. G .. Squ azzo, S. L.. & Koo, E. H. ( 1996). Enhance d rele ase ofamyloid beta-
protei n from co do n 670/67 1 "swe d ish" mutant beta-am ylo id pre cu rsor prot ein occu rs
in bo th secretory and cndocytic pathways. 1111' Jo urnal ofH iological Chcmi strv,
27 ! ( 15 ). 9 100-9 107.
Perr in, V.. Rcguli cr , E.. Abbas-Tcrk i, T.. Hass ig. R.. Brou ille t, E.. Ac bischcr, 1'...
Dcg lon, N. (200 7). Nc uro protcction by Hspl 04 and Hsp 27 in lcnti viral-b ascd rat
models o fh untingto n's disease, Molecula r Thcrapy: TheJourn al oftlu:American
SocictvofGon« Thcrap», ! 5(5) . 903 -9 11. doi :10 .I03 X/mt. sj.6300141
Plumier, J. C. Hopk ins. D. A .. Robert son . H. A .. & Currie, R. W. (19 97). Constitutive
expressio n ofthe 27-k Da heat sho ck prote in (H sp 27) in se nsory and mot or neu ro ns o f
the rat nervo us sys te m, Tlu:Jo urnal ofCompara tive Ncurologv. 384(3). 409-4 2X-
P0I1e1ius. E.. Dean , R. A.. Gustavsson. M. K.. Andreassen. U.. Zc ttcr bcrg , 11.. S iemers .
E.. & Blcn now, K. (20 10a). A novel abcta isoform patte rn in CSF reflects ga mma-
sccrc tasc inhi bi tio n in a lzhci mcr disease, -ilzhcirncr's Research & Therapy . .:'(2). 7.
do i:10 . l IX6/a lzrUO
Port clius. E.. Brinkrnalm, G.. Tr an. A.. Andrcas son. U.. Zcttcrbcrg, H.. Westm an-
Brinkmalm . A... . Ohrfclt, A. (2010b) . ldcnti fication ofnovcl N- tcrln ina l li'ag mcnts
o f amy lo id precu rsor prot ein in cerebrospin al fluid. Expcrinu-ntol Neurology. 223 (2 ).
35 1-358 . do i:DOI : 10.101 6/j. cxpncu roI.2009 .06.011
Price, D. L Tanzi. R. E.. Borchelt. D. R.. & Sisodia. S. S. ( 199X). Alzheimer's disea se:
Genet ic studies and transgen ic models. A I/I///a/ ReviewofGeneti c s. 3.7.46 1-49-'.
doi:10.1 I46/annurc v.gcncU2.1.46!
Priller, C.; Bauer, '1'. Mittcrcggcr. G.. Krebs, B.. Kretzschmar, H. A.. & l lcrrns. .I. (200(l).
Synapse format ion and function is modulated by the amyloid precursor protein. Tlu:
Journal ofNeuroscience : 711 c qf/icia/.!o//ma/ oft h« Societyfor Neuros cience.
.70(27). 72 12-722 1. doi: I0.152.1/.INEUROSC I.1450-06.2006
Qiu, W. Q.. Walsh. D. M.. Yc, Z.. Vckrcllis, K.. Zhang. L Podlisny, M. IL . . , Sclkoc,
D. .I. (199X). Insulin-degrading enzyme regulates extracellular levels of amyloid beta-
protein by degradation , 711c Journal o/ B i%gim/ Chcmis trv. .773(49). -'27-'O--'27-'X.
Qucrfurth . H. W.. Wijsman, E. M.. St George-Hyslop, P. H.. & Sclkoc. 0 . .1. ( 1995). Bcta
API' mRNA transcription is increased in cultured fibroblasts from the familial
alzhcimcr's discasc-l family, Molecular Brain Research. .78(2). -' 19--'-'7.
Read, D. E.. & Gorman. A. M. (2009a). Hcat shock protein 27 in neuronal survival and
neurite growth. Biochemical and Biophysi cal Research Conununications . 38.7. 6-X.
Read, D. E.. & Gorman. i\. M. (2009b). Heat shock protein 27 in neuronal surviva l and
neurite outgrowth. Hiochcmical and Biophysicat Research Connnunica tions. 38.7( I).
6-X. doi: I0. 10 16/j.bbrc.2009.02. 114
Reinh ard . c.. Heb ert , S. S.. & De Stroo pcr, B. (2005). T he am yloid -bet a pre cur sor
protein: Integrat ing structure with bio logic al function. The /:"M80 Journal. ':-1(2.\ ).
3996-4006. doi : I0 . 1038 /sj .e mboj .7600860
Rck as, 1\. . Adda . C. G.. Andrew Aquilina. J .. Barnham. K. J.. Sunde. M.. Galat is, D.. _
Carver. J . A. (2 00 4 ). Intera ction o f the molecular chapero ne alph aB- cr ystali in w ith
a lpha -sy nuc lc in: Effects on amy loid fibril format ion and chaperone activity . Jo urnal
o(Molecular Biolog y. 340(5) . 1167-118 3. doi : 10. 101 6/j .jmb. 2004 .0 5.054
Rcnkawck , K.. Steg e. G. 1.. S: Bosm an. G. .I. ( 1999) . Deme ntia. g lios is and expression of
the small heat sho ck proteins hsp 27 and a lpha B-cr ystallin in park inson' s di sease ,
Ncu rorcpo rt. J()( II ).2273-227 6.
Rcn kawc k. K.. V00l1er. C. E.. Bosman . G _J.. van Workum, F. P.. & de Jon g. \V. \V.
(1 994) . Express io n of a lpha B-c rystallin in a lzhcimer's di sea se . I/e/a
Ncuro pathologica. 8 7(2). 155-1 60.
Rcv csz. '1'.. Holt on . J_ L . S: Lashl ey. T . (2002) . Spo radic and familial cere bra l amy loid
angio pathies. Brain Pathology . ' ':( 3 ). 343-3 57. doi: I0 _1111/j . 1750-
3639 .2002.th0 0449.x.P M ID 1214 680 3
Roga lla. '1'_. Ehrnspcrgcr, M.• Preville, X., Kotl yarov, 1\.. Lutsch , G.. Duca ssc , C., .
Ga es te l. M. ( 1(9 9) . Regulation of I-Isp2 7 o ligo merizat ion. chapero ne fun ct ion. and
prot ecti ve acti vit y ag ai ns t o xidat ive stress /tumor necro sis factor a lpha by
phosph orylat ion. 1111'Journ al ofBiological Chcni istrv. ': 74(27 ). 18947- 18956 .
Rou se. .I.. Cohen. P.. Tri gon . S .. Morangc , M.. Alonso -L lamuzarc s. A.. Zama nillo . D.. .
Ncbrcda, A. R. ( 1( 94 ). A no vel kin ase cascade triggered by stress and heat shock tha t
st imulates MAPK AP kinasc-Z and phosph orylat ion of the sma ll heat shock prote ins.
e-n. 78(6). 1027-1 03 7.
Sa bo , S. L.. lkin, A. F.. Buxb aum . .I. D.. & Grccnga rd. P. (2003 ). Th e amy loi d prec ursor
prot ein and its regu lat o ry protein , FE65 . in gro wth co nes and sy na pses in vitro and in
vivo . The Jour nal oiNcuroscicncc : Tlu: Officia/ Journal oft he Soci ctvfor
Neuroscience. 23( 13). 5407-54 15.
Sama li. A.. Robert so n. .I. D.. Pete rson , E.. Manc ro , F.. van Zcij l. L.. Pau l. C.. .
Orrc nius . S. (20 01) . Hsp27 prot ects mitocho ndri a of thc rmo to lcrant cel ls aga ins t
ap opt ot ic st im uli. Cell Stress & Chaperon es. Il( I) . 49-5S.
Sa nta rc lla. R. A.. Ski niot is. G .. Go ldie. K. N.. Ti ttmann, 1'.. G ross . H.. Mandclk ow. E.
M.. . . Hoc ngcr, A. (200 4) . Surface-deco rat io n ofmicro tu hulcs by hu man tau.
Journal ofMo lecu lar Biolog », 33 9(3 ). 539-55 3. do i: I0 . 10 16lj. jmb.200..Ul 4.00S
Sarto. c.. Binz. P. A.. & Mocarcll i, 1'. (2000). Hcat shoc k prot eins in hu man ca nce r.
Elcctro pltorcsi s, 2 / (6 ). 12I S-I 22 6. do i:2-H
Sast rc, M.. & Gentlema n, S. M, (2 0 10). NSAIDs : How they wo rk and their pro spect s as
therapeut ics in a lzhc imcr's d isca sc . Frontiers i l/ilg il/g Neurosci ence. 2.20.
do i: I0 .33S 9/ tilagi.2 0 I0.00020
Schaffer. B. A.. Bertram. L.. Miller, B. L.. Mullin. K.. Weintraub, S.. Johnson. N.. .
Gcschwind, D. H. (200X). Association ofGSK3B with alzhcimcr disease and
fron tot empo ra l dementia. Archives o(Ncur%g.l'. o5( 10). 136X-1374.
doi: I0. 100 1larchncur.65.10.136X
Schcuncr, D.. Eckman. C.. Jensen, M.. Song. X.. Citron. M.. Suzuki. N.. . . Kukull, W.
(1996) . Secreted amylo id beta-protein similar to that in the senile plaqu es or
alzhcimcr's disease is increased in vivo by the prescnilin I and 2 and API' mutat ions
linked to familial alzhcimcr's disease, Nat Mcd. 2. XM-X70.
Schcuncr, D.. Eckman. c.. Jen sen. M.. Song. X.. Citron. M.. Suzuki. N.. . . Younkin. S.
( 1996). Secreted amylo id bet a-p rotein similar to that in the senile plaque s or
alzhcimcr's disease is increa sed in vivo by the prcscnilin I and 2 and API' mutat ions
linked to familial alzhcimcr's disease. Nat ure Mcdicin«, 2(X). XM-X70.
Schrader- Fischer. G.. & Paganctti. P. A. (I (9 6). Effect of alkalizing agcnts on the
pro ce ssin g o ft he bet a-am yloid precurso r protein. Brain Research. 7/ o( 1-2). 91-100 .
do i: I0.10 16/0006-X993(96)00002-9
Sclkoc, D. J. (2006a). Amylo id bet a- pep tide is produ ced by cultured ce lls during normal
met abo lism: A re pr ise . .Iourna! ofA lzhcinu-r's Discasc: Jnl) , 9(3 Suppl), 163-16X.
Sclkoc, D. J. (2006 b). T he ups and downs or abcta. Nature Medicine, /2(7) . 75X-9;
discussion 759. doi:10.103X/nm0706-75X
Sclkoc, D. J. CW(7). Developing prevent ive therapies fix chronic discascs: Lcssons
learned from alzhcimcr's discasc. Nutri tion Revi ews. o5( 12 I't 2). S239-43.
Sclkoc, D. .I. (2001\). Soluble oligorncrs ofthc amyloid beta-protein impair synaptic
plasticity and behavior, Bchavioura! Brain Research. /CJ](I). 106-113.
doi: I 0. 10 l6Ij.hhr.2001\.ll2.0 16
Sc lkoc , D. J. (20 11). Rcsolving co ntroversies on thc path to alzhcimcr's thcrapcut ics.
Nature Medi cine, 17(9) . 1060-1065. doi: I0.1031\/nm.2460; 10.1031\/nm.2460
Sclkoc, D. J.. Yamazaki. T.. Citron. M.. I'odlisny. M. 13.. Koo, E. II.. Tcplow, D. 13.. &
Haass. C. ( 1996). The role of API' processing and traffick ing pathways in the
formation of amyloid beta-protein, Annals oft he New York Aca demy ofSciences. 777.
57-64.
Seubert, 1'.• Vigo-Pclfrc y, c.. Esch, F.. l.cc, M.. Dovey, II.. Davis. D.. . . . Swindlehurst,
C. ( 1992). Isolation and quantif ication of solublc alzhcimcr's beta-peptid e from
biologica l fluids. Nature. .l5CJ. 325-327.
Shankar. G. M.. Bloodgood. B. L.. Townsend, M.. Walsh. D. M.. Selkoc. D. J.. &
Sabatini. B. L. (2007). Natural oligorncrs of thc alzhcimcr amylo id-beta protcin
induce reversible synapse loss by modulating an NMDA-typc glutamatc receptor-
dependent signaling pathway. 111(' Journal ofNeuroscience : Tlu: ()!licial .lo ul'11a l o(
tlu: Societyfor Neuroscience. .?7(11). 21\66-21\75. doi:10.1523/.1 EUROSCI.4970-
06.2007
Shankar. G. M.. Li, S.. Mehta, T. II.. Garcia-Munoz, A.. Shepardson. N. E.. Smith. I...
Sclkoc, D. J. (200X). Amyloid-beta protein dimcrs isolated directly fro m ulzhcimcr's
brains impair synaptic plasticity and memor y. Na ture M ed icine. 14( X). X37-X42.
doi :10. I03X/nm I7X2
Shennan. M. Y.. 8: Goldberg. A. L. (200 1). Cellular de fenses aga inst unfolded prote ins:
A cell biologist thinks about ncurodcgcnerati vc diseases. Neuron. 19( I). 15-32.
Shih. I.. 8: Wang. T. L. (2007). Notch signaling. gamma-sccrctasc inhibitors. and cancer
thera py. Cancer Research, 07(5). IX79- 1XX2. doi: I0. 115XI000X-5472.CAN-0(1-395X
Shimura , II.. Miura-Shim ura, Y.. 8: Kosik. K. S. (2004) . Binding o fta u to heat shock
protein 27 leads to decre ased concentration o f hyper phosphorylated tau and enhanced
ce ll survival. 'I1/C Journal ofH iologica t Chcmis trv, 17Y( 17). 17957- 17962.
doi : I0. 1074/jbc.M40035 1200
Shinohara. II.. Inaguma. Y.. Goto, S.. lnagaki, T.. 8: Kato. K. ( 1993). Alpha B crysta llin
and HSP2Xarc enhanced in the cerebral corte x o f patients withal zhc imcr 'sdiscasc.
Journal oft lu: Neurolo gica l S Ci CII CCS, 1!Y(2) . 203-20X.
Sinha. S.. 8: Licbcrburg. I. ( 1999). Cellular mec hanisms ofhcta-a rnyloid production and
secretion, Proceed ings ofthe National Academy ofSciences oft lu: United States o]
America. 90(20). 11049-11053.
Sisodia. S. S. (1992). Beta-amyloid precursor protein cleavage by a membrane-bound
protease, Proc Nat! Acad Sci US/I. 89. 6075-6079.
Sisod ia. S. S.. Koo. E. II.. Hoffman, 1'. N.. Perry . G.. & Price, D. L. (1993). Identification
and transport off ull-length amyloid precursor proteins in rat peripheral nervous
system. The .Iournal oiNcuroscicn cc : Tlu: Officia/./ouma/ ofth» So cicty ./iJl"
Neu rosci ence, /3( 7).3 136-3 142.
Small, S. A., & Gandy, S. (2006) . Sorting through thc cell biology ofalzhcimcr 's disease:
lntraccllular pathways to pathogenesis. .I.Ncuron. 52. 15-31.
Small. D. H.. Clarris, H. L.. Williamson. T. G.. Reed. G.. Key, B.. Mok, S. S.. ..
Nurco rnbc, V. (1999). euritc-o utgrowth regulating functions oft he amyloid protein
precursor ofa lzhcimcr's disease. Journal otA lzhcimcr's Disease . .IAIJ . / (4-5). 275-
2X5.
Smits. H. A.. van Bcclcn. A. J.. de Vos. . M.. Rij smus. A.. van dcr Bruggcn, '1'..
Verhoef J.. . otter. H. S. (200 1). Activation o fh uman macrophagcs by amyloid-
hcta is attc nuatcd by astrocytcs. Jou rnal O( / III IIIU IIO/o g.l' (Baltimo re. Md. : /95(1).
/ titl(1 I). 6X69-6X76.
Song, C; Pcridcs, G., Wang. D., & Liu, Y. F. (2002). Beta-amyloid peptide induces
formation of actin stress fibers through p3Xmitogen-activated protein kinase. Journ al
ofNcu rochcmistrv. 83(4). X2X-X36.
Soscia, S. 1.. Kirby, J. E.. Washicosky, K. J.. Tucker. S. M.. lngclsson, M.. Hyman, B.. .
. Moir, R. D. (20 I0). The ulzhcimcr's disease-associated amylo id beta-protein is an
antimicrobial peptide . P!oS 011 1'. 5(3). e9505. doi: I0.137 l/journal.ponc.(1009 505
Spillantini, M. G.. Crowther, R. A.. Karnphorst. W.. l lcutink. 1'.. 8.:van Swictcn. J. C.
( 1998). Tau pathology in two dutch families with mutations in thc microtubule-
binding regio n of tau. 71/('Ameri can Journal ofPathologv. !53(5). 1359-1363.
doi : IO. I0 16/S0002-944 0( 10)65721-5
Spillantini, M. G.. & Goedert , M. (2000) . Thc alpha-synuclcinopathics: Parkinson' s
disease, dement ia with lcwy bodies, and multiple system atrophy. -inna!s (!( I!/(' NCI I'
York Academy oiScicnccs. 9] (). 16-27.
Spillant ini, M. G.. Murrell. J. R.. Goedert, M.. Farlow. M. R.. Klug, A.. 8.:Ghctt i, B.
(1998). Mutation in thc tau gene in familial multipl e system tauopath y with presenile
dementi a. Proceedin gs oitlu: National Acadcmv O( S ciCII CCS oft lu: United States (I{
America. 95( 13). 7737-774 1.
Spurns. 0 .. Honey. C. 1..& Kotter, R. (200 7). ldcnti ficat ion and classification of huhs in
brai n networ ks. P!oS 0 111'. ] ( 10). c I049. doi: I0.137 1/journal.ponc.OOOI049
Spurns, 0 ., & Kotter. R. (2004) . Moti fs in brain network s, PI.oS Bio!ogy. ] ( II) . c36 l ) ,
doi : IO. 137 1/journal.phio.00203(19
Spor ns, 0 .. Ton on i, G .. & Edelma n. G . M. (2000). Co nnec tiv ity and complexity: The
relat ionship bet ween neuroa nato my and brain dynamic s. Neura l Networks : 71/c
(~flicial .foumal ofthe Internat ional Neural Network Society. 13( X-9). 909- 922.
Stc inhi lb. M. L.. T urner, R. S.. & Gau l. J. R. (200 1). The protease inhibit o r. MG IJ 2.
block s maturation ofthe amy loid precursor protein swedis h mutant pre ventin g
c leavage by bct a-sccrct asc , 71/c Journal ofBio log ical Chcmi strv. ': 7n(6) . 44 76-44 X4.
do i: I0.1074/jkMOOX793 200
Stc inhilb, M. L.. Turner, R. S.. & GauL.I. R. (2002) . ELIS A ana lysis of'beta-sccrctasc
c leavag e ofthe swed ish am yloid precu rsor protein in the secretory and cndocytic
pathw ays. Journ al ofNcurocl u-mistrv. 8IJ(6 ). 1019-102X.
Stetler, R. A.. Gao . Y.. Sig nore, A. 1'.. Cao . G.. & Chen, J. (2009 ). HSI' 27: Mech ani sm s
ofcellular protect ion again st neu ron al injury. CUrrCl/I Molecular Mcdicin«. 9(7). X63-
Xn.
Sullivan. C. 1'.. Jay . A. G.. Sta ck. E. C.. Pakaluk . M.. Wadliu gc r, E.. Fine. R. E.. .
Mor in. 1'. J. (2011) . Rctromcr disrupti on prom ote s umy loidog cnic API' proce ssin g.
Ncuroh iology ofD isease, 43(2 ). 33X-345 . doi : I0. 10 l6Ij.nbd .20 11.04 .002
Suzuk i. T ., & Naka ya, T . (200X). Regula tion ofamyloid beta-protein precursor by
pho sphorylation and protein interacti ons. The Jou rnal ()j'Niological Chcmi strv ,
':83( 44 ). 29633 -2963 7. doi :10.1074/jkRX00003200
Sweeney. !'. .I.. Darker. J. G.. Neville. W. A.. Humphrie s. J.• & Camilleri. P, (llJlJ:» .
Electrophoretic techniques till ' the analysis of synthetic amylo id h-A4-re lated
pcptidcs. Analytica l Hiochcmistrv , 1 /1. 17lJ- IX4.
Szekel y. C. A.. & Zandi. !'. 1'. (20 I0). Non-stero idal anti-in flammatory drugs and
alzheime r's disease : The epidemiological evide nce. eNS & Ncurol ogica! lrisordcr»
IJl'lIg Target s. Y(2). 1:>2-I :>lJ.
Taba ton, M.. Zhu, X.. Perry. Goo Smith . M. A.. & Gilibcrto , L. (20 10). Signaling effect or
amyloid-heta(42 ) on the processing of Aheta!'P . /:\ p l'I' i lll cl/ la l Neuro logy. 11 / ( I ). IX-
25. doi: I0. 10 16/j.expneuroI. 200lJ.OlJ.002
Tanzi. R. Eoo Gusclla. .I. Foo Watkins. P. c.. Bruns. G. A.. St George -Hyslop. 1'.. Van
Kcurcn. M. 1.. .. Neve. R. L. ( llJX7). Amyloid beta protein gene: CONA. mRNA
distribution, and genetic linkage ncar the alzhei mer locus. Sci ence. 135(4 7lJI) . XXO-
XX4.
Tanzi. R. E.. & Bertram . L. (200 1). New frontiers in alzhcimcr 's disea se genetics.
Neuro n, 31(2) . IXI- IX4.
Tanzi. R. E.. McClatchey. A. I.. Lampcrti, E. 0 .. Villa-Kornnroff L.. Gusclla. .I. Foo &
Neve. R. I.. ( llJXX) . Protease inhibitor domain encod ed by an amylo id protein
precursor mRNA assoc iated with alzhcimer's disease. Na ture, 33 / (( 156). 52X-5:>O.
doi :10.I<UXn:> 152XaO
Ta nz i. R. E.. Moir. R. D.. & Wagner . S. L. (200 4). C learance o la lzhc imcr's abeta
peptide : The man y roads to perd ition . Neuron. 43(S). 60S -608 .
doi :10.10 16/j.neuro n.2004.08 .024
Tarr. P. E.. Roncarat i, R.. Pcl icci, G.. Pcl icci, P. G.. & D'Adam io, L. (2002) . Tyrosi ne
phosphor ylat ion of the beta-am yloid precur sor prote in cyto plasm ic tail promotes
interact ion w ith she. 'I11CJournal ofBiologica ! Chcmistrv. ] 77( 19). 16798-16804 .
doi : 10.1074/jb e.M 1102 86 200
Ta ru, II .. lij ima, K.. Hasc, M.. Kirino , Y.. Yagi. Y.• & Suzuki. T . (200 2) . Interactio n of
alzhc imcr's beta -amylo id precur sor famil y protein s with sca ffo ld protein s of the .INK
signa ling casca de . 'I1w Journal ofB iological Chcmistrv, ] 77(22 ). 20070-2007 8.
doi: 10.1074/jbc .M 108372200
Ta sh iro . K.. Hasegaw a. M.. lhara . Y.. & lwatsub o, T . ( 1997). So matodcndri tic
loca liza tio n o f phosph or ylated tau in neonata l and adult rat cer ebra l co rtex.
Ncurorcport, 8( 12).2797-280 1.
Tay lor. A. R.. Robin son . M. 13.. Gilo ndo rwa . D. J.. Tyrell, M.. & Milli gan. C. E. (2007).
Regul ation o f heat shoc k protein 70 relea se in as trocytcs: Role o f s igna ling kinascs.
Dcvcl oprncntal Ncuro bio logv. (j 7( 13). 18IS- 1829. doi : IO. I00 2/dneu .20SS9
T her iault. .I. R.. Lambert . H.. Chavez-Zobe l. A. '1'.. Charest. G .. Lavigne. P.. & Landr y. .I.
(200 4 ). Essential role of the NlI2- termina l WD/EPF moti fin the pho sphor ylation -
activa ted pro tecti ve function of mammalian Hsp27. TheJournal otBiotogi ca!
Chcmi strv, 1 7Y(22). 23463-2347 1. doi: I0.1074/jhc.M402325200
Thi na kara n. G .. & Koo, E. H. (200X).Amyloid precurso r protein traffick ing. processing,
and fun ctio n. TheJournal ofHio tog ical Chcmis trv. 183(44). 2CJ6 15-2CJ6 1CJ.
do i: I0. 1074/jhc.RXOOOICJ200
Thinakuran. G.. Tcplow, D. B.. Siman, R.. Greenberg, B.. S: Sisodia, S. S. (I CJ9(J ).
Metabolism o ft he "swedish" amyloid precursor protein variant in ncuroZa (N2a)
ce lls. ev ide nce that c leavag e at the "bct a-sccrcta sc '' si te occurs in the golgi apparatus.
Thl' Journal ofBio log ica! Chcn iistrv. 1 7! (16). CJ3CJO-CJ 3CJ 7.
Tic ha ucr .T .. Saud. K.. & von Bcrnha rd i. R. (2007). Modulation by as trocyt cs of
microglial cell-mediated ncuroinflammation: Effect on the activat ion of microg lial
signaling pathways. Ncuroi nnnunomo dulation. ! -/(3-4). l6X- 174.
doi:IO.115CJ/OOOI10642
Turner. A. J.• Isaac. R. E.. & Coa tes , D. (20(l!) . T he ncpril ys in (NEI') fam ily of zinc
mctal loc ndo pc ptida scs: Gcno rn ics and function . Biolissa vs : New s and Reviews in
Molecular, Cel lular and f) l'\'('!o{illll'l/ta! 8i o!og,r. 13( 3). 26 1-26CJ. doi:2-K
T urner, 1'. R., O'Connor. K.. Tate. W. 1'.• & Abraham. W. C. (2003). Ro les of amyloid
precursor protein and its fragments in regulating neural activity. plasticity and
memo ry . Progress in Ncuro hio logv, 7{)( I ). 1-32.
Van Mo nt fort. R.. Slingshy. C. & Vierling. E. (200 1). Structure and funct ion of thc small
heat shock protein/alpha-crystallin family of molecular chaperones Advan ces ill
Protein Chcmistrv. 5Y. 105-156.
Vargas-Roig. L. M.. Fanel li. M. A.. Lopez. L. A.. Gago, F. E.. Tello, 0 .. Aznar. .I. C . &
Ciocca . D. R. (1997a). Heat shock proteins and cell proliferation in human breast
cancer biopsy samples . Cancer Detecti on and Prevention. 1 1(5 ). 44 1-45 1.
Vargas- Roig, L. M.. Fanelli. M. A.. Lopcz. L. A.. Gago, F. E.. Te llo, 0 .. Aznar. .I. C . &
Ciocca. D. R. (1997h). ll cat shock protei ns and ce ll proliferation in human bre as t
cancer biopsy samples. Cance r Detecti on and Prevention. 1 1(5). 44 1-45 1.
Vassar. R.. Bennett, 13. D.. Babu-Khan, S.. Kahn. S.. Mcndiaz, E. A.. Denis, 1'.. .
Locloff R. (1999). Bcta-sccrct asc cleavage ofalzhc imcr's amyloid prccursor protein
hy the transm em b ran e aspartic prote ase BACl:. Science, 18(j. 735-74 1.
Vc krc llis. K.. Yc, Z .. Q iu. W. Q .. Wa lsh . D.. Hartl ey. D.. Chcsn ca u, V.. . . Sc lko c. D. .I.
(2000) . Ne uro ns reg ulate extra cel lular level s ofamy loid beta -pro tei n via prote ol ys is
hy insulin-degrading enzyme. 711e .!II III'I/al ofNeuroscience : 7'lICO!licial .!II/ll'I/ al II(
thcSocictyjorNcuroscicncc. 1(}(5). 1657-1665.
Vingtdcux. V.. Harndanc, M.. Loycns, A.. Gclc, 1'.. Drobcck. H.. Bogard. S.. .
Sergeant, N. (2007). Alkalizing drugs indu ce accumulation ofamyloid precursor
pro tein by-products in luminal ves icles ofmultivcsicular bodie s, TheJournal IIf
Biolog ica! Chcm istrv, 181(25 ). IXI97-1X205. doi:10.1074/jhc.M609475200
Vlcm inckx . V.. Van Dammc, P.. Goffin. K.. Dc lyc , II.. Van Dcn Bosch . L.. &
Rob bcr ccht , W. (2 002). Upregulat ion o f HS P27 in a tran sgenic model o fA LS.
Journal ofNcuropatholog v and Exp erimental Neurology. ti/( II). 96 X-974 .
vo n Bergen . M.. Ba rghorn, S .. Biernat . .I.. Mandclkow. E. M.. & Mandclkow, E. (2005).
Ta u agg rega t io n is driven by a tran sition from random co il to beta she et structure.
Bioch imi ca 1:'( lt ioph vsi ca I ICla . 173 1)(2-3). 15X-166.
doi :IO . IOI6 /j .bba d is.2004.09 .0 10
vo n Bergen , M.• Barg hor n, S.• l. i, L.. Marx. A.. Biern at, .I.. Mandclko w, E. M.. &
Mundclkow, E. (200 1). Mutation s o f ta u prot ein in fronto temporal dem ent ia promote
aggre gation of pai rcd helica l filaments by enh ancin g loca l beta -structure, TheJournal
ofB iological Chemistry. 2 7n(5 1). 4X165-4X174 . doi : I0 .1074/jbc .M 105 196200
vo n Bergen . M.. Li, L.. & Mand c lkow , E. (2005). Intrin s ic fluorescent det ect ion o f tau
conform ation and aggregation. Mc(hods ill Mol ecula r Hiology (C/{/ iOIl, N..J.). ]1)1).
175-1 84 .
vo n Bcrnh ardi , R.. & Eugcnin. .I. (200 4) . Microglia l react ivity to beta -am yloid is
modu lated by astrocytcs and proinflammatory factors, ltrain Research. I (J25( 1-2).
186- 193. do i: I0.1 0 16/j .b ra inrcs, 2004.07.0X4
Wa lsh. D. M.. Klyub in, I.. Fadccva . .I. V.. C ullen, W. K.. An wyl. R.. Wo l fe, M. S.. .
Sc lkoc, D. .I. (200 2) . Natura lly secreted oligomcrs of amyloid beta prot e in po tentl y
inh ibit hippocampa l lo ng-term potentiation in vivo . Nature. .JIn. 535-539 .
Walsh. D. M.. Klyub in, I.. Fadccva. .I. V.. Rowan. M. .I.. 8: Sclkoc, D. .I. (2002 ).
Amyloid-beta oligomcrs: Their production, toxicity and therapeutic inhibition.
Hioch cmical So ciety Tran sa ct ions. 30(4).552-557. doi: I0. 1042/
Walsh. D. M.. 8: Sclkoc, D. J. (2004). Oligorncrs on the hrain: The emerging role o f
soluble protein aggregates in ncurodcgcncration, Prot ein and Peptide Letters. 11(:1).
21:1-228 .
Walter. S.• 8: Buchner. J. (2002). Molecular chaperon es--eellular machines for protein
folding, Angcwand t«: Chemic (lnrcrna tional Ed.in Engtish], 4 1(7 ). 1098-IIU .
Wang. R.• Sweeney. D.. Gandy. S. E.. 8: Sisodial. S. S. (1996) . The profile of so luble
amyloid b protein in cultures cell media. 111e Jou rnal ofB iological Chcmistrv.
27 / (50 ). :11894-:11902 .
Waudby. C. A.. Knowles, T. P.. Devlin. G. L.. Skcppcr. .I. N.. Ecroyd. II.. Carver. .I. A.. .
. . Meehan. S. (20 10). The interaction ofa lphaB-crystallin with mature alpha-
synuelei n amyloid fibrils inhibits their elongatio n. lt iophvs ica! Journal . Y8(5).84:1-
851. doi:10.10 16/j.hpj.2009.10.056
Weideman n. A.. Paliga. K.. Durrwang, U.. Czech. C.. Evin, G.. Masters. C. L.. 8:
Bcyrcuthcr, K. ( 1997). Formation of stable comp lexes between two alzheimer's
disease gene products: Prescnilin-2 and beta-amyloid precursor protein. Nat Mee/..
3(:1).:128-:1:12.
W ilcock . D. M.. Mor gan . D.. Gordon. M. N.. Ta ylor . T . L.. Rid nou r. L. A.. Wink . D. A..
& Co lton. C. A. (201 1). Ac tivation of ma trix mctal loprotci nascs II)llowi ng anti -abeta
imm uno thera py ; implica t ions 1111' microh cmorrh agc occ urre nce , Jour nal o]
Ncnroinflantmati on, 8. 115. doi : I0.11 86/ 1742- 2094- 8- 115
W ilhc lmu s, M. M.. Boel ens. W. C.. Otic- Ho ller. I.. Kamp s. B.. de Waal. R. M.. &
Verbeck. M. M. (2006). Sma ll hea t shock prot ein s inhihit amy lo id- beta protein
aggre gatio n and cerebro vascular amyloid-beta pro tein toxic ity. ltra in Research.
! 089( 1). 67-78. do i: 10.10 16/j .bra inrcs .2006 .03 .058
W ilhclmus. M. M.. de Waal. R. M.. & Verbeck, M. M. (200 7). Heat shock prot ei ns and
amateur ch ap erone s in am yloid -bet a acc umulat io n and c leara nce in a lzhcimcr's
dise ase . Molecul ar Neu robiology, 35 (3 ). 203-2 16.
W ilhclmus, M. M.. Otic- Ho ller. I.. Wcssel ing. 1'.. de Waa l. R. M.. Boe lens, W. c..8.:
Verbeck, M. M. (2006). Specific as soc iat ion of sma ll heat shock prote ins with the
path o logic a l hallmarks of al zhcimcr's di sease brains. Ncuropatho!ogy and /lpp!ied
Ncuro biolo gv , 3.7(2 ). 119- 130. doi :I O.IIII /j . 1365-2990.2006 .006 89.x
W ill iam s. K. L.. & Mcarow, K. M. (20 11). Pho sp hor ylation status o f heat shock protein
27 influence s neurite grow th in ad ult do rsa l root gang lio n sensory neur ons in vitr o .
Jo urnal oiNcuroscicncc Research, 8 9(8). 1160-ll n . do i: I0. 100 2/jnr. 22634:
IO.I 002 /jnr. 226 34
William s. K. L.. Rahimtula . M.. & Mcarow, K. M. (2005) . Hsp27 and axo nal growth in
adult sensory neurons in vitro . Hill e Neuro science. 0. 24. doi:10.1 186/1471-2202-6-
24
William s. K. L.. Rahimtu la. M.. & Mcarow , K. M. (2006) . Heat shock protein 27 is
involved in neurite extension and branchin g o f dorsal root ganglion neuro ns in vitro .
Journal oiNeuroscicncc Resear ch. 8.J(4). 7 16-723 . doi: I0. 10021jnr. 20983
Yamazaki. 1'.. Koo, E.. & Sclkoc, D. ( 1996). Traffic king ofcell-surface amylo id beta-
protei n precursor . II. endocytosi s. recycl ing and lysosomal targeting detected by
immuno localization . Journal ofCell Science, 1()l)(5) . 999- 1OOS.
Yang. T . T .. Hsu, C. T.. & Kuo, Y. M. (2009) . Cell-derived soluble oligomc rs o f human
amyloid-beta pcptidcs disturb cellular homeostasis and induce apoptos is in primar y
hippocampa l neurons. Journ al ofNe ural Transmission (Vienna . -tustria : fl)l)o ).
1/0( 12). 1561-1569. doi:10. 1007/s00702-009-m I 1-0
Yang. Y.. Turner . R. S.. & Gaul. .I. R. ( 1998). The chaperone l3il'/GR I'7S hinds to
amyloid precur sor protein and decreases Aheta40 and Ahcta42 secretion. The Journ al
ofHio log ica l Clicmistr v, .?73(40).25552-25555.
Yao , Z. X.. & Papadopou los. V. (2002). Function o f' hcta-amyloid in cho lesterol
transpo rt: A lead to neurotox ic ity. Tlu: FASD I Journal : O/li cial l 'uhlicatiol/ oft h«
Federation ofA merica n Societies/ill' lispcrimcnta! Hiolog..!', / o( 12). 1677- 1679.
doi:10. 10961lj .02-02S5f]e
Ye ung-Pe arse . T . L Bai. J .. Chang. R.. Zhcn g, J. Boo Lo'Turco. J. J .. 8: Sc lkoc , D. J.
(2 007). A critica l function tor beta-amyloid prec ursor protein in neu ron a l migration
revea led by in utero RNA inter feren ce , nil'Journ al ofNeuroscien ce : The OJ/icia/
Journa l otthc Societyfor Neu roscience, 17(52) . 144 59- 14469.
do i:10. 152-' /JN E ROSCI A 70 1-07.2007




